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SUMMARY
Yeast (Saccharomyces cerevisiae NCYC No.240) w ill synthesise a 
cytochrome P-450, with the characteristic spectral peak at 450 nm, in 
reduced form in complex with carbon monoxide. Thfedrug-metabolising 
enzyme, cytochrome P-450, microsomally-located in the yeast c e ll, is 
produced rapidly during early phase of growth, up to 17 hours in 1% 
and 2.5% glucose media. None is produced in 0.1% glucose medium. The 
cytochrome P-450 subsequently disappears from the yeast, while the 
appearance of cytochrome a + a^  can now be noted. Conversely, the 
cytochrome P-450 concentration parallels the growth curve in high 
glucose media (5-20%), where cytochrome a + a^  formation is repressed, 
presumably due to the low concentration of in tracellu lar cyclic AMP 
under these conditions. Maximal levels of cytochrome P-450 are observed 
therefore at the end of the growth phase (40 hrs of culture) in high 
glucose media. Rapid disappearance of the enzyme occurs after th is , as 
the level o  ^ cytochrome a + a  ^ nses with fa lling  glucose concentration 
in the media.
Yeast and derived microsomal fraction containing cytochrome P-450-, 
could achieve the 4-hydroxylation of biphenyl, using NADPH or NADH, without 
any 2-hydroxylation. The efficiency of the yeast enzyme in 4-hydroxylation 
was similar to that of the live r enzyme. The increment of drug metabolising 
activ ity  and P-450 level obtained on disruption of yeast suggests that 
yeast is as active in the undisrupted state. Of the disruption techniques 
used the Vibromill technique seems generally to give the best activ ity  
retention and P-450 content. The yeast enzyme v/as less thermostable and 
less radiation stable especially v/hen the enzymes were in the reduced form.
S. cerevisiae appears to carry out drug metabolism sim ilar to the 
hepatic enzyme system. The derived microsomal fractions from yeast can 
carry out various drug metabolism reactions. The most active reactions 
carried out by yeast cytochrome P-450/P-448 were 4-hydroxylation of 
biphenyl; N-demethylation of N-ethy1morphine and aminopyrene; 0 -demethyl- 
ation of p-nitroanisol; Ocdeethylation of coumarin; 0-deethylation of 
resorufin and hydroxylation of the carcinogen, benzo(a)pyrene...
The production of cytochrome P-450 in breviers yeast(has been 
extensively studied,and i t  was possible to solubilize cytochrome P-450 
using sodium cholate in the presence of various stab ilisers . The 
solubilised P-450 was less stable to storage and heat. Partial purification  
of the solubilised cytochrome P-450 has been achieved using gel f ilt ra t io n  
and ion exchange chromatography. The purified sample had considerably 
increased s tab ility  to storage at 4°C. The yeast cytochrome P-450 has been 
characterised as P-450/P-448 system similar to that o f the cytochrome P-450/ 
P-448 inducible in mammalian liv e r by polycyclic hydrocarbons.
The solubilised yeast and liv e r cytochrome P-450 has been successfully 
immobilised on various supports, and the immobilised preparation has been 
stabilised further, to thermal denaturation, by glutaraldehyde. We have 
demonstrated the 4-hydroxylation of biphenyl and 3-hydroxylation of benzo- 
tajpyrene with immobilised preparation of cytochrome P-450.
I t  is suggested that production of yeast on a large scale, perhaps by 
continuous fermentation, followed by disruption together with isolation of 
cytochrome P-450 in immobilised and stabilised form, would permit its  use 
in removing carcinogens and their highly reactive metabolites from food 
stuffs, such as smoked and toasted foods and some drinks. The enzyme could 
also be used to prepare useful metabolites of drug and carcinogens, which 
would otherwise have been very d iff ic u lt  and expensive to synthesise.
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CHAPTER I 
GENERAL INTRODUCTION
INTRODUCTION 
Cytochrome P-450
The cytochromes were f ir s t  discovered in bakers' yeast by Keilin 
in 1925, who called them respiratory pigments due to their presence 
in respiratory chains. Klingenberg and Garfinkel (1958) independently 
discovered P-450 as a CO binding pigment in liv e r microsomes. In it ia l 
studies on cytochrome P-450 were carried out by Omura and Sato (1962) 
who showed this cytochrome to have an absorption band, in reduced form 
bound to CO, at 450 nm. Omura and Sato (1964) la te r established the 
haemoprotein nature of the pigment, and its  relatively ready conversion 
to an inactive form of which the reduced haemoprotein-CO complex absorbed 
lig h t maximally at 420 nm (cytochrome P-420). The names cytochrome P-450 
and cytochrome P-420 were given to the active and inactive forms.
Cytochrome P-450 is based on a tetrapyrrole structure containing an iron 
atom at the centre of each porphyrin group. As such, each molecule of 
cytochrome P-450 can bind one molecule of CO, by means of its  haem moiety. 
The resulting complex gives a signal under electron spin resonance 
typical of low spin compounds.
Cytochrome P-450 is found in abundance not only in hepatic microsomes 
but also in the microsomes and mitochondria from the adrenal cortex (Omura 
et j*!, 1965). Lesser amounts are found in the kidney and intestinal mucosa. 
Yohro et aj[ (1967) have reported cytochrome P-450 from corpus luteum 
mitochondria. This haemoprotein is found in the live r microsomes from a 
variety of vertebrates, including several mammals, bird, snake, frog and 
fish . (Omura and Sato, 1965; from Rhizobiurn bacteroids, (Appleby, 1968); 
from Pseudomonas ptida (grown on camphor); Claviceps purpurea (Ambike, 
et a l , 1970), and Torulopsis (Heinz, et al_, 1970). Cytochrome P-450 was 
f ir s t  demonstrated in insects, including the housefly, by Ray (1965), and
since that time i t  has been demonstrated in a number of other insect 
species from different families, Wilkinson and Brattson (1972).
Hammond et j*]_ (1970) have reported a carotenoid hydroxylase system from 
Staphylococcus aureus. An extrapolation of this system to higher 
plants would suggest that cytochrome P-450 would be found in the leaves 
of higher plants for hydroxylated carotenoids are important constituents 
of chloroplasts. Though the hydroxylase system has been found in leaves, 
cytochrome P-450 seems absent (Markham et al_, 1972). Cytochrome P-450
i
has been detected in the microsomes of cotyledons of pea and maize seeds 
(Moore, 1967). Cytochrome P-450 has been reported also from Corrdebacterium 
species (Lebeault, et afU 1971); Candida tropical is (Carti edge et a l , 1972); 
and £ . carlsbergensis (Lindenmayer, et af[, 1964).
Tissue concentrations of cytochrome P-450
Tables I to V summarize values reported for the concentrations of 
cytochrome P-450 in various tissues. The values reported are for normal 
levels, in animals which have not been exposed to conditions which may 
influence the tissue concentrations of this enzyme, unless otherwise 
mentioned (Conney, et j*l_, 1960; Fotus ert cL(, 1969; Knoxet jH , 1956, 1965; 
ScKomke et a l , 1973). The values for certain microbial cytochrome P-450 
were determined using cultures grown with inductive agents. The determinations 
have been performed using difference spectrophotometry in the region of 450- 
490 nm of the reduced haemoprotein-CO complex, in most cases a millimolar 
extinction coefficient of 91 cnf  ^ has been used (Omura and Sato, 1964).
I t  has, however, been reported that certain (uninduced) cytochrome P-450 
may have different spectral extinction coefficients, (McIntosh et al ,^ 1973; 
Mannering, 1971; Stripp et a l, 1971).
Table I Levels of cytochrome P-450 in mitochondria
Tissue Cytochrome P-450 concentration 
(units -  see below)
Bovine adrenal cortex 0.79 -  1.5 (A) 
8.3 (B) ,
Female rat adrenal cortex 1.75 -  2.44
Bovine corpus luteum 0.17 -  0.18
Human term placenta 0.123
Human placenta (87-101 days). ND
Human fetal live r (87-101 days) 0.35
Rat testis ND
Hamster testis ND
Cat testis present
Dog testis 0.04
Pig testis 0.07
Sheep testis ND
Bovine testis ND
Human testis 0.02
The minimolar extinction coefficient used for estimation of the cytochrome 
P-450-C0 complex in a ll cases was 91 cm” ^ . The cytochrome P-450-C0 complex 
concentration is expressed as nmol/mg protein except for bovine adrenal 
cortex mitochondria (B) which is expressed as nmol/mg nitrogen. ND = not 
detected {Wickramasinghe, R.H. (1975) Enzyme, 19, 348-376).
(51
Table I I  Levels of cytochrome P-450 in steroidogenic
microsomes (Wickramasinghe, R.H. (1975): 
Enzyme, lj^, 348-376). For units, extinction, 
coefficients and abbreviations see Table I
Tissue Cytochrome P-450 concentration
Human adrenal cortex
Bovine adrenal cortex
Male horse adrenal cortex
Female sheep adrenal cortex
Female pig adrenal cortex
Male rabbit adrenal gland
Bovine corpus luteum
Bovine ovary
Pig ovary
Rabbit ovary
Human testis
Bovine testis
Sheep testis
Pig testis
Dog testis
Cat testis
Rabbit testis
Guinea-pig testis
Hamster testis
Rat testis
Mouse testis
Pheasant testi s
Frog testis
Human term placenta
Human placenta (97-101 days)
Human fetal adrenal (97-101 days)
0.24 - 0.54 
0.47 -  0^78 
0.76 
0.80 
1.14 
1.20
0.03 -  0.07 
0.05 
0.17 
0.06 
0.005
ND - 0.025 
0.06 
0.10 
0.10 
0.10 
0.040 
0.078 
0.03 
0.071 
0.24 
0.08 
0.035 
0.042 
ND 
1.42
(6 )
Table I I I Levels of cytochrome P-450 in hepatic microsomes. 
(Wickramasinghe, R.H. (1975): Enzyme, 1J3, 348-376) 
For units see Table I .
Tissue Cytochrome P-450 concentration
Human 
Bovine 
Male horse 
Female sheep 
Female pig 
Male dog 
Rabbi t  
Male rabbit 
Female rabbit 
Female guinea pig 
Male hamster 
Female hamster 
Rat
Male rat 
Female rat 
Mouse
Male mouse 
Male cat 
Goose (female)
Hen
Male carp 
Female carp
Female gibe! [Crucian carp) 
Trout
Human fetal (97 - 175 days) 
Rat fetal
0.26
0.94
0.88
0.67
0.42
0.75
1.55 
1.72
1.55 
0.79 
1.14 
0.94
0.71 -  0.92 
0.82 
0.71 
0.99 
0.61 
present 
0.18.
0.24
present
0.38
0.15
present
0.04 -  0.23
ND -  0.032
(7 )
Table IV Levels of cytochrome P-450 in other non-steroidogenic
microsomes (Wickramasinghe, R.H. (1975): Enzyme, 1_9, 348-376) 
For units and abrreviations see Table I
Tissue Cytochrome P-450 concentration
Bovine kidney cortex 
Bovine kidney medulla 
Male horse kidney cortex 
Female sheep kidney 
Female pig kidney cortex 
Male dog kidney 
Male rabbit kidney 
Female guinea pig kidney 
Male hamster kidney 
Female hamster kidney 
Female rat kidney 
Male mouse kidney 
Female sheep adrenal medulla 
Female pig adrenal medulla 
Bovine pancreas 
Female pig pancreas 
Bovine pituitary  
Calf thymus 
Female pig thyroid 
Bovine cerebellum 
Male rabbit small intestine 
Female ra t lung
trace
ND
0.05
0.06
0.18
0.17
0.16
0.14
0.14
0.14
0.07
0.06
0.55
0.61
ND
ND
0.07
ND
ND
ND
0.07 -  0.26 
present
( 8 )
Table V Levels of cytochrome P-450 in other tissues
(Wickramasinghe R.H. (1975):Enzyme, 1£, 348-376)
Tissue Cytochrome P-450 concentration
Cell cultures
Hamster fetal (microsomes) 0.008 -  0.012
Mouse fetal (microsomes) 0.012
\
Plant
E. macrocaspa (endosperm) present
Insects
Housefly eggs, purae ND
Housefly larvae present
Male housefly abdominal microsomes 0.20
Female housefly abdominal microsomes o.n
Cockroach gut and fat-body microsomes present
Microorganisms
C. tropical is (microsomes) 0.005 -  0.11
P. putida strain Cl (induced) 0.1
P. oleovorans ND
The millimolar extinction coefficient used for estimation of the cytochrome 
P-450-C0 complex was 91 cnf  ^ except in P. putida where a coefficient of 95 
was used. The cytochrome P-450 concentration is expressed as nmol/mg protein. 
ND = not detected.
(?1
Molecular Basis of Activity
The hydroxylation reactions carried out by cytochrome P-450 are 
termed mixed-function oxidations (Mason, 1957) or mono-oxygenations 
(Hauaishi, 1962). The overall reaction for the hydroxylation of a 
substrate may be represented as follows:-
R - H + 0 2 + 2 e = R -  OH + H20
' 1 
The reducing equivalents (or electrons) for this reaction are supplied
by NADH in the case of the camphor metabolizing system (Gunsalus,1968, 
1971, 1972), and NADPH for the mitochondrial hydroxylases (Omura, 1966; 
Wikramasinghe, 1972) and NADPH plus possibly NADH for hepatic microsomal 
systems (Estabrook, 1969). The system as a whole comprises the haemo­
protein (cytochrome P-450) and the NADPH-cytochrome P-450 reductase 
(G ille tte , Davies and Sasame, 1972). NADPH may, however, be the only 
source of electrons required for steroid hydroxylations by adrenal micro­
somes (Narasimhulu, 1971). The oxygen for the reaction is supplied by 
dissolved oxygen. The haemoprotein in the reduced state does, however, 
bind with CO thus lim iting the accessibility to oxygen and thereby 
inhibiting the reaction. The photochemical action spectrum of various 
hydroxylation reactions,however,: has demonstrated that lig h t can lim it  
this inhibitory effect of carbon monoxide with that of 450 nm causing 
maximum reversal,„ (Xooper et: al_, 1965). An indication of how this 
hydroxylation of certain substrates is believed to take place is given by
the simplified mechanistic-scheme shown in Figure 1. Cytochrome P-450 is 
+++shown as P-450 (the valence state of the iron of the haemoprotein is 
indicated); ‘S' is the drug substrate, and 'SO' is the hydroxylated drug 
metabolite. The flavoprotein NADPH-cytochrome c reductase is shown as 
FPi; the NADPH2~cytochrome b5 reductase is shown as FP2 , and 'x ' indicates
an unknown carrier from cytochrome or FP-j to cytochrome P-450 
(Estabrook £ t 1971).
,+++
NADPH
.++
,+++P-450
.++ NADHP450
>++
SO +
t'
Figure I Mechanism of hydroxylation of xenobiotics by cytochrome 
P-450 (Estabrook et al_, 1971).
The reduction (fdVic to ferrous) of cytochrome P-450 is believed to 
be the rate limiting step in the overall process of microsomal metabolism 
(jGigon £ t  al_, 1969; Hildebrandt et a^, 1968). I f  the binding of the drugs 
to oxidised cytochrome P450 is  to have any significance with respect to 
participation in the overall reaction, some means must be found for the
drug-cytochrome P-450 (ox) complex to become the drug-cytochrome P-450 
(red) complex. The following scheme was proposed by Imai and Sato for 
aniline hydroxylation:-
+++ +++P-450 + aniline  >(P-450 ) — aniline Type I I  binding.
,n yirn+++\ -t  Microsomes ^ n' .„ + +  -i*
CP-450 )-am line electron t r ansfer *  P~450 - * " l l ln e -
system
P-450++ -  aniline + 0^  ► (P-ASO^.O^J-aniline.
t
P-450.0  ^ - aniline  ---------------------- > P-4504++ + p-aminophenol.
+++Where P-450 -aniline and P-450.0  ^ indicate the aniline and oxygen 
are bound to a non-haem site and the haem iron of cytochrome P-450 
respectively. I t  seems likely  that often the substrate combines f ir s t  
to form a complex with the oxidised form of cytochrome P-450. This complex 
is then reduced either directly by NADPH cytochrome c reductase or 
indirectly through an unknown electron carrier. The reduced cytochrome 
P-,450 substrate complex rapidly combines with molecular oxygen to form 
an oxygen-cytochrome P-450 substrate complex which quickly decomposes to 
form the oxidised substrate and the oxidised form of the cytochrome. 
According to this view, the rate lim iting step is the reduction of the 
complex of the substrate and the oxidised cytochrome. I t  also seems lik e ly  
that under anaerobic conditions the cytochrome, catalyses the reduction 
of azo and nitro compounds, but the rate lim iting step may be either the 
reduction of the cytochrome or the transfer of electrons from the 
cytochrome to the azo and nitro substrates.
The requirement of NADPH for the oxidation of drugs and the reduction 
of cytochrome c and azo compounds such as neoprontosil and nitroso compounds 
suggests that certain parts of the microsomal electron transport system
involved in drug oxidation might also participate in the reduction reaction. 
Oxygen s lightly  impairs this and completely blocked the mitroreductase, 
whereas carbon monoxide inhibits azoreductase and nitroreductase ac tiv ities , 
whereas neither have significant effect on cytochrome c.
Many of the activities of the microsomal NADPH-dependent mixed function 
oxidases in rabbit live r are greater in the smooth surfaced than in the 
rough surfaced endoplasmic reticulum. The hydroxylation of aniline and 
N-demethylation of ethylmorphine could be correlated with increased in NADPH 
cytochrome P-450 reductase activ ity . This suggested that the rate lim iting  
step for the metabolism of ethylmorphine and aniline might be the rate of 
cytochrome P-450 reduction and not the decomposition of the oxygen P-450- 
substrate complex. These observations have Ted to the hypothesis that 
substrates are interacting with a microsomal haemoprotein (cytochrome P-450) 
forming an enzyme-substrate complex.pre-requisite to the incubation with oxygen 
during the reactions of substrate hydroxylation.
Liver microsomes incubated in buffer in the presence of aminopyrine and 
varying amounts of NADPH showed that formaldehyde production increases 
linearly for a brief period of time after which i t  terminates because of the 
expenditure of the NADPH added. I f  varying amounts of NADPH are added to the 
microsomes one observes that twice as much formaldehyde is obtained.when twice 
as much NADPH is added. NADH is relatively incompetent in supporting mixed- 
fuction oxidation reactions, but NADPH and NADH exert a greater than additive 
effect in terms of formaldehyde produced (Estabrook e t al ,^ 1969).
Remmer et al (1966) showed that the rate of aniline hydro^lation agrees 
fa ir ly  well with the content of P-450. However, comparison of the rate of 
hydroxylation with the content of P-450 present in liv e r  microsomes indicates
a lack of correlation between the two c rite ria . When the rate of drug 
metabolism does not parallel a rise in cytochrome P-450 this may possibly 
be explained by a qualitative change that occurs in the cytochrome P-450; 
the micro-environment, particularly the phospholipids may determine the 
functional nature of cytochrome P-450 even to the extent of selecting 
which substrates can reach the active s ite . The activ ity  of the 
cytochrome P-450 is not always directly proportional to the concentration 
of cytochrome P-450 in liv e r microsomes, for example the 'marked species 
(Gigon et jiT_, 1969) and sex differences (Schenkman et a]_9 1967) in the 
metabolism of drugs such as ethylmorphine cannot be attributed to the 
relatively small differences in cytochrome P-450 content, which are found 
between the various animal species and between the sexes of rats. Moreover, 
differences in the relative rates of metabolism of various drugs could 
not be due solely to differences in the P-450 content of live r microsomes.
Microsomes are known to lose some of their a b ility  to metabolise 
certain drugs when stored in the cold. This is probably due to the loss 
of the type I  binding site and may be due to fa tty  acid release from 
the phospholipid and triglycerides by endogenous lipases. Storage of 
microsomes at -5°C for seven days causes almost complete loss of type I 
binding but with l i t t l e ,  or no effect on type I I  binding (Shoeman et a l, 
1969}.
Enzymatic Functions
The substrates hydroxylated, reduced and otherwise metabolised 
(e.g. cholesterol side.chain cleavage, which is a special type of mixed- 
function oxidation) by cytochrome P-450 are very much and varied in their
chemical structure. They include drugs (G ille tte  et al_, 1969, 1972;
Kato, 1971), hydrocarbons and carcinogens (Cardini ^ t al ,^ 1970;
Gelboin, 1971; Nebert, 1970); steroid hormones (McKerris, 1968); 
pesticides (Casida, 1970; Perry, 1970; Philpot et al_, 1971 , 1972); 
fa tty  acids, (Coon et a l , 1969) and bile  acids (Boyd, 1969). Mixed- 
function oxidases concerned with cholesterol biosynthesis (Gaylor et a l,  1973) 
and steroid hormone degradation (Engel et ajU 1961; Lipset, 1971) are also 
known to occur in the liv e r. G ille tte  and others (Brodie et al_, 1971;
G ille tte  et al_, 1969) have reviewed the role of cytochrome P-450 in drug 
metabolism.
Characteristics of Various Cytochrome P-450
Hepati c Cytochrome P-450
This haemoprotein is present in hepatic smooth and rough-surfaced 
microsomes and Golgi bodies in several species (Garfinkel, 1958;
G ille tte  et al_, 1972; Ichikawa et a l , 1970). Estabrook et_ af[ (1968) 
reported that cytochrome P-450 is the major haemoprotein of the liv e r  
from weanling rats that its  concentration is about 20 times greater/g 
of liver than any of the cytochromes of the mitochondria.' By contrast* 
the adult male rat liv e r was found to contain 30-43.5 nmol/g wet weight 
of live r 0 9  wet weight of liv e r being estimated to contain 70-75 mg 
mitochondrial protein and 50-60 mg microsomal protein.(Estabrook et a l ,
1970; Schenkrnan e t a l, 1973). In isolated rat liv e r microsomes 
cytochrome P-450 was found to be 0.71 nmol/mg protein and cytochrome b^  
was 0.47 nmol/mg protein (Estabrook et a l , 1968), while a fte r induction 
with phenobarbital rat live r microsomal cytochrome P-450 increased to 
2.1 nmol/mg protein and 5^  increased much less, to 0.56 nmol/mg protein.
Wada £ t  al_., (1964) found control rat hepatic microsomal cytochrome P-450 
values of 0.92 nmol/mg protein which rose to 1.99 nmol/mg protein and 
1.21 nmol/mg protein after injection with phenobarbital (100 mg/kg body 
weight for 4 days) or 3-methylcholanthrene (4mg/kg) respectively. Rabbit 
liv e r cytochrome P-450 concentrations in smooth and rough surfaced microsomes 
and Golgi bodies are 1.59, 0.96 and 0.20 nmol/mg protein respectively 
(Ichikawa jrt al_, 1970). Inducing with phenobarbital, rabbit liv e r  microsomal 
cytochrome P-450 can be increased to 5 nmol/mg protein (Ichikawa e t a l ,
1967- Nishibayashi et 1968). On the other hand the steroid hydroxylation 
activ ity  leading to bile  salt biosynthesis, can be induced by feeding cholest- 
ryzamine rather than phenobarbital, or 3-methylcholanthrene (Nitropoulos 
et a1_, 1972; ScFiolan et a l , 1968).
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The rates of liv e r  cytochrome P-450 hydroxylation reactions can 
vary according to the substrate and the type of enzyme preparation 
used. Conversion of aniline to p-aminophenol has often been studied 
as a model activ ity . Liver microsomes from phenobarbital or 3-methyl- 
cholanthrene-pretreated rats have hydroxylase activ ities of 0.23 and 
0.15 pmol/min solubilised cytochrome P-450, respectively (Fujita e t a l ,
1971). Coon and Lu (1969) have studied extensively the hydroxylation 
of laurate to to-hydroxylaurate. Rabbit liv e r microsomes effected this 
hydroxylation at 2,800 pmol/kg protein/min. Various authors (Conney 
et a l, I960, 1967; Gelboin, 1971; G ille tte  et £ [ ,  1969; Long, 1969) 
have reviewed the hepatic microsomal P-450-dependent hydroxylases.
Cytochrome P-450 of the steroid hormone producing organs
Cytochrome P-450 has been reported to carry out steroid hydroxylation 
reactions in the adrenal cortex, corpus luteum of the ovary, testes and 
placenta (McKerns, 1968; McIntosh et jil_, 1971 , 1973; Uzgiris et al_, 1971;
Ford etjal_, 1971; Mason et al_, 1973; Meigs et aTi_, 1968; ftyan et al_, 1966) .
Tne cytochrome nas been found in both the microsomes and the mitochondria 
of these organs. These various cytochrome varieties carry out hydroxylations 
in the biosynthesis of steroid hormones, which are influenced by a variety 
of factors such as age, sex and metabolic rate of the individual (Bransome, 
1968; Ross e t al_, 1970; Salhanick et al_, 1968; Tamaoki, 1973). Bovine 
adrenal cortex mitochondria have about 15 nmol cytochrome P-450/g adrenal corte 
as calculated from the data of Mitani and Horie (1969). The rat adrenal 
cytochrome P-450 is in the range of 65-70 nmol/g adrenal gland. Following 
hypophysectomy the cytochrome P-450 content of the rat adrenal fa lls  to 
a very low level. Hov/ever, the cytochrome P-450 levels and steroid hydroxylati 
capacities can be restored on administration of ACTH (Kimura, 1969; P fe iffe r  
et 'aU 1972). In the female rats, on the other hand, administration of
synthetic androgens resulted in a marked fa ll in the level of adrenal 
mitochondrial cytochrome P-450 and the rate of corticosteroidogenesis, 
even when ACTH was used to maintain the weight of the adrenal gland 
(Brownie et a l , 1970). The d ifficu lties  in determining the content and 
function of cytochrome P-450-dependent steroid hydroxylases in endocrine 
tissues, have been discussed by various authors (Bryan et al_, 1965;
Cooper et au[, 1973; Fawcett £ t  al^ , 1969; Greep, 1971; McKerns et_ al_, 1968;
McKerns, 1969).
Adrenal cortex mitochondrial cytochrome P-450 has been found to be 
localised in the inner mitochondrial membrane and effects the 118- and 
18-hydroxylations of steroids and the transformations of cholesterol to 
pregnenolone (Greengard et al^ , 1967; Nakamura £ t  al_, 1966; Omura et a l ,
1966; Sulimovici et a][, 1969; Tanrakoki, 1973). The conversion of 
cholesterol and cholesterol sulphate to pregnenolone and pregnenolone 
sulphate respectively, by bovine adrenocortical mitochondrial enzymes have 
been reported to be 1,500-5,900 pmol/kg protein/min. The 17- and 21-
hydroxylation activ ities of the adrenal cortex appear to be located in the
smooth-surfaced microsomal fraction.
In the testis of rat and pig the cytochrome P-450 is located exclusively 
in the in te rs tit ia l cells. The cholesterol side-chain cleavage and testo­
sterone llB-hydroxylation appears to be located in the mitochondria, while 
the 7a-, 17a- and 19-hydroxylase activ ities  are located in smooth-surfaced 
microsomal fractions (Ford ^ t al_, 1971; Tamaoki, 1973). Despite the 
presence of cholesterol side-chain cleavage activ ity  in  testis mitochondria, 
the presence of cytochrome P-450 is d if f ic u lt  to demonstrate in these 
organelles in certain species. The mitochondrial steroid hydroxylation 
activ ities  of the endocrine tissues consists of the hydroxylations
relating to the conversion of cholesterol to pregnenolone and thence to 
progesterone, and 118- and 18-hydroxylations. In the adrenal cortex 
these three reactions are the main steps in the biosynthesis of the mineral- 
ocorticoids, aldosterone and 11-deoxycorticosterone. These reactions also 
d iffe r  from microsomal steroid hydroxylations in being dependent on the 
functioning of small molecular weight iron-sulphur proteins of which 
that in the adrenal cortex is termed adrenodoxin (Wikramasinghe, 1974; 
Wikramasinghe et al^ 1974). t
Progesterone is also a product of the mitochondrial steroid 
hydroxylations in the endocrine glands and is an intermediate for 
mineralocorticoid biosynthesis while having weak anti-aldosterone effects 
[G1aze e t aT, 1971). The evolutionary significance of the dependence of 
mitochondrial cytochrome P-450 on the functioning of an iron-sulphur 
protein may lie  in the mitochondrial and microsomal systems having developed 
along different lines in different prokaryotes before the formation of the 
eukaryotic ce ll. I t  is possible that eukaryotic cells formed by the 
inclusion of these organelles were better fitte d  to survive through 
possessing more control over their internal environment. I t  has also 
been envisaged that an even earlier function of cytochrome P-450 in 
chemical evolution was to "fix" atmospheric oxygen in the era before the 
organised cell had developed alternative, more complex biochemical pathways.
Insect microsomal P-450
Morello et a/[ [1971) reported the hydroxylation of naphthalene at a 
rate of 950 pmol/kg protein or 3.47 ymol/ymol cytochrome P-450/min, which 
is faster than that observed with rat liv e r microsomes. Musea domestica 
Vicina has been reported having cytochrome P-450 with the content per 
abdomen in female housefl ies [more than 24 hrs emergence from the pupa)
being considerably more than in males. The cytochrome P-450 declines 
with age after about the tenth day. I t  was also found that the 
cytochrome P-450 content and the a b ility  to metabolize insecticides 
were greater in flies  fed milk than in those fed sugar. Perry (1970) 
has reported the inhibition of cytochrome P-450 by synergists and the 
potentiation of insecticides against resistant strains. The cytochrome 
P-450 from insects is readily converted to cytochrome P-420 but in 
many respects the insect cytochrome P-450 shows many of the characteristics 
of the mammalian hepatic system (Hodgson et al_, 1970; Philpot et aT, 1972).
Plant cytochrome P-450
The biochemical reactions leading to the synthesis of gibberellin  
plant growth hormones have been shown to possess many of the characteristics 
of mixed function oxidations. Murphy et al_ (1969) postulated that a 
cytochrome P-450 participates in these reactions in the endosperm of the 
immature seeds of Echinocystis macrocarpa.
Microbial cytochrome P-450
Pseudomonas putida has been studied in relation to cytochrome P-450. 
These studies have served to elucidate many physical and chemical 
characteristics of the haemoprotein which, unlike the mammalian enzyme 
species, is soluble and better suited to rigorous purification procedures.
£ . putida cytochrome.P-450 cam:
Cytochrome P-450 is known to degrade camphor by a hydroxylation 
reaction in this microorganism. The system is inducible by bicyclic mono- 
terpenes, but different compounds do not lead to the induction of d ifferent 
forms of the enzyme (Gunsalus et a l , 1971, 1972; Hartl i ne jrt a]_, 1971), 
unlike the hepatic microsomal P-450. Peterson (1971) reported that the
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growth of bacteria for 18-20 hrs in media containing 6g/l camphor,
resulted in about 20-30 pmol extractable cytochrome P-450/kg wet cell
paste. The sonicate contained 0.1 nmol cytochrome P-450/mg protein
(using a millimolar extinction coefficient, 446-490 nm, of 95 cnf^
for the reduced haemoprotein-CO complex). The specific activ ity
fireported is 15 x 10 ymol/kg cytochrome P-450/min or 600 ymol/ymol 
cytochrome P-450. The u tiliza tio n  of camphor:oxygenrNADPH for the 
hydroxylation reaction is 1.0:1.0:1.1. ,
Candida tropi cali s cytochrome P-450
This protein is found in the microsomal fraction only. The enzyme 
can be induced and growth of the organism on tetradecane increases the 
cytochrome P-450 content from 0.005 to 0.11 nmol/mg microsomal protein 
and the decane hydroxylase activity from 200 to 3,300 ymol/kg microsomal 
protein/min, (Gallo et al_, 1973).
Corynebacterium sp. strain 7E IC cytochrome P-450
This cytochrome P-450 hydroxylates hydrocarbons. The hydroxylation 
of n-octane to 1-octanol in the presence of NADH and molecular oxygen 
has been reported. A six-fold increase of cytochrome P-450 concentration 
was obtained on growing cells on n-oct®ine as carbon source as against 
acetate n-octane-induced cells showed specific ac tiv ities  of 4,260 ymol/kg 
total protein/min (Xardini et al_, 1970).
Rhizobium japonicum bacteroid cytochrome P-450
Cytochrome P-450 has been described from the bacteroids of the nitrogen- 
fixing 1egume Rh. Japonicum. An estimated molecular weight of 50,000 was 
found. I t  was also suggested that this enzyme has two protohaem moieties 
with an adjacent copper and that i t  functions in nitrogen reduction.
The bacteroids contained 0.08 nmol cytochrome P-450/mg protein 
(Appleby, 1968).
Isoenzymes of cytochrome P-450
The different chemicals metabolised by cytochrome P-450 of various 
tissues poses an intriguing question of considerable interest to 
enzymologists, pharmacologists, biologists, endocrinologists and others 
working in various disciplines. The question is whether the wide 
variety of enzymatic reactions are effected by a number o f cytochrome 
P-450 species, or as to whether one species exists with its  specificity  
being determined perhaps by the (highly lip id ) environment in which 
each functions. Hepatic microsomal P-450 has been shown to metabolise 
drugs, hydrocarbons, pesticides and bile  acids, while adrenal cortex 
mitochondrial cytochrome P-450 participates in side-chain cleavage of 
cholesterol and 113 ~ and 18-hydroxylations of certain steroids. Adrenal 
cortex microsomal cytochrome P-450 seems to be performing 17a- and 21- 
hydroxylations of steroids.
The term cytochrome P-450 is generally used to include forms of which 
the reduced CO complex absorbs ligh t maximally at 446, 448 and 454 nm 
as well as that originally described with absorbance a t 450 nm.
Recent spectrophotometric evidence suggests that cytochrome P-450 
exists in more than one form, (Imai et al_, 1967; Sladek e t al_, 1969;
Jefcoate et 1969; Fujita et a[, 1970). An important manifestation of 
the occurrence of the multiple forms is the finding that the oxidised 
form of cytochrome P-450 from various sources such as l iv e r  microsomes 
(Jefcoate £ t al^ , 1969) and adreno-cortical mitochondria (Mitani e t a l , 1969) 
show two different types of absorption spectra one having the soret peak
at 395 nm and the other at 416 nm. These spectra have been supposed 
to correspond to the 'high spin' and 'low spin' states respectively of 
the cytochrome. However, i t  has not yet been clarified whether these 
two different spectra are due to the presence of two distinct molecular 
species of cytochrome P-450 or whether there is a single species of the 
haemoprotein whose spectral properties are affected by environmental 
conditions. For ra t liv e r microsomal P-450, Yoshida and Kumaoka (1972) 
concluded that cytochrome P-450 solubilised (with sodium cholate) can
i
be reversibly converted from the high to low spin form depending on the 
environmental conditions. The two states are thought to be in equilibrium 
and the formation and destruction of intramolecular hydrophobic in ter­
actions seem to affect the equilibrium. They concluded that the 
occurrence of two spectrally different forms of cytochrome P-450 was 
not due to the presence of two different molecular species of haemoprotein 
but to an equilibrium between two different states of a single species of 
cytochrome P-450. Hildebrandt £ t  al_ (1969) suggested that some of the 
forms of cytochrome P-450 may be mixtures which are in equilibrium.
Adrenocortical cytochrome P-450
Cytochrome P-450 from andrenocortecal mitochondria takes part in  
the side-chain cleavage of cholesterol and its  esters, and 118- and 
18-hydroxylations. The most convincing evidence of the occurrence of 
various forms of cytochrome P-450 taking part in certain hydroxylations 
has resulted from studies on this tissue. Various authors (H all, 1973;
Jefcoate £ t  a l , 1970; Shikita et al_, 1973; Wilson et al_, 1970 and Young 
et af(, 1969), have reported the partial separation of some of these 
activities and other considerations suggesting multiple species of 
cytochrome P-450 in these mitochondria.
The way in which steroid hormones are secreted by the adrenal cortex 
is influenced by age and metabolic state and the biosynthesis of the 
hormones appears to d iffe r in the three zones of the manranalian adrenal 
cortex (Deane £ t  a^, 1949; Sayers, 1950). Ichikawa (1970) reported that 
the mitochond|jrptl and microsomal cytochrome P-450 varied in a consistent 
manner between the zona glomerulosa, z. fasciculata and z . reticularis  
which enhances the possibility of the existence of d ifferent species 
of substrate-specific hydroxylases in this gland. The investigations oni
the biochemical basis of the adrenogenital syndrome have also led some 
investigators to consider that the 21-hydroxylation of progesterone and 
17a-hydroxypnogesterone in human adrenal cortex microsomes may be effected 
by biochemically and genetically different species of cytochrome P-450.
Induction and breakdown of cytochrome P-450
Cytochrome P450 is in inducible enzyme; its  formation in animal 
tissues being induced by phenobarbital (Remmer et a l, 1976; Garner and 
McLean, 1969; Kuntzman et a l , 1968) and by 3-methyl cholanthrene and other 
polycyclic hydrocarbons (Conney and Gilamn, 1969; Sladek and Mannering, 
1966; Long, 1969; Jefcoate and Taylor, 1969; Nebert, 1969). The increase 
is a synthetic increase rather than due to a decrease in its  breakdown 
(Garner and McLean, 1969; Grein et a/[, 1970). I t  requires protein 
synthesis (Orrenius et a l , 1965; Marshal and McLean, 1968, 1969) and 
leads to the formation of specific apoproteins of P-450 depending on the 
inducing substrate (Sladek and Mannering, 1966; Long, 1969). This is of 
importance insofar as the dependence of induction on protein synthesis 
might have been due to more indirect causes. Thus induction of SrALA- 
synthetase is required for haem synthesis (Baron and Tephley, 1969a, b, 
1970} and the labelled 6-ALA is found in P-450 (Levin e t a l, 1970).
Haematin present acts as a repressor of the induction of microsomal 
protein synthesis by drugs (Marver et al_, 1968). An inducible enzyme 
must also undergo rapid breakdown in the absence of an inducer. This 
has been shown for P-450 (Schmid et a l , 1966; Robinson et^aT, 1966; ; .
Robinson, 1969).
Induction of hepatic microsomal cytochrome P-450 and associated 
hydroxylati on acti Vi t i  es
The increase of specific content of hepatic cytochrome P-450 and 
microsomal hydroxy1ation a c tiv it ie s ,is  usually done by induction with 
phenobarbital, 3-methylcholanthrene and the b ile -sa lt sequestering 
agent, cholestyramine (G ille tte  £ t£ l_ , 1961 , 1972; Gram et a l ,1971; 
Mitropoulos e t al^ , 1972; Scholari e t a\_s 1968). However, the hepatic 
microsomal hydroxylations are not simultaneous and equivalent. Pheno- 
barbital induction, generally, increases the metabolism of many drugs, 
while polycyclic hydrocarbons induce a lesser number which include azo 
dye N-demethyl ati on and aniline and 3,4-benzpyrene hydroxylations (Conney, 
1967; G illette 'et'a l^ , 1972; Gram et al^ , 1971).
Induction of rat hepatic microsomes for example, by phenobarbital 
increased the cytochrome P-450 and NADPH-cytochrome P-450 reductase 
contents and aminopyrine demethylase a c tiv ities , while 3,4-benzpyrene 
hydroxylation was only slightly stimulated. The la tte r  ac tiv ity  was 
markedly increased following a single injection of 3,4-benzpyrene which 
also caused formation of cytochrome P-448, but not an increase in the 
rate of reduction of haemoprotein (Gnosspelius et cb(, 1970). 3-methyl- 
cholanthrene induces the hydroxylation activ ity  within a matter o f hours 
while phenobarbital takes a few days to induce the a c tiv ity . Gram et al 
(1971) reported that additive effects can be obtained by simultaneous
induction with phenobarbital and polycyclic hydrocarbons. Hrycay et al 
(1972} reported that the peroxidase activ ities of rat hepatic cytochrome 
P-450 towards progesterone 17a-hydroperoxide and cumene hydroperoxide 
were differently influenced by induction with 3-methylcholanthrene and 
phenobarbital. The hepatic microsomal steroid hydroxylation leading 
to bile acid formation are cytochrome P-450-dependent. However, the 
induction of this activ ity  is accomplished by feeding cholestyramine 
rather than by treatment with phenobarbital or 3-methylcholanthrene.
Extinction coefficients and spectral data
Several workers have studied the spectral characteristics of various 
preparations of the reduced cytochrome P-450-C0 complex to relate i t  to 
the possible presence of several species of cytochrome P-450. For example,
Greene e t al_ (1971) found that pretreatment of male rats with 3-methyl- 
cholanthrene changes the millimolar extinction coefficient of hepatic 
microsomal cytochrome P-450 from 85 to 102 cm~^  while phenobarbital 
pretreatment did not cause this change. Fujita and Mannering (1971), 
however, found that hepatic microsomal cytochrome P-450 from phenobarbital 
pretreated rats had a millimolar extinction.coefficient of 58 cnf  ^ while 
that from 3.methylcholanthrene-pretreated rats had one of 78 cnf^.
Differences in extinction coefficients may also be related to age (Stripp 
et al^  (1971). The observations of sex-linked variations in N-demethylation 
of ethylmorphine, and significantly different millimolar extinction coefficients 
of hepatic microsomal cytochrome P-450 of male (79.6 cnT )^ and female (94.1 cnf^) 
rats, support the possibility of the presence of d ifferent species of cyto­
chrome P-450 in this tissue (Stripp et a l , 1971), especially since the sex 
related differences in hepatic microsomal P-450 content appears to bear 
l i t t l e  relationship to rates of drug metabolizing activ ities  (Gram et al ,^ 197])
Differences have also been seen in optical spectra resulting from the 
addition of ethyl isocyanide to dithionite-reduced hepatic microsomes 
from phenobarbital and 3-methylcholanthrene pretreated rats.
Aniline and other substrates of the drug metabolizing system produce 
characteristic spectral changes when they combine with cytochrome P-450 
which probably reflects certain alterations in the conformation of 
proteins. Alcohols in fa ir ly  high concentrations also produce spectral 
changes. Remmer et al_ (1966) and Imai and Sato (1966) showed that drugs 
and other foreign compounds combine with hepatic cytochrome P-450 to 
produce difference spectra of two general types, type I and type I I .
Type I compounds for example, hexobarbital, give a difference spectra 
with Amax. 385-390 mp and a minA 418-427 mp. With type I I  compounds, 
for example, aniline, a difference spectra with A max 425-435 , and Amin 
390-405 mp is produced. I t  has been suggested that type I binding spectrum 
results from an alteration in the electronegativity of the sixth ligand 
of the haem. Non-polar substances are able to invade the hydrophobic 
region of the apoenzyme (possibly the active site) and displace the 
sixth ligand. I t  is also suggested that two forms of cytochrome P-450 
exist; one is the unreacted enzyme, and the other is the substrate bound 
enzyme. In the course of metabolism of the substrate, the f i r s t  form is 
converted to the second form and the transition is accompanied by the type 
I spectral change. I t  is to be noted that the a b ility  of compounds to 
form binding spectra with cytochrome P-450 does not guarantee th e ir  
metabolism; many alkylamines combine with cytochrome P-450 to produce 
type I I  binding spectra, But are not metabolised (Imai and Sato, 1967).
Tbey have also reported that phenobarbital and benzene are hydroxylated 
by microsomes although they do not produce binding spectra.
Mason et £l_, (1965) suggested that the endoplasmic reticulum consists of 
a bimolar layer of lip id  covered on both sides with protein. The protein 
forms a strong lipoprotein complex (inner layer) and a weak lipoprotein 
complex (outer layer). The outer layer contains the readily solubilized 
components of microsomal electron transport:NADH cytochrome b  ^ reductase, 
cytochrome b^, NADPH P-450 reductase and NADH P^450 rdductase. The inner 
strong complex contains P-450, postulated to be microsomal Fex or P-420 
and cuprous copper held by lipoprotein in a specific configuration. The 
functions of this organisation being the metabolic control of the oxidations 
and reductions of (a) water soluble metabolites and (b) lip id  soluble 
metabolites. The specificity towards various xenobiotic substances, drugs, 
carcinogens and other foreign substances may be controlled, not by a 
variety of drug specific mixed function oxidases, but by the lip id  
configuration which controls the rate of diffusion and the geometry of 
presentation of foreign molecules to the mixed function oxidase.
Solubilization and partial separation of microsomal P-450
Cytochrome P-450 from many sources including mammalian tissues have
resisted solubilization and purification and have come to be accepted as
membrane-bound. A partial purification of cytochrome P-450 (phenobarbital-
induced) and cytochrome P-448 (3-methylcholanthrene-induced, or cytochrome
P-450) of rat live r microsomes has been reported. The cytochrome P-450
and P-448 exhibit different substrate specificities fo r kenyphetamine and
3,4-kenypyrene. The millimolar extinction coefficients for the reduced
haemoprotein-CO complex of cytochrome P-450 was 91 cm~^  and fo r cytochrome 
-1P-448 was 103 cm (Lu et_ al_, 1972). Many attempts to solubilize and to 
purify these cytochromes have led to the formation of ca ta ly tica lly  
inactive forms with ferrous carbon monoxide absorption at 420 nm, and
(28)
therefore termed cytochrome P-420. Using rabbit live r microsomes Ichikawa & 
Yamano(1970)were able to form P-420 by extraction with detergents in the 
presence of sulphydryl reagent, which can be reconverted to P-450 by
treatment with reduced glutathione in the presence of polyols. They were
unable to reconvert to P-450 the P-420 formed by treatment with urea, 
amides, monohydric alcohols, ketones, n itr ile s , guanidine salts or sodium 
dodecyl sulphate.
Yu and Gunsalus (1974) were able to demonstrate a conversion of P-420
to enzymatically active P-450 cam, by for example, using cysteine in
excess. The method of forming the P-420 did, however, affect the results.
They postulated that at least one type of P-450 6am to P-420 cam conversion 
is associated with a modification of the sulphydryl groups.
C. tropical is cytochrome P-450 is located in the microsomal fraction 
of the cell homogenate according to the work of Gallo e t al_ (1971); but i t  
is solubilised more easily than the corresponding pigment of liv e r micro­
somal membranes. Treatment with deoxycholate in the presence of stabilizing  
agents was found to be necessary for the solubilization and resolution of 
the liv e r enzyme system (Omura et a l, 1964). Cytochrome P-450 from C. 
tropicalis was solubilised and resolved in the absence of detergents 
(^ Duppel ^et al_, 1973). These workers induced cytochrome P-450 in_C. tropicalis  
LM7 by growth on hydrocarbons under aerobic conditions and resolved the 
P-450 system functional in hydrocarbon, fa tty  acid, and drug hydroxylation.
Imai and Sato (1967) concluded that the ultimate effect of each 
agent converting cytochrome P-450 to P-420 is to disrupt the association 
between the haemoprotein and microsomal lip id . Depending on the agent 
this may occur either by its  action on the lip id  or by an effect on the
protein associated with the lipd. Since, with few exceptions, i t  is 
those drugs possessing high lip id  solubility which react with the drug 
metabolising system, the active area of P-450 has been assumed to be 
in contact with or embedded in , a highly hydrophobic part of cytochrome 
P-450 protein or in the lipids of the microsomal membrane.
According to Imai and Sato (1967) the specific structural relationship of 
the haem to the hydrophobic region seems to be maintained by the special 
conformation of the P-450 protein or by the high lip id  content in the 
membrane. The unusual spectral properties of cytochrome P-450 are 
ascribed to a hydrophobic interaction of the haeme with nearby components. 
Depending on the agent employed the conversion of cytochrome P-450 to 
P-420 would result from the disturbance of the hydrophobic environment 
around the haeme either by primary action of the agent or secondary effects 
caused by conforational changes in the ahemoprotein. The observation 
that P-450 can be solubilised by detergents but not by proteases which 
solubilise about half of the microsomal protein (Omura; and Sato, 1964) 
favours the concept of a strong interaction of lip id  and protein.
Radiation and thermal s tab ility  studies
Radiation injury is assumed to be caused by radiolysis product of 
water, and 0^  N^ O and C2H,-0H are assumed to affect the radiosensitivity 
primarily by acting as radical scavengers. In most biological systems the 
radiation injury is greater when exposure is carried out in the presence 
of oxygen than i t  is under anoxia.
Irradiation of water with ionizing radiation is believed to give rise 
to the following principle species H^ot, OH* H and
Attempts to identify those species responsible for inactivation of enzymes
in dilute solutions have been made primarily by studying the effects 
on the radiosensitivity of various substances added to the enzyme 
solution (Myers et al_, 1964); the effect of pH on the radiation sensitivity; 
and (More et al_, 1955) the degree of inactivation a fter subjecting the 
enzyme solution to the particular species in question, produced by other 
means than by ionizing radiation.
Wiseman and Williams (1971) showed that thermal inactivation of
alcohol dehydrogenase was progressively increased by MAD+ a^ove ^*5
”1“with zero recovery of enzyme reached at about 4 mM NAD I ' Grisolia and 
Joyce (1959) reported an analogous effect substituting either radiation or 
ultrasonic treatment for the heat treatment. Wiseman and Williams (1971)
.f  .
reported a close analogy between NAD promotion of thermal inactivation,
but for ultrasonic treatment they observed the opposite e ffect, i .e .
protection of the enzyme by NAD+ . The suggestion was made then that
NAD+ may be binding to some other binding s ite , other than the active s ite .
Subsequent conformational change may thus be responsible for the enhanced
destruction of the enzyme whether by* heat or as a consequence of y-irrad iation .
McKinley-McKee et a\_ (1971) have suggested that ligand binding to alcohol
dehydrogenase may inactivate i t  through subsequent conformational change.
Such binding of NAD+ or conceivably its  breakdown products, appears to
enhance the destabilization of this enzyme caused by beat or y-irrad iation .
The energy supplied to the systems by heating from 18° to 43°C, for example,
4is about 10 times that supplied by 500 rads of y -irrad ia tion , so local
.f.
heating is apparently not the cause of the sim ilarity in response to NAD .
Other studies on the effect of y-rays and x-rays on d ilu te  solutions of this 
enzyme have supported the concept that free radicals are produced by a 
variety of reations with water followed by their rapid reaction with thiol 
groups in cysteine residues of alcohol dehydrogenase Ganske et al (1970).
These thiol groups can be protected by reduced glutathione (Barron et al_, 1954)
or cysteine and cysteamine C^ °PP 1966) and such radiation protective
agents are known to be free radical scavengers. Binding of free radicals 
could modify the active site of the enzyme either directly or through 
conformational change as suggested (McKinley-Mackee et a l , 1971).
Rat adrenal cortex function is stimulated for a limited period after 
whole body x-irradiation, and this response of the adrenals has been 
thought to be due mainly to increased secretion of ACTH from the p itu itary . 
Adrenal function seems to play an important role in induction of and 
recovery from radiation syndrome. Yago et al_ (1967) determined the levels 
of DNA, RNA, protein, nictotinamide nucleotides, enzymes and cytochrome 
P-450 and b,- in rat adrenals after 24 hrs of a single injection of ACTH 
(10 units) and 24, 48 and 72 hrs after whole body x-irradiation at a lethal 
dose (IK r). These authors found that at these times adrenal nuclei showed 
abnormal high RNA polymerase activ ity . The concentration of nicotinamide 
nucleotides did not change during the experimental period. In mitochondria 
succinate dehydrogenase increased rather abruptly 72 hrs after x-irradiation  
while NADH^  cytochrome c reductase decreased significantly during the 
experimental periods. P-450 was increased after 24 hrs but was significantly  
decreased after 48 and 72 hrs. NADPH^  cytochrome c reductase remained 
unchanged after 24 and 48 hrs but had decreased after 72 hrs. In microsomes, 
cytochrome bg and NADH^  cytochrome c reductase decreased significantly a fter  
ACTH and x-irradiation. P-450 and NADPH^  cytochrome c reductase remained 
at the control levels, with a temporary increase of the former, 24 hrs after  
x-irradiation.
Stabilization of Enzymes
Denaturation is usually defined as an irreversible process, arising 
from the destruction of the active site (catly tic  s ite ) of the enzyme
inherent in the amino acid residue sequence in a re la tive ly  small portion 
(20-30 residues) of the protein macromolecule. Some authors use the 
term thermal denaturation for unfolding, which fa ll short of enzyme 
inactivation. In recent years the studies of enzyme conformational changes 
by a variety of physical techniques, have revealed the great complexity 
of response of enzymes to small molecules. These include the so called 
allosteric changes in enzyme conformation, including dissociation of
sub-units, caused by binding ligands that act at sites distinct from the
/
active site of the enzyme. Many cases are now known of reversible loss of 
enzyme activ ity  e.g. by cooling or acidification, in some cases due to 
dissociation into inactive subunits. For example, inactive sub-units 
of chorismate mutase are formed above 60°C, and activ ity  is restored upon 
cooling to 30°C (Gorish and Lingens, 1973).
The activation energy for thermal denaturation (usually irreversible) 
of an enzyme w ill depend on the number and type of bonds that need to be 
broken before the detrimental changes or conformation associated with loss 
of catalytic activity occurs. The denatured enzyme would be expected to 
be in a much lower molecule energy state for a fu lly  irreversible thermal 
denaturation process which is usually an unfolding of the globular molecule 
Investigation of inactivation rate at different temperatures allows the 
calculation of the activation energy (Ea) for thermal inactivation (using 
the linear plot of log inactivation rate against reciprocal of absolute 
temperature, based on the Arrhenius equation. Other simple studies can 
also allow the determination of e.g. the binding constants and protection 
constants where appropriate for various ligands (Chuang and B ell, 1972).
The concept of s tab ility  of an enzyme refers to tne endurance of 
catalytic activity despite storage, use (Wiseman, 1975) and the presence
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of a variety of possible destructive agents including solvents and heat. 
Minimised enzyme loss at a given temperature is essential in enzyme 
standards and is desirable in isolation storage, processing and in some 
products. The stabilization at a given temperature is also the aim of 
user and modifier of enzymes. The s tab ility  can be increased by the 
free-energy liberated during oligomer formation from the protomer sub­
units, so that the oligomer is more stable than the protomer. I f  the 
integrity of the catalytic site is maintained better ( i .e .  stabilized)
i
in one of the allosteric states of the enzyme, and a ligand is responsible 
for holding the equilibrium of conformational forms of the enzyme in 
favour of one form, then the ligand may act as a s tab ilizer of the enzyme.
Thus the catalytic s ite , and so the enzyme ac tiv ity , may be more stable 
to heat in the presence of an allosteric effector. I f  this effector is 
as is often found, an inhibitor, the inhibited enzyme w ill display a 
greater resistance to thermal denaturation. This would be shown by 
heating the enzyme followed by removal of the inhibitor prior to assay 
of residual activ ity . Substrates and inhibitors that bind to the catalytic  
s ite , also often stabilise an enzyme. Changes and restrictions of conformation 
may be achieved by immobilization of enzymes to support molecules. Increase 
in conformational s tab ility  can also be achieved by cross-linking the 
enzyme, in addition to the natural disulphide cross-links in the te rtia ry  
structure of some enzymes. These new cross-links may be across the 
quaternary structure too, so preventing the dissociation of sub-unit 
structures normally held together by non-covalent bonding. L itt le  is 
known about why some enzymes are much more stable than others. The valid  
comparisons are between the mesophilic and thermophilic enzyme produced 
by the corresponding micro-organisms. The thermally stable enzymes produced 
by thermophilic microorganisms have been extensively studied but i t  is
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clear that the causes of increased s tab ility  are many, and w ill need to be 
explained for each case on the basis of a small difference in amino acid 
sequence and thus an opportunity for bonding that can resist the effect 
of temperature.
I t  is important to note that thermal s tab ility  and pH s tab ility  are 
interrelated. Thermal s tab ility  studies are performed at a particular pH, 
which for theoretical purposes should be the pH of maximal thermal s tab ility  
(often the isoelectric point of the enzymes) rather than the pH optimum, at 
which some enzymes, e.g. yeast alcohol dehydrogenase, pH 8.8 , are relatively  
unstable.
Immobilization
Immobilization refers to the modification of an enzyme so as to restric t 
its  gross movement and keep i t  in a relatively defined region of space 
(Wingard, 1972).
Four different principles are currently being used for the immobilization 
of enzymes:
(a) Entrapment inside a molecule la ttice
(b) Physical adsorption
(c) Extensive cross-linking
(d) Covalent linkage to an insoluble carrier
The last approach is the most desirable, but its  application requires 
the solution of several intricate technical problems. The immobilization 
of enzymes by fixation to an insoluble matrix provides, in principle, a 
means of using enzymes repeatedly in a dynamic way as heterogeneous specific 
catalysts, thereby alleviating the problems of spearation, cost and supply, 
and also allows the use of enzymes in automated processes. Since the
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development of immobilized techniques, there have been several reviews 
on immobilized enzymes [Barker et al_, 1971; Melrose, 1971- Falle, 1972;
Weetal, 1975; Barker'and Kay, 1975).
Immobilization by ionic adsorption on DEAE-Sephadex and CM-Sephadex.
The enzyme a-chymotripsin has been covalently bound on to CM-Sephadex 
(Zaboresky, 1973). Immobilization by adsorption usually lowers the specific 
activ ity . Suzuki et a l , 1966; 1967, reported only 33% retention of the
I
specific activ ity  of the native enzyme when invertase was bound on to 
DEAE-cellulose. Tosa £ t jil_ (1969) reported 50% loss v/hen aminoacylase 
was immobilized on DEAE cellulose. Immobilization by adsorption can result 
in an increase or decrease in thermal s tab ility  relative to the native 
enzyme. Enhanced thermal s tab ility  was found for aminoacylase on DEAE- 
Sephadex and DEAE-cellulose (Tosa £ t  al_, 1969), for lactate dehydrogenase 
attached to DEAE-cellulose (Wilson et £l_, 1968) and for phosphomonoesterase 
adsorbed on to CM-cellulose (Zaborasky, 1971). On the contrary, decreased 
thermal s tab ility  was observed for ATP deaminase absorbed on to DEAE cellulose 
(Chung et al_, 1968).
When an enzyme is immobilized on a charged carrier, changes can occur in 
its  pH optimum (Baker and Kay, 1975). The pH optimum was decreased for  
glucoamylase on DEAE-Sephadex (Zaborsky, 1973) and for ATP deaminase, amino­
acylase on DEAE cellulose (Chung et 1968; Tosa et al_, 1967). Conversely, 
the pH optimum can be increased for enzymes bound on to a negatively charged 
support, such as CM-Cellulose or CM-Sephadex.
Changes in the value of the apparent Michael is constant (K^) can also 
occur upon immobilization. Thus apparent for aminoacylase adsorbed on 
to DEAE Sephadex or DEAE Cellulose was either increased or decreased relative  
to the of the native enzymes depending upon the substrate used (Tosa et a l , 
1969).
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Effects of Immobilization of Enzymes on Stability
Most reports deal v/ith the thermal s tab ility  of immobilised enzymes, 
rather than the pH, solvent, salt or proteolysis s tab ility . Some of 
these have compared with the corresponding free enzyme at the pH optimum 
of the free enzymes. The sh ift in pH optimum of one or two units are 
common in enzymes immobilized to highly charged supports. Comparison
should be done at the pH of maximal thermal s tab ility  at the appropriate
/
temperature as determined in separate experiments. Melrose (1971) has 
reported several immobilized enzymes, and their s tab ility . About 60% 
were more stable than the free enzyme; 16% were less stable. Many 
enzymes are stabilized by their substrates, and s tab ility  data without 
mention of the substrate concentration is therefore of l i t t l e  significance 
in relation to enzyme use. I t  is tac itly  assumed by many workers as 
may well be justified  in most cases, that the increase in s tab ility  due 
to substrate w ill be much the same in the free and immobilised enzyme. 
Increases in thermal s tab ility  following immobilization are usually 
considered to be due to conformational constraints introduced by the 
presence of the support.
O ilis (1972) constructed a theoretical model (generalised by Korus 
and O'Driscoll, 1975), to show the effect of a slow rate of diffusion 
on the temperature dependence of the measured rates of an enzyme in free 
and immobilized form. The effectiveness factor of the immobilized 
enzyme is low when diffusion is slow with respect to reaction rate, so 
that any differences in the temperature dependence of measured rates 
w ill be increased under these conditions. The effectiveness factor of 
an immobilized enzyme is lower at high enzyme concentration, where 
presumably the substrate access is more hindered. Especially here there
is a non-linear relationship between measured enzyme activ ity  and 
true concentration. L ittle  loss of measured activ ity  may therefore 
be observed on heating the immobilized enzyme despite the inactivation 
of a significant number of enzyme molecules because the remaining 
enzyme becomes more effective at lower active concentration. The 
theoretical model predicted for the immobilized enzyme, due to 
diffusion effects was that one would observe no change in "T optimum", 
but there would be a broadening of the activity/temperature curve, and
i
therefore a greater recovery of enzyme activity above or below "T 
optimum". Effects of diffusion can be decreased also by use of rapid 
recirculation reactors (Ford et al_, 1972). In those cases where 
destabilization of enzyme occurs on immobilization on a particular 
support, the loss of conformational s tab ility  has no doubt out-weighed 
the effects of diffusion.
I t  is , however, feasible to increase, a r t i f ic ia l ly ,  the apparent
s tab ility  of the immobilized enzyme by increasing the diffusion e ffect,
provided that the increase in K and decrease in 'can.be tolerated. r m max
Thus high immobilized enzyme concentration on the support combined 
with large particle size or membrane thickness, and low s tirrin g  or 
recycle rates, could maximise the practical thermal s ta b ility  o f the 
enzyme - especially in the presence of its  substrate during its  
u tiliza tio n .
Reports of shifts in pH optima, and of improved s tab ility  to either 
acids or alkalis for a particular immobilized enzyme can also be 
considered as a diffusion artefact, where highly charged supports have 
effectively altered the internal pH. For example, a negatively charged 
support such as carboxymethylcellulose, which has carboxy-groups, and 
COO" groups except at a very low pH, can be considered at low diffusion
rates to have a local internal environment more acidic than the
external medium. A higher pH of the external medium is therefore
needed to reach the pH internally that is equivalent to the normal
pH optimum for the enzyme. The pH optimum for the enzyme is due
- +mainly to the balance of COO and NH^  manifest at the active centre 
of the enzyme. pH s tab ility  may be controlled by the balance of 
these charged groups, at a particular temperature, in relation to the 
probability of adverse and irreversible unfolding occurring of the 
whole molecule.
Stabilization of Enzymes by Chemical Modification including 
Cross-Linking Reactions
Chemical modifications of many enzymes and proteins have been 
reported over the last forty years or more. These findings have been 
used recently and extended with the aim of stabilising enzymes either 
free, prior to immobilization, or simultaneously with immobilization. 
Enzymes treated with .cross-linking agents can be modified, or cross- 
linked. I f  cross-linking occurs, such links may be intramolecular., 
or intermolecular (perhaps across sub-units} or both. Intramolecular 
links are favoured at low concentrations of enzyme and reagents. 
Increases in thermal s tab ility  by cross-linking apart from that 
associated with immobilization may be due to increased r ig id ity  of 
important conformational features of the enzyme or in some cases the 
prevention of sub-unit dissociation. I t  is s t i l l  not fu lly  understood 
that what controls the s tab ility  of an enzyme and comparison of the 
structure of the corresponding enzyme from mesophilic and thermophilic 
organisms show that a small change in the amino acid sequence can have 
a large effect on e.g. a-helix content and thermal s ta b ility . This 
is especially true where the activation energy of thermal denaturation
is particularly low as in the mesopholic or unmodified enzyme.
Bernhard and Rossi (1968} have discussed the theoretical and 
experimental investigations on the relative s tab ilities  of chymotrypsin 
and acyl-chymotrypsin. No denaturation fo the acylated enzyme occurred 
with some of the denaturing agents tested. Differences are to be 
expected with these depending on their mechanism of action. For example,
guanidine hydrochloride breaks hydrogen bonds, while with the detergent,
!
sodium dodecyl sulphate, solvation of hydrophobic amino acid side chains 
occurs plus charge disruption of electrostatic bonding such as salt-links  
through the sulphate groups and sodium ions in the aqueous solvents. 
Nevertheless, salts can stabilize enzymes. All such effects w ill depend 
on the pH employed. Other studies have involved the citraconylation of 
chymotrypsin, or trypsin, using citraconic acid which converts functional 
amino groups to functional carboxyl groups (Barker et al_3 1977). Other 
reports of stabilization, often thermal, include very many studies on 
the use of glutaraldehyde-usually in the presence of a solid support 
[for review see Zaborasky, 1973). One particular case of interest here 
is the preparation of water-soluble papin derivatives which had been 
extensively modified with glutaraldehyde at 0°c(pH 6 .0 ), by reaction of 
80$ of its  available amino groups. Bifunctional reagents have been 
shown to stabilize many enzymes including, lysozymes by phenol disulphonyl 
chlorides; glycogen phosphorylase b by glutaraldehyde; and chymotrypsin 
by formaldehyde. Some other enzymes, however, were destabilized by 
bifunctional reagents (see review by Zaborsky, 1973).
Snyder et al (1974) have reported the stabilization to heat and 
protease digestion of human splenic a-galactosidase 'A' intended for 
human therapy purposes. Here use was made of the antibody to the enzyme
produced in the goat by repeated immunization with the highly purified 
enzyme. Alternatively, the enzyme could be stabilized by treatment 
with the bifunctional cross-linking reagent, hexamethylene diisocyanate, 
but not with the monofunctional reagent, butyl isocyanate. I t  is 
perhaps not surprising that chemical modification of thermolysin by 
tetranitromethane (Ohta et al_, 1974) and its  acetylation with N-acetyl- 
imidazole (Ohta et art, 1972) led to a thermal destabilization of this 
extremely heat stable enzyme. The susceptibility of chemically modified 
enxymes to proteolytic attack has been reviewed (Habeeb, 1971). Both 
stabilization and destabilization have been reported in different cases.
An important attempt to stabilize enzymes by covalent modification 
is concerned with the attachment of carbohydrate. Several glycoprotein 
enzymes such as yeast invertase, a phosphomannan protein, are particularly  
thermo-stable. Thermostable enzymes from thermopholic organisms do not, 
however, appear to be necessarily glycoproteins. Stabilization by covalent 
attachment of polysaccharides has been reported (Marshall and Rabinowitz, 
1975; Christensen and Vegarud, 1975; Christensen et al_, 197G). The la tte r  
authors reported the thermal stabilization of lysozymes or 8-glucosidase 
coupled to dextrans and compared the case of yeast invertase. Such glyco- 
conjugates were stable also to chymotrypsin attack. I t  is not clear why 
stabilization occurs following the binding of carbohydrates.
The present investigations were carried our from the following points 
of view:
( i )  To elucidate the identity of a CO-binding pigment in J>‘. cerevisiae 
and to investigate the best culture conditions for the "induced" 
production of yeast cytochrome P-450 and other components of this 
hemoprotein system.
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( i i )  To study the effects of physico-chemical agents on the s tab ility
of yeast cytochrome P-450 in comparison with the hepatic system 
in the absence and presence of substrates and other substances.
( i i i )  To isolate the microsomal fraction from yeast and live r homogenates
and to carry out a direct comparison of their drug metabolising 
activ ities and P-450 levels.
(iv ) To solubilise and achieve at least a partial purification of 
yeast and hepatic cytochrome P-450.
(v) To fractionate the soluble fraction of both systems; immobilize
the system and develop a method to stabilize the system by a 
cross-linking reagent — and study the catalytic activ ity  of 
the preparation.
(v i) To suggest the functional sim ilarities of cytochrome P-450 of
S* cerevisiae with the hepatic system.
CHAPTER I I  
MATERIALS AND METHODS
CHAPTER I I .  MATERIALS AND METHODS
MATERIALS
The materials and chemicals were supplied by the following companies: 
Oxoid Ltd
Mycological peptone. Powdered yeast extract,Sabourad' dextrose agar. 
Industrie Biologiave Francaise 
Snail gut enzyme.
Sigma Ltd. London
f
The sodium salt of nicotinamide adenine dinucleotide; glucose-6- 
phosphate dehydrogenase; nicotinamide; semicarbazide hydrochloride, 
micro-crystalline cellulose; cellulose phosphate; phenyl-methylsulphonyl- 
fluoride; 8-hydroxyquinoline; 2-4,-dinitrophenol (sodium s a lt); benzo(a)- 
pyrene; CM cellulose; coumarin, 7-ethoxycoumarin; sodium cholate.
BDH, Poole, England
EDTA; cysteine; aniline; p-aminophenol; folin-phenol reagent; glucose; 
sodium chloride; glycerol; sodium dithionite; biphenyl.
Koch-Light Ltd.^ Colnbrook
2 -mercaptoethanol; p-nitroanisole.
Hopkins and Williams Ltd.
2 -hydroxybiphenyl; 4 -hydroxybiphenyl,
Aldrich Chemical Co., Milwaukee, U.S.A.
Aminopyrine (4-dimethylaminoantipyrone); Tween 80.
May and Baker Ltd., Dagenham
Ethylmorphine (g if t ,  gratefully acknowledged).
Pierce Chemical Company, U.S.A.
Corning controlled pore size glass-beads (g if t ,  gratefully acknowledged) 
ethoxyresorufin; resorufin.
Instruments
pH measurements were made using an EIL pH meter, model 7030. For 
speed centrifugation an MSE minor bench centrifuge and Minstral 6L were 
used, Whereas for high speed centrifugation an MSE high speed 18,
Superspeed 50 and Superspeed Beckman were employed: a ll centrifugations 
were carried out at 4°C.
Spectrophotometers used included the Pye-Unicam SP 1800 and Perkin 
Elmer 356 for high resolution measurements and the Pye Unicam SP 500 and
i
600 and Cecil CE 272 for routine measurements of colour production.
Enzyme assays were carried out at 37°C in a shaking v/ater bath (Mickle 
Engineering Co., Gomshall, Surrey) the tubes being shaken at 75 oscillations/ 
min. Sample mixing v/as achieved by use of a whirlmixer, and extraction 
procedures involved the use of a rotary shaker. For irradiation of the 
samples a Co60 y-source was used.
METHODS
Growth of Yeast:
The yeast was inoculated on to Subourad. Dextrose Agar Slopes and a fter  
three days growth at 30°C the slopes were stored at -4°C until inoculation 
in the culture media. Two small loops of yeast were inoculated into a 
250 ml conical flask containing 200 ml of autoclaved media. Flame 
sterilization  techniques were used throughout the procedure. The culture 
media consists of:
15% Glucose 
2$ Mycological peptone 
1% Yeast extract and 
0.5% Sodium chloride.
After shaking for two days at 30°C the contents were filte re d  with
a vacuum water pump and the relatively  dry yeast then suspended in 0.1 M 
phosphate buffer pH 2.4, for ultrasonic and vibromilling treatments.
For protoplast formation yeast cells were pretreated in 0.1 M c itra te -  
I^PO^ buffer pH 5,8 for 30 min at 30°C with the following additives:
0.14 M 2-mercaptoethanol
0,04 M ethylene diaminetetracetic acid (EDTA)
After this incubation the cell suspension was added to weighed centrifuge 
tubes and centrifuged for 5 mins in an MSE bench centrifuge at 1000 g.
f
The liquid was decanted and the wet weight of yeast measured. The yeast 
was.then incubated at 30°C for 50-60 mins with snail gut enzyme, 0.33 ml/g 
wet weight of yeast, in 5 ml of phosphate buffer, pH 5.8. The suspension 
was then centrifuged for 5 mins at 1000 g and the precipitate washed in 
phosphate buffer, recentrifuged and fin a lly  suspended in 0.1 M phosphate 
buffer, pH 7.6. Hughes et al_ (1971) showed that the concentration of 
buffer appears to be important. Also various strains of yeast vary 
greatly in their susceptibility to treatment. Variation is also found in 
resistance to attack by snail gut enzymes when susceptible strains are 
grown under difrerent growth conditions.
Ultrasonication:
The harvested yeast cells were suspended in 0.1 M phosphate buffer, 
pH 7,4 at V ]o  W/ v and cooled with an ice jacket whilst ultrasonicated 
at \  max (2.2 amps) with a Dawe Soniprobe, for 5 mins.
M illing:
For Vibromilling about 15 g harvested yeast cells were loaded in 
a stainless steel vessel of the mill (E. Buhler, Tubingen, West Germany), 
The vessel was f il le d  with glass beads (dia. 0.15 mm). The contents 
v/ere milled for 1 min at \  the maximum speed with a cold water jacket.
More beads were then added to f i l l  the vessel, and the mining continued 
for a further period of 5 mins. The beads were decanted off and washed 
in 0.1 M-phosphate buffer. The milled yeast cell suspension was separated 
and transferred into 50 ml polypropylene tubes, The heavy fraction was 
removed by centrifugation in an MSE bench centrifuge at speed 3 for 10 mins. 
The supernatant was taken off from both the ultrasonicated and Vibromilled 
yeast and the heavy fractions were discarded.
Preparation of Liver Homogenate
The rats were killed by cervical dislocation and the livers rapidly 
removed into cold (4°C) 0.1 M-phosphate buffer. After removal of excess 
blood and mysentery, the liver was washed in buffer and this was followed 
by rough scissor-mincing. The contents were transferred to a cold Potter- 
Elvejhem homogenizer and homogenised by 10 up-and-down strokes of the 
teflon plunger operated by an electric d r i l l ,  at max speed. The homogenate 
was diluted with buffer such that 1 ml of homogenate contained the 
equivalent of 250 mg liver (from the mincing stage onwards a ll operations 
were carried out at 4°C).
Preparation of post-mitochondrial supernatant:
Yeast
The supernatant obtained by discarding the heavy fractions was 
transferred into new 50 ml cold polypropylene centrifuge tubes and centrifuged 
at 2000 g for 15 mins (8 x 50 ml rotor, High Speed 18 Centrifuge). The 
supernatant derived from this spin was designated as post-mitochondrial 
supernatant (PMS).
Li ver
The 25% (W/ v) homogenate obtained above was transferred to a 50 ml 
polypropylene centrifuge tube and centrifuged at 10,000 g for 20 mins
(8 x 50 ml rotor High Speed 18 centrifuge). The supernatant (PMS) was 
separated off into separate cold tubes.
Preparation of microsomal fraction:
The resulting PMS both in yeast and liv e r was transferred to 10 ml 
polypropylene centrifuge tubes and centrifuged at 105,000 g for 60 mins,.
10 x 10 ml rotor, Superspeed 50 centrifuge. After this spin the super­
natant was discarded and the pellet resuspended in phosphate buffer,
both with yeast and liv e r. I f  i t  was not a clear and clean pellet i t  was
v i  '
washed by resuspension in cold 1.15% KC1 ( /v ) using a single complete 
stroke of the glass Teflon homogenizer and further centrifugation at 
105,000 g for 60 mins. The pellet in each case was fin a lly  resuspended 
in 0.1 M-phosphate buffer pH 2.4 in glycerol (4.1 V/ y).
Spectrophotometric Determi nati on 
Measurement of Cytochrome P-450
Two cuvettes were used on a SP 1800 spectrophotometer. The scanning 
wavelengths used were. 390 nm to 490 nm, at 4.0 •/mm/sec scan speed;
1 mm s l i t  width and usually at 0.5 sensitivitv (depending on the turbidity  
of the preparation). Each cuvette was f ille d  with 3 ml of whole yeast 
cells (V-jQ W/ v)» yeast microsomal fraction or live r microsomal fraction  
( i  W/ v) which had a ll been reduced with a few grains of sodium dithionite. 
With the test cell only, carbon monoxide was bubbled steadily through the 
solution for 30 seconds and the difference spectrum recorded against the 
reference cell (without CO bubbled through i t ) .
The above method has been used for liver microsomes (Omura and Sato,
1964; Omura and Sato, 1964). The P-420 - P-490 difference used to
determine cytochrome P-420 and P-450 - P-490 difference used to determine
-1 -1 -1cytochrome P-450 is based on a protoheme content of 110 Cm and 91 cm mM
respectively. This is certainly valid for washed liv e r  microsomes. When 
yeast suspensions were used the base line showed significant d r if t  with 
wavelength, particularly over the important 400 nm to 440 nm region. The 
results were, in the beginning, expressed on P-420 -  490 nm difference and 
450 - 490 nm difference basis (for a comparison with lite ra tu re ) and also 
on the basis of symmetrical peak heights basis. The P-420 and P-450 
values used for interpretation of results were f in a lly  obtained from 
subtraction of CO difference spectrum from the base line-obtained 
using both cells reduced with dithionite before the CO bubbled through 
the test c e ll. Until new extinction coefficients have been devised 
for yeast P-420 and P-450, the extinction coefficients of liver microsomes 
had to be assumed to be s t i l l  applicable. The coefficient for P-450 may 
also be invalid for yeast P-450 as i t  is an average absorbance coefficient 
of two isomers and the present work (heat s tab ility  studies and induction 
work) suggests the presence of two non-identical isomers of cytochrome P-450 
in yeast.
Determination of protein (Lowry et a l , 1951)
The coloured complex formed is thought to be due to a complex between 
the alkaline copper-phenol reagent and the tyrosine and tryptophan 
residues of the protein. This complex formation is d irec tly  proportional 
to the protein concentration only in the range of 50 pg to 200 pg.
Bovine serum albumin solutions of concentration 50 pg to 200 pg were 
made up and used to prepare a standard curve. 1 ml of d is tille d  water was 
used as reagent blank. To 1 ml of each BSA solution 1 ml of an appropriate 
dilution of yeast on live r samples were added, with 1 ml of copper reagent 
(1 ml 1 %o copper sulphate; 1 ml 2% sodium potassium ta rtra te  and 20 ml 
of sodium carbonate in 0.5 M NaOH). The mixed solution was le f t  at room 
temperature for 10 mins before the addition of 3 ml of Folin-Phenol reagent
(5 ml Folin Phenol reagent diluted in 50 mis of d is tilled  water) and mixed. 
After heating at 50°C for ten minutes the optical densities were read at 
540 nm and a standard curve prepared by plotting optical densities versus 
pg BSA per ml. All reagents were freshly prepared before each determination.
This modification of the Lowry method uses a comparatively smaller 
volume of more concentrated copper reagent and a larger volume of more 
dilute Folin Phenol reagent mixed with sufficient force to ensure adequate 
preliminary mixing and final mixing can be postponed until after the reagent 
has been added to a ll samples. Heating the final mixtures of samples and 
reagents at 50°C also accelerates development, thus reducing the time of 
assay to minutes.
Drug Metabolism Assays 
Cofactor Solution
Microsomal drug metabolising enzymes require NADPH and oxygen. NADPH can 
be added directly or supplied by the auxiliary enzymatic reaction.
Mg++
G-6-P + NADP ----------------— > 6 -Phosphoglucono-
G-6-P lactone + NADPH
dehydrogenase
La Du jet al^  (1955) reported that aminopyrene demethylation was greater in 
the presence of magnesium ions. However, magnesium did not affect the rate 
of demethylation when NADPH was added directly. Probably adequate amounts 
of magnesium were present in the microsomal pellet. However, Jnirus, R, H. 
(1974) observed that magnesium was essential for hexobarbital and for the 
conversions of chlorpromazine to the corresponding sulphoxide. Therefore 
in most of the cofactor solutions magnesium and nicotinamide is added to 
stabilise the oxidised coenzyme by inhibiting NADPase ac tiv ity . The practice 
of adding nicotinamide has been criticised by Schenkman and Es tab rook,.. 1967,
who found that nicotinamide inhibits reactions when they are conducted for 
short periods of time (15 mins). With low enzyme concentrations and optimum 
concentrations of NADPH. They suggest that nicotinamide inhibits by combining 
with cytochrome P-450. Furthermore Mannering (1971) found that nicotinamide 
did not affect the maximal velocity of the Km of microsomal ethylmorphine 
demethylase, Semicarbazide is incorporated in some of the assays since 
i t  traps formaldehyde.
Determination of biphenyl 2 ,4 -hydroxylase activ ity  >
Biphenyl is metabolised to 2 and 4-hydroxy derivatives in liv e r  
(Creaven et <*!> 1965) while i t  is metabolised exclusively to the 4-hydroxy 
derivative in yeast.
Biphenyl
2-Hydroxybi phenyl 4-Hydroxybi phenyl
Fluorimetric and Quantitative Assay:
Incubation system consists of
Tris buffer pH 8.1 25 yM 0.50 ml
Biphenyl 3 yM 0.25 ml
MgCl2 
KC1 1.15%
10 yM 0.20 ml
0.30 ml
NADPH or
NADP 1.5 yM 0.25 ml
G-6-P
G-6-P-D 2 units
Yeast fraction or
Liver fraction 0,50 ml
After incubation for 20 min reaction is terminated by addition of 
2N-HCL (0,5 ml). Biphenyl/s are extracted with 10 ml of n-heptane for 
5 min and aliquots of the heptane layer one further sim ilarly extracted 
with 0,1 N NaOH (10 ml). After separation of phases by pentrifugation 
2.0 ml aliquots of the aqueous layer are placed in a cuvette and 0.5 N 
succinic acid is added (0.5 ml). Fluorescence is measured at two wavelengths, 
338 nm and 415 nm, with excitation at 275 nm and 295 nm respectively.
Blanks v/ere prepared by addition of substrate a fte r incubation.
Similarly, standards containing either 2-hydroxybiphenyl (6 yg) or 4-hydroxy- 
biphenyl (30 yg) in 5% ethanol.
Thin Layer Chromatography
The yeast fractions were incubated in a media containing a reduced 
cofactor solution and the substrate. For the NADPH generating system the 
media contained NADP (2 mM), Glucose-6-Phosphate (25 mM) and glucose-6-  
phosphate dehydrogenase (2.5 units). For the NADH generating system the 
media contained NAD (2 mM). Sodium lactate (50 mM) and Lactate dehydrogenase 
(1.25 mg protein). Additionally both systems contained magnesium sulphate 
(10 mM) and biphenyl substrate (15 mM) which was added to^the mScTIjjm dissolved 
in a solution of 1.15% KC1 containing 4% Tween 80. The mixture (usually 
10 ml) contained the yeast fraction of about 1 g wet weight of yeast. The 
mixture in 0,1 M phosphate buffer (pH 7.4) was incubated for 1 h with thorough
■ -  ./ ! , - V A . f >  '
aeszotCdYii by a rotary shaker. After the incubation the reaction was stopped as 
in fluorimetric assay and the mixture was extracted for 10 min with 2 ml of
hexane containing 0.1 ml of amyl alcohol. The hexane layer was then 
separated from the aqueous phase and was tested for hydroxylated biphenyl 
metabolites by s ilica gel thin layer chromatography. The silica gel 
had added fluorescent indicator (HF 254). Standard spots of h-hydroxy 
and 2-hydroxy biphenyl were also applied. The mobile phase was a 95:5 
mixture of benzene/absolute ethanol and detection was by fluorescence; 
purple spots upon a green background.
Aniline hydroxylase activ ity  '
Aniline is hydroxylated by rat live r microsomes to p-aminophenol.
3U? NH,
Aniline OH
p-aminophenol
Incubation mixture consists of (Guaawno et a l> 1969):
Tris-HCl buffer (0.3 M, pH 7,6) 0.5 ml
Aniline hydrochloride (0.04 M, pH 7.6) 0.5 ml
MgCl2 (0.1 M) 0.1 ml
NADP (0.01 M) )
) 0 .2  ml
Giucose-6-phosphate (0.1 M) )
Microsomal fraction 0.5 ml
(Yeast 3/1 w/ w; Liver 4/1 v/ w
After incubation for 15 min the reaction is stopped by addition of solid 
NaCl (approx 1 g). Peroxide-free ether containing 1.5% (V/ y) isoamylalcohol 
is added (12  ml) and p-aminophenol is extracted in a rotary shaker for 
20 min. Ether aliquots (10 ml) are subsequently added to 40 ml of alkaline  
phenol (0.5 M tripotassium orthophosphate containing 1% w/ v phenol) and
extracted on a rotary mixer for 30 min. The blue colour is measured at 
620 nm. Suitable blanks and standards (0.1 mol in 0.1 M HC1 are carried 
through the same procedure.
Measurement of Ethylmorphine, Imipramine and Aminopyrine N-demethylase 
A ctivity:
Ethylmorphine, aminopyrine and imipramine are metabolised in v itro  
to the N-demethylated derivatives, the methyl group being lost as formaldehyde 
which, after trapping with semicarbazide, can be measured, by the Nash 
reaction (Nash, 1953).
CH3
N
OCH2CH3 1
Ethylmorphine
Unstable intermediate
+ HCHO
Formaldehyde
Incubation Mixture consists of:
Tris - buffer 0.3 M, pH 7.6 0.50 ml
MgCl2 0.1 M 0 .1  ml
Ethylmorphine 0.06 M 
Semicarbazide
0.25 ml
Hydrochloride 2% at pH 7.0 
Cont..,
0 .2 0  ml
Glucose^-phosphate - 50 ymol/ml ) 0.50 ml
NADP 10 ^mol/ml 
G-6 -phosphate dehydrogenase 
10 I.U./ml
)
)
Incubation is carried out for 10 min and is terminated by addition 
of 15% ZnSO^  (1.0 ml) followed by a 2:1 mixture of saturated solutions 
of Ba(0H)2  and ^ 2 8 4 0 7  (1 ml). Protein is removed by centrifugation and. 
aliquots of supernatant (0 .2  ml) are added to 2 ml of freshly prepared 
Nash reagent (4M-ammonium acetate containing 4 m l/litre  of acetylacetone).
The mixture is incubated for 40 min in a shaking bath at 37°C. The 
absorption at 412 nm is measured. Suitable blanks and standards (0.3 moles) 
are carried out through the same procedure.
p-Nitrobenzoate reductase
Hepatic microsomes reduce p-nitrobenzoic acid to p-aminobenzoic 
acid probably through the formation of nitroso and hydroxyl-amine intermediates
anaerobic
NADPH
NHOH
C00H C00H C00H C00H
p-aminobenzoic
acid
Incubation mixture is essentially that of Fouts and Brodie (1957).
p-Nitrobenzoic acid 0.01 Mm
0.05 M-Tris buffer pH 7.6
MgCl2 0.05 M, pH 7.6
NADP 0.006 M
Glucose-6-P •
Glucose~6~P-D 
Cont,..
0.05 M ) 
)
10 units/ml )
2 .0  ml
0.5 ml 
0.5 ml
0.5 ml
FMN 0.25 mM 0.5 ml
Microsomal fraction 25% 0,5 ml
Tubes are kept in an ice bath while N2 is flushed through (1-2 lb /in^) for 
10 min to maintain anaerobic conditions. Incubation is carried out under
for 30 min and the reaction is terminated by the addition of 12.5% TCA
(0.5 ml). Protein is centrifuged down and to 2.0 ml of the supernatant, 
0.1% NaN02 (0.5 ml) is added and tubes are allowed to stand for 30 min. 
This is followed by 0.5 M - ammonium sulphate (0.5 ml and fin a lly  0.1% NED 
(0.5 ml). Volume is made up to 10 ml with water and tubes are allowed to
stand for 30 min. The mauve colour is determined at 545 nm. Suitable
blanks and standards (0.25 moles) are carried through the same procedure.
Microsomal Cytochrome b^  content
Cytochrome b^  is measured as the difference spectrum of NADH reduced 
microsomes against oxidised microsomes. The method is that of Omura and 
Sats (1964).
Microsomal suspension (25% liver; 30% yeast) is diluted v/ith 0.1 M
phosphate buffer pH 7.4 and then added into two glass cuvettes. In one
cuvette 0.1 ml of NADH (1 mg/ml) is added and a difference spectrum is
obtained between 390 and 450 nm. Cytochrome b  ^ is taken as the difference
in optical density between 410 and 426 nm ( i .e .  trough and peak). Molar
-1 - Iextinction coefficient for cytochrome b^  185 mM cm
NADP^cytochrome-c-reductase
The enzyme is located in the microsomes and is believed to function 
as a component of the mixed function oxidase system. The activ ity  is  
measured essentially by the method of Williams and Kamin (1962).
In two cuvettes the following are added:
Potassium phosphate buffer
0.05 M, pH 7.6 containing 10~^ M KCN 1,7 ml 1.8 ml
Cytochrome C (0.1 mM) 1.0 ml 1.0 ml
Microsomal suspension 0.2 ml 0.2 ml
NADPH (0,03 M) 0.1 ml -
After establishing a base line the reaction is commenced by addition 
of NADPH and the reaction is immediately followed at 550 nm for 1-2 min.
The in it ia l velocity is taken as the measure of cytochrome c reduction. 
Molar extinction coefficient 18.5 mM ^cnT .^
Measurement of benzo(a)pyrene hydroxylase
3-Hydroxyb’enzpyrene is the major metabolite both in live r and yeast. 
The method used for live r is essentially that of Kuntzman et <al_ (1966).
The incubation tubes are of 15 ml capacity (stoppered) and stored in ice, 
to which the following reagents are added:
Cofactors in buffer.
NADP (10 ymole/ml)
G-6-P (50 ymole/ml)
G-6 -P-D (10 I.U ./m l) 0.4m l 0.4ml
MgS04 (100 mM) 0.1 ml 0.1 ml
0.1 M Phosphate bufferCpH 7.4)0.9 ml 0.9 ml
Microsomal fraction 0.2 ml 0.2 ml
Benzpyrene substrate 0.1 ml 0.1 ml added after incubation,
After the addition of substrates the tubes v/ere flushed out with 
oxygen and stoppered and mixed briefly  in a whirlmixer and were placed in 
a covered 37°C shaking water bath for 20 min. Reaction was terminated by 
plunging tubes into the ice bath. 2 ml.of cold acetone was rapidly added 
and the contents were mixed in a whirlmixer. The substrate was then
added to control tubes followed by 8 ml of n-hexane to a ll  tubes.
The extraction of 3 -hydroxybenzpyrene was carried out on a rotary - 
shaker for 20 min in total darkness. Into 10 ml stoppered tubes, 4 ml of 
upper layers (substrate and hydroxymetabolite in n-hexane) and 5 ml of 1 M 
NaOH were added rapidly. After 2 min extraction in total darkness followed 
by rapid centrifugation the upper n-hexane layers were rapidly aspirated and 
the fluorescence of the lower alkaline layers detected immediately using a 
Perkin Elmer MPF 3 fluorescence spectrophotometer. Fluorescence observed 
at 510 nm with excitation at 382 nm. As the f 1 uorescence'of the products 
is destroyed by NaOH, measurements were carried out within 10 min after 
addition of a lk a li.
Standard:
A 0.3 yg/ml solution of quinine sulphate in 0.05 M I^SO^ was used as
a standard by observing fluorescence at 445 nm with activation at 340 nm.
1 yg of quinine sulphate was taken = 42.05p mole of 3-hydroxybenzo(a)- 
pyrene.
Measurement of p-nitroanisol 0-demethylatioa activ ity
O-deJethylase activ ity  of liver and yeast microsomes was measured 
using the Perkin Elmer 356 dual beam spectrophotometer.
Incubation
To a 10 x 10 mm cuvette were added the following:
P-nitroanisol (3mM in water) 0 .2  ml
Tris/HCl buffer pH 7.8 2.0 ml
NADPH (0.2 ymole in 10 y l ) 0.01 ml
Microsomal fraction 0.30 ml
The mixture was preincubated at 37°C for 3-4 min. The reaction was then 
started with the addition of NADPH and mixing the reagents. The optical
density was followed on the spectrophotometer with the following settings:
X-j 490; X2 420; Select X2
S lit  width 4 nm Pen position 'O'
Dual beam settings 1) polintrometer (dual on sp lit off)
11) s lits  
111) cell holder
Shutter open 
Response S or M
Range A 0.03 '
Voltage fu lly  counterclockwise 
Recorder 10 mV 
Float up
Chart speed 5 mm/min
leave attenuater X2 fu lly  open and balance with X-j p-nitrophenol was
used as a standard, which was put into the cuvette with the added reagents.
Measurement of 7-ethoxycoumarine O-deethylase activ ity
The micoosomal (yeast and liver) 0-deethylsae activ ity  was measured 
on Perkin Elmer fluorimeter using 7-ethoxycoumarine as the substrate. The 
method used is essentially that of U llrich et aj_ (1972).
Incubation
To a 10 x 10 mm cuvette the following are added:
Microsomal fraction 1.8 ml
_3
Ethoxycoumarine (10 M) 0.2 ml
After establishing the base line , the reaction was started by the 
addition of 10A ! (2 x 10~^ M in buffer) of NADPH. The fluorescence was 
measured at the 370 nm excitation, with 450 nm emission wavelength. The 
s l i t  width v/as 3 nms. Coumarine was used as a standard to calibrate the 
fluorimeter.
Direct fluorimetric assay of a microsomal 0-dealkylation (preferentially
induced by 3-methylcholanthrene) using ethoxyresorufin
The method used- is essentially that of Burke et aj_ (1974). Liver 
microsomes from rat and microsomes from yeast O-deethylated ethoxyresorufin 
to resorufin in an NADPH- and oxygen-dependent reaction involving the 
flavoprotein NADPH cytochrome c reductase and cytochrome P-448/P-450. The 
reaction was performed in a fluorimeter cuvette and monitored directly  
by recording the increase in fluorescence associated with the formation 
of resorufin. 3-methylcholanthrene pretreatment of the ahimals and yeast 
cells increased the reaction.
Assay of ethoxyresorufin metabolism
The general reaction mixture, prepared in a fluorimeter cuvette 
contained:
Buffer (Potassium phosphate 0,1 M pH 7.8) 2 ml
Microsomal fraction 20 y l
Ethoxyresorufin (50 yM in 1.25% w/ v Tween 80) 10 y l
A baseline of fluorescence was recorded at an excitatjion wavelength 
of 510 nm and an emission wavelength of 586 nm with a Perkin Elmer 
spectrophotofluorimeter, with s l i t  arrangement 1 mm. A 10 yl aliquot of 
NADPH (50 mM) was stirred into the mixture to start the reaction and the 
progressive increase in fluorescence, as ethoxyresorufin was deethylated to 
resorufin, was recorded. The reaction was done in a ir at 30°C. The 
fluorimeter was calibrated with 10 yl of resorufin (0.01 mM in ethanol). 
Ethoxyresorufin and resorufin (10 yg/ml) in aqueous solution underwent 
total decomposition within 2 hrs when exposed to bright, room lighting , 
although they were stable in light which was at the fluorescence excitation  
wavelength of either compound. Consequently, solutions of these compounds 
were prepared and stored in the dark, and the metabolic reaction was performed 
in a room with dim lighting.
(.60)
CHAPTER I I I
Regulation of Cytochrome P-450 Biosynthesis in Relation to Yeast Growth
Ishidate _et al_ (1969) reported that Saccharomyces cerevisiae 
(JYD-56) synthesises a cytochrome P-450 (peak at 450 nm in reduced 
CO complex) which is similar in spectral characteristics with the 
hepatic drug metabolising enzyme system (Parke, 1972). I t  was also 
suggested that P-450 in yeast was presumably involved in a special 
electron transport system resembling that operating in live r microsomes. 
The conditions of biosynthesis of cytochrome P-450 include the mito-
i
chondrial repression. These conditions include anaerobic growth, and 
aerobic growth in high glucose concentration or in low glucose con­
centration in the medium containing inhibitors (Ishidate et al^ , 1969), 
such as erythromycin or chloramphenicol, that prevent the biosynthesis 
of mitochondrial enzymes especially cytochromes a+a3 . Similar behaviour 
was also found with respiratory deficient mutants.
The content of P-450, in wild type yeast cells grown anaerobically 
decreased sharply on exposure to aerobic conditions (Ishidate ert aj_, 1969) 
This change paralleled the formation of mitochondria within the cells .
High concentrations of glucose and chloramphenicol inhibited both the 
decrease in P-450 and the development of mitochondrial type of respiration 
A similar decrease in P-450 was also observed when cells of a semi- 
anaerobically-grown respiration deficient mutant were aerated. The weak 
respiration of anaerobically grown mutant yeast cells was insensitive to 
antimycin A. The rate of this insensitive respiration was proportional to 
the content of P-450 in various types of cells .
In Su cerevisiae (NCYC No. 240) the cytochrome a+a  ^ is at a high 
level in 0.1% glucose medium where no cytochrome P-450 is produced even 
in the early phase of growth. In high glucose medium the level of 
cytochrome P-450 fa lls  after 40 hrs of culture growth correspond!*ng to a 
rise in the level of cytochrome a+a^. I t  is not clear, however, why the
levels fa ll rapidly to zero by 72 hours although the glucose concentration 
in the medium fa lls  rapidly at this time of the culture growth. The 
glucose concentration normally fa lls  to 8%, from the original 20%, by 
about 50 hrs and presumably some enzyme may be degraded by that time when 
the cultures are in the stationary phase of the growth.
Cytochrome P-450 in Brewer's yeast is an inducible enzyme when grown 
on 3-methylcholanthrene-containing medium (Wiseman and Gondal, unpublished 
work). This induction is similar to the induction of cytochrome P-450 in 
Fiepatfc system, leads to the production o f P-448 type of cytochrome .The inductio 
in P-450 levels in yeast is achieved only in 20% glucose medium. With 
the induction of "p-450" there is a corresponding decrease in cytochrome 
P-420 level. There is , hov/ever, no induction when yeast is grown in 1% 
glucose medium. Wiseman and Lim (1975) reported the appearance of cytochrome 
P-450 in 0.5% glucose as controlled by the media concentration of pheno­
barbital , a classical inducer of hepatic drug metabolising enzymes (Parke,
1975). There is no production of cytochrome P-450 in 0.5% glucose in the 
absence of phenobarbital. The time of culture controls the concentration 
of cytochrome P-450 found in the presence of pherbarbital in _S. cerevisiae.
Rapid degradation occurs when growth ceases. Phenobarbital does not decrease 
the rate of degradiation of the enzyme. Inhibition by cycloheximide suggests 
the stimulation of de novo synthesis by phenobarbital.
Materials and Methods
Saccharomyces cerevisiae (NCYC No.240) was grown on agar slopes for
three days and stock cultures were stored in the dark at 4°C. The cultures
were grown in conical flasks in a shaking water bath at 30°C and 50 rev/min.
The growth medium contained glucose in the range 0.1% to 20% ^ /v . The
o
glucose and the growth medium were sterilized separately at 151b/in for - 
15 min in an electric autoclave or an ordinary pressure cooker. The medium 
when sterilized with high glucose concentration, usually took on a very dark
colour after autoclaving which lead to a very low level of cytochrome P450.
I t  was therefore assumed that the glucose in the medium was degraded to 
form masking pigments due to the high temperature required for s te riliza tio n . 
Separate s teriliza tion  was, therefore, necessary a ll through the work.
The yeast cultures were grown separately for 17 hrs to 70 hrs.
The yeast growth data were derived after f iltra t io n  (wet weight). The
levels of cytochrome P450 were estimated in whole yeast cells and the
1 wderived microsomal fraction, on a / 1 0 /v dilution with phosphate 
buffer pH 7.4. The absorption spectra at 450nm reduced Co complex 
were obtained using an SP 1800 recording spectrophotometer. Details of 
this estimation and the estimation of cytochrome a + a  ^ by absolute 
spectral determination have been described in Chapter 2. As described 
in the material and methods section the difference spectra were obtained 
using sodium dithionite reduced samples, and Co bubbled through the 
reference cuvette only. The whole yeast cells had their cytochrome P450 
in a reduced state even without the addition of dith ionite, while the 
derived microsomal fraction had to be reduced with sodium dithionite.
The milling of whole yeast cells seems to have oxidised the cytochrome P450, 
as the yeast homogenates also had to be reduced before a difference 
spectrum could be obtained.
2.2 Result$.
The growth of the yeast in various glucose concentrations is shown 
in Fig. (2 .1 ). The related cytochrome P450 along with P420 are shown 
in Fig. (2 .2 ). The two curves (2.1) and (2.3) are to be considered in 
relation to each other as regards the production of cytochrome P450 as 
the yeast grows.
Rapid production of this enzyme, in early growth phase occurs only
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at 1% and 2.5% glucose medium, while none is formed in 0.1% glucose 
medium.' The early production of cytochrome P450 is delayed in 5%
(or above) glucose medium, and the increasing concentrations are observed 
only towards the end of the logarithmic phase of growth. The accumulation 
of cytochrome P450 could not be correlated with the rise in alcohol 
content of the media in late growth phase.
I t  has been shov/n that cytochrome P450 is present transiently even 
in medium containing as l i t t l e  as 1% glucose in the early growth phase
t
of the culture (Wiseman £ t cfh 1975a). Different concentrations of 
glucose in the growth media, 1% to 20% have now been used. The change 
to high glucose accompanied by high levels of cytochrome P450 in late  
lo g a r i th m ic  phase of growth, is observed to begin at 3% or 4% glucose 
concentration in the media. The subsequent loss of cytochrome P450 in 
1% glucose medium can be correlated with the rise in concentration of 
cytochrome a + a^. The level of P450, then drops in the 1% glucose 
medium in correspondence with the rise in the cytochrome a + a^  level.
The potential inducers for cytochrome P450 are 3MC ( 3-methylchol- 
anthrene) and phenobarbital. (Wiseman e t al_. 1975) have shown the effect 
of phenobarbital concentration on the induction of P450 in yeast. They" 
showed that none of this enzyme was found at 0.05% phenobarbital in 
the growth medium, while at 0.15% phenobarbital, a concentration of 
2nmol. cytochrome P450/g wet weight of yeast was reached. The 
concentration of cytochrome P450 in the yeast drops during the stationary 
phase of growth in 0.5% glucose, with 0.2% phenobarbital present. This 
behaviour is similar to that reported for 1% glucose medium where 
transient accumulation of the enzyme is followed by a rapid decline to 
30% at 40 hrs, of the maximum level reached at 17 hrs. This pattern is  
quite unlike that in 20% glucose where there is relatively l i t t l e
cytochrome P450 present after 17 hrs but high levBs are reached at 
30 hrs followed by a decline, when growth ceases, to zero at 70 hrs.
With yeast grown in 20% glucose for 30 or 40 hrs in the presence of 
0 . 2% phenobarbital there was no increase in the existing high level of 
cytochrome P450.
3MC with a concentration of .ImM in 20% glucose medium, does induce
the 450nm absorption peak, which rise from 5 to reach 6.5n mol/g yeast,
after 40 hrs of growth period. This induction, however, is related to 
the 448 type of the cytochrome rather than 450 type. SMC on the other
hand has no inducing effect when used with 5% glucose medium, which may
suggest the transformation of P450 produced by glucose "induction" to 
give P448, by the action of 3MC.
2.2.2 Effect of detergent, antibiotics and enzyme inhibitors on cytochrome
P450 loss under deadaptation conditions.
With yeast either grown in 0.1% glucose for 24 hrs or grown in 1%
glucose for 70 hrs, P450 was undetectable. When the yeast was transferred
to the medium containing 20% glucose medium, P450 appeared in 17 hrs 
at a level of 3n mol/g of wet weight of yeast) and the level then declined
to 1.5 in 40 hrs. On the other hand, when yeast cells grown in 20%
glucose medium were then transferred to 20% non growth medium with or 
without the detergent, inhibitor or antib io tic , cytochrome P450 was found 
to be protected from destruction by the 20% glucose medium.
2.2.3 Effect of an inhibitor of cytochrome P450
The best known inhibitor of cytochrome P450 is carbon monoxide.
Pre-gassing of the 20% glucose medium with CO, did not in h ib it the growth 
of the yeast. The cytochrome P450 binds inrreversibly with Co i .e .  the 
binding with CO is irreversible by gassing with 0£ or a ir .  I t  is possible,
therefore, that the P450 CO complex may be stable even a t a yeast 
harvesting time of 3 days.
In deadaptation experiments, yeast cells were grown in 20% glucose 
for 40 hrs at 30°C. The harvested yeast (lgm wet weight) was transferred 
to 100 ml non growth medium of 0.1M P. Buffer pH 7.4. The yeast cells 
were incubated in a shaking water bath for several hours at 30°C. The 
minimum concentrations of detergent, antibiotic and the inhibitors were 
added to the non growth culture medium. Fig. (2.4) shows the degradation
i
of P450 in 6 hrs when suspended in the medium containing OHM phosphate 
buffer, and shaking in the v/ater bath at 30°C. When the medium was 
supplemented with EDTA, a detergent or and an antibiotic the cytochrome P450 
showed a greater s tab ility  (see Figs. 2.5, 2.6 and 2 .7 ). Cytochrome P450, 
however, was not stabilised when the medium was supplemented with various 
inhibitors like 8 : -hydroxyquinoline and phenylmethylsulphonyl fluoride and 
2,4:-Dinitrophenol (see Figs. 2.8 and 2.9, 2 .9.1^.In 0.1% glucose medium, 
the yeast cytochrome P450 remained at the same activ ity  in non aerated 
medium, while i t  was destabilised under aerated conditions i .e .  shaking 
in water bath at 30°C. The non growth medium supplemented with inhibitors 
do not stabilise P450, as shown before in deadaptation studies. The 
non-growth medium, on the other hand, supplemented with 20% glucose medium 
stabilises the cytochrome P450 to a greater extent. As previously shown 
a recovery of 0 to 20% and 0 to 52% has been achieved by using the 
increased level of glucose in the growth medium.
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Discussion
The glucose repression of mitochondrial formation is known to be 
associated with the lower intracellu lar levels of adenosine 3 1- 5 1 cyclic 
AMP in high glucose medium. Fang and Butow (1970) reported that when 
yeast protoplasts prepared from anaerobically grown cultures were 
transferred to a low glucose medium they showed respiratory adaptation.
In a medium containing 5% or 10% glucose, derepression was inhibited but 
could be overcome by addition of cyclic AMP. The presence of cytochrome
f
P450 was irreversibly related to the formation of mitochondria in the 
yeast system. Under these conditions, the biosynthesis of cytochrome P450 
may be associated with the loss of cyclic AMP during incubation in high 
glucose media.
Rapid destruction of cytochrome P450 can occur when the glucose 
level fa lls . The mechanism of these effects is not fu lly  understood. The 
transient appearance of cytochrome P450 in 1% glucose medium is associated 
with the only slow rise of cytochrome a + a  ^ as the growth of yeast 
begins during the f ir s t  17 hrs. The much faster growth rate of yeast 
occurs with low levels of intracellu lar cyclic AMP (in 20% glucose medium 
rather than in low glucose media). Inhibition of the growth of E.Coli 
by exogenous cyclic AMP has been reported (de Roberts et al_., 1973).
The inverse relationship between cytochrome P450 and formation of 
mitochondria is observed. Cells grown in 20% glucose media and transferred 
to 0.1% glucose form mitochondria. At high glucose concentration (20%) 
mitochondrial formation is repressed, and the decrease in P450 is 
prevented, in contrast to the case of 0.1% glucose medium. The effect 
of 0 . 1% glucose was enhanced when the cells suspension was kept standing 
instead of shaking. This may be explained by the fadt that in the presence
of oxygen, unsaturated fatty acids of phospholipids undergo peroxidation 
(Hochstein et a K , 1968), a process which destroys the architecture of 
microsomal membranes and leads to the formation of malonyldialdehyde.
This process could be blocked by EDTA (Levin et a K , 1973), by inhibiting  
lip id  peroxidation. But in the adaptation study, with the addition of 
ImM EDTA plus 0.1)% glucose, this did not restore the level of cytochrome 
P450. This leads to the assumption that the degradation of cytochrome 
P450 during adaptation may not be only due to lip id  peroxidation of 
microsomal membrane. Yu and Coon (1974) showed that cytochrome P450 in 
Pseudomonas can be reconverted from cytochrome P420 by treatment with 
sulfhydryl compounds such as cysteine, 3-mercaptoethanol or thioglycolic 
acid. Hence the loss of cytochrome P450 during deadaptation may be 
due to oxidation of a sulfhydryl group in this enzyme.
Ishidate et £]_. (1969b) reported that with yeast grown under 
semianaerobic conditions mitochondria are absent, and fermentation supplies 
the energy demands of the cells. However, the mitochond%a do not 
disappear but exist as pro-mitochondria which are unable to support 
oxidative phosphorylation. Clark-Walker reported (1972) that 
pro-mitochondrra occur in yeast grown under conditions of high glucose 
concentration in the nutrient media or under semi-anaerobic conditions.
Here the yeast is unable to synthesise the inner mitochondrial membranes, 
due to deficiency of unsaturated fatty acids during growth anaerobically 
or in high glucose concentration media.
In the study of an RD mutant Wiseman et al_. showed that the wild
type yeast grown in 0.1% glucose forms cytochrome a + a^  but the RD mutant 
does not produce any cytochrome a + a3 . The la tte r  showed a small, amount 
of cytochrome P450 present when grown even in 0.1% glucose. The inverse 
relationship between cytochrome P450 content and formation of mitochondria
was shown under these conditions, which repress the adaptative formation 
of mitochondria.
Many antibiotics have been used to investigate the process of aerobic 
adaptation and of Repression in glucose-grown yeast. Various antibiotics 
inh ib it protein sythesis in bacteria and they prevent the formation of 
mitochondrial cytochromes in yeast cells in a similar manner to glucose 
repression. Wilkie,Cl 972).; Rousseau and Hal verson,Cl 973) have reported 
that chloramphenicol, tetracycline and erythromycin, are specific 
inhibitors of mitochondrial protein synthesis due to combination.with 
ribosomes. The specific inhibitor, rotonone, an extremely toxic 
insecticide, blocks electron transfer from NAD to cytochrome b, and 
hence prevent the process of synthesis of cytochrome a + ag.  Wiseman et al_.(i*\i5«.)
have shown that cytochrome a + ag levels decrease in the presence of
chloramphenicol with increase in cytochrome P450 level. Tetracycline, 
erythromycin and imipranine showed that same effect as chloramphenicol.
The role of cytochrome P450 produced in yeast grown under high 
gluccse concentrations is not fu lly  understood. Alexander et a/k (1974) 
reported that the conversion of lanosterol to zymosterol, by demethyl a ti on,
in yeast disruptates could be inhibited (57%) by CO, but not by
inhibitors of mitochondrial cytochromes .such as cyanide or antimycin-A.
This is suggestive of a role for cytochrome P450 in this conversion, 
which is in the pathway of ergosterol synthesis in yeast, and may explain 
its  accumulation in the yeast under conditions o f glucose repression of 
the structural materials of the mitochondrion. The accumulation of 
ergosterol or its  precursors under conditions of glucose repression may 
be beneficial for the rapid restoration of functional mitochondrial 
membranes after glucose depletion, under aerobic conditions.
An alternative explanation is that the ergosterol is required for
proliferation of the membranes of the endoplasmic reticulum that contain 
the cytochrome P450, such as with the observed proliferation of these 
membranes upon induction of cytochrome P450 content of the yeast 
(Gibbons and Mitropoulous, 1973). This may therfore encourage this 
proliferation of the endoplasmic reticulum, so allowing an increasing 
amount of cytochrome P450 to be present in the cell in the form of 
membrane bound enzyme. I t  is of interest in this connection that the 
cytochrome P450 of liv e r is involved also in the biosynthesis of cholesterol. 
The role, therefore, in liv e r, of cytochrome P450 is in the metabolism 
of drugs and perhaps the removal of toxic lip id  hydroperoxides. The 
accumulation of cytochrome P450 only in the absence of functioning 
mitochondria (when cyclic AMP level is low) may reflect the absence then 
of toxic radicals produced as a by product of oxidative phosphorylation. 
Furthermore, our work with drug metabolism may indicate the involvement 
also of yeast cytochrome P450 in the metabolism of drugs and carcinogenic 
xenobiotics.
The molecular basis for the phenomenon of microsomal enzyme induction
r*
is not fu lly  understood. Administration of phenobarbital to rats 
increases the rate of synthesis of certain microsomal drug metabolising 
enzymes in a selective manner and promotes proliferation of smooth 
endoplasmic reticulum in live r. Conney and Gilmann (1963) suggested that 
the increased enzyme activity by phenobarbital induction was inhibited 
by Actinomycin-D and implied that the mechanism of this synthesis is 
de novo protein synthesis. Vankatesan and Steel (1975) reported that 
phenobarbital could produce a 30% increase in the amount of ribosomes 
and mRNA in cells. In rat liv e r, Ambike et a/L (1970) reported that a 
small increase occurs in cytochrome P450 level caused by phenobarbital.
In deadaptation study, phenobarbital did not show any protection in P450
degradation. This suggested that phenobarbital is not decreasing the rate 
of degradation of cytochrome P450 but is a genuine inducer of biosynthesis, 
as suggested for liv e r. This was further indicated by our la tte r  work 
on the induction of cytochrome P448 of yeast with 3-methylcholanthrene.
Kawaguchi et a1_. .(1973) concluded that cytochrome P450 is not 
involved in ergosterol synthesis nor in the desaturation required for 
the formation of the unsaturated fatty  acid moiety in yeast phospholipids, 
unless saturated fatty  acids could replace these. This cqnclusion is 
contrary to the studies on a cell-free system from Saccharomyces cerevisiae 
that can convert lanosterol to zymosterol (Alexander e t a l . ,  1974).
The system in the pathway for ergosterol biosynthesis, involves a 
demethylation reaction, and i t  was inhibited by Co. This was also 
confirmed by our la tte r  work on the demethylation reaction carried out 
by Saccharomyces cerevisiae. This may suggest the involvement of cytochrome 
P450 in the pathway. Kawaguchi et aK (1973) however, considered 
w-hydroxylations to be unlikely in the yeasts because of the presence 
of the cytochrome P450 in semianaerobically grown yeast and tts  
disappearance upon aerobic adaptation. An alternative view would be that 
the hydroxylation of oleic acid might be required under conditions of 
mitochondrial repression. In support of this, 3% Tween was found to 
increase the level of cytochrome P450 in brewers yeast at late phases 
of growth Wiseman et a_T_.(])976].. This would be a case of substrate induction 
which would suggest that cytochrome P450 catatlyses the hydroxylation of 
oleic acid prior to incorporation into membranes possibly of the endoplasmic 
reticulum or more like ly  of the mitochondria.
(83 )
CHAPTER IV
RADIATION AND THERMAL STABILITY 
INTRODUCTION
Various reports have appeared on the effect of substances including 
CO factors such as NAD , as stabilizers or destabilizers of their respective 
enzyme in v itro . Grisolia (1969) has published a comprehensive review of 
both types of effect. Bernard and Rossi (1968) have reviewed the best 
known effect, which is the stabilization of an enzyme by its  substrate.
Grisolia et^a]_(1959) noted that a loss of yeast alcohol dehydrogenase 
activ ity  was seen when the preincubation medium (Tris-HCl pH 7.4) at 43°C 
contained some NAD+. '
Work by Yonetani and Theorell (1962) on liver alcohol dehydrogenase
showed the opposite effect. These workers reported that some stabilization
at 75°C (pH 7.0) with, in fact, quite low concentrations of NAD+ (0.04 mM)
relative to other studies. Wiseman et al (1971) found no stabilization at
this concentration of NAD+ (43°C, pH 8 .8 ) but observed a concentration
+ +dependent inactivation of alcohol dehydrogenase by NAD or NADP . We have 
compared the thermal s tab ility  of oxidised and reduced forms of cytochrome 
P-450 from rat liver microsomal fraction with those from brewer's yeast 
microsomal fraction (Wiseman et cH_, 1975b). Radiation s ta b ility  studies 
were also carried out on the yeast disruptates. Further, investigation 
was made of concentration dependent protection, by type 1 and type 2 
substrates, of the oxidised conformational form of live r microsomal cytochrome 
P-450 against thermal denaturation assisted by 0.6% (4 mM) Tween 80. This 
is a non-ionic detergent that clearly binds to lip ids, and further, shows 
the spectral characteristics of a type 1 binding ligand (Burke et al_, 1972; 
Parke, 1975).
Material and Methods
Brewer's yeast (Saccharomyces cerevisiae, N.C.Y;- ^N0.240) was grown 
for 45 hrs and cytochrome P-450 measured as reported in "Material and Methods".
We used 20% glucose media in this study.
Yeast was disrupted by use of a Vibromill (6  min) and by use of snail 
gut enzyme (Williams' and Williams, 1973). Slightly better yields of cytochrome 
P-450 are obtained after the snail gut enzyme procedure. Microsomal 
fraction was obtained from disrupted yeast cells (or ra t live r homogenate 
made by use of the Potter-Elvelijem homogenizer) in 100 mM-Potassium phosphate 
buffer, pH 7.4, by d ifferentia l centrifugation, f in a lly  at 105,000 g for 1 hr.
Samples (oxidised or dithionite-reduced forms) were jieated at 46°C and 
separate experiments v/ere terminated at 5, 10, 20 and 30 min for determination 
of residual cytochrome P-450. In the indicated experiments the additives 
were:
( i )  Tween 80 (0.6% in 1.15% KC1).
( i i )  11 mM-N-ethylmorphine in water or in Tween 80 (0.6% in 1.15% KC1).
( i i i )  6 mM-aniline in water or in Tween 80 (0.6% in 1.15% KC1).
(iv ) 11 mM-N-ethylmorphine + 6 mM-aniline hydrochloride in water or Tween 
80 (0.6% in 1.15% KC1).
The KC1 has no additional effect alone, to heating just in the 100 mM- 
potassium phosphate buffer, pH 7,4, present in a ll experiments. Tween 80,
0,15% and 0.3%, showed similar but small effects to 0.6% Tween 80. Where 
stated, certain samples with or without Tween 80 alone were saturated with 
CO before heating. The concentration-dependence of the protective effects  
of each of N-ethylmorphine and aniline was investigated at a series of 
concentrations as indicated. All heating experiments were performed in a 
water bath and in trip lica te  throughout this work and the means were taken 
(variation in results was very small).
The N-ethylmorphine hydrochloride was obtained as a g if t  from May and 
Baker Ltd., Dagenham, Essex, U.K.
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For radiation studies, we used a CO y-ray source (0.11 MR/hr).
Yeast was disrupted by use of ,a Vibromill (6 min) as before or 
by use of snail gut enzyme. The disrupted cells were suspended in phosphate 
buffer (100 mM pH 7.4) at a concentration of V-jq W/ v - Samples were 
made in trip lic a te  with 10 ml suspension in each. Radiation was carried 
out at room temperature. To correct for the minimal loss of cytochrome P-450 
at room temperature, control samples in trip lica te  were kept at the room 
temperature. Any loss in these standards was corrected in the irradiated 
samples.
Results and Discussion
The values of cytochrome P-450 and P-420 are in nmols/g wet yeast. The 
above table of values shows the effect of 60CO y-rays on disrupted yeast 
cells. The doses delivered ( i .e .  0 to 0.8 MR) were not sufficient to 
calculate the conventional D^ values. The values, of y-ray dose 
were increased from 0.8 to 10 MR to give enough points on the survival 
curve and thence calculate the D^ y values for cytochrome P-450. F ig(3) 
shows the biphasic nature of the loss of cytochrome P-450 on irradiation  
in a preparation made by snail gut enzyme disruption of the yeast cells .
About 40% of the total is more lab ile  to radiation (37% survival, i .e .
Dgy 195 KR) the rest having a D^ y of 2.4 MR.
Biphasic inactivation is also seen in heat-stability for studies.
Fig(3.1)shows the presence in microsomal fraction of a thermolabile (46°C) 
component in the dithionile-reduced live r cytochrome P-450 and in the oxidised 
form of yeast cytochrome P-450. The oxidised form of the live r enzyme is 
almost completely stable at 46°C for 30 min. The reduced form of the 
yeast enzyme is rapidly destroyed by heating at 46°C. Studies at 37°C 
agree with these conclusions. This raises the suggestion of an oxidised-
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reduced form conformational change, perhaps controlled by substrate or 
oxygen binding, which may be important for the noted rate lim iting step 
in the mechanism for oxidation of substrates, in conversion of oxidised 
into reduced form (Gumsalus et al_, 1973).
Tween 80, as expected for a detergent, decreased the recovery of 
liver microsomal cytochrome P-450 on heating at 46°C for 30 min. The 
recovery of the oxidised form was decreased from 85 to 38% but the recovery 
of the reduced form was unchanged at 38% (Fig. 3.2 ) .  The recovery of
i
the la tte r was increased slightly (to 48%) i f  the heating was in the 
presence of CO with or without the Tween 80. CO has no effect on the 
recovery of the oxidised form, confirming that i t  binds only to the reduced 
form. We noted (Wiseman jit  al_, 1975b) the biphasic curve of cytochrome P-450 
loss (as percentage survival, log scale) that suggested the presence of more 
than one conformation in the reduced form of the live r enzyme (and in both 
the oxidised and reduced forms of the yeast enzyme).
The present results agree with this suggestion, for i t  seems that with 
Tween 80, but not heating alone destroys a 62% (100 down to 38%) component 
of the live r oxidised forms of cytochrome P-450 that is destroyed with 
heating alone when in the reduced form (the la tte r  is p a rtia lly  protected, 
i t  seems, by CO binding to the ferrous iron). The residual 38% of the 
cytochrome P-450 is stable to heating alone or with Tween 80 for both 
oxidised and reduced forms, and may represent a particularly stable 
conformational type for this enzyme.
Analogous results were obtained with yeast microsome P-450, except that 
the enzyme is less stable to heat than the liver enzyme. Recentrifugation 
at 130,000 g of Tween 80-treated samples showed that no cytochrome P-450 
has been solubilized (a l i t t l e  was found in the cytochrome P-420 form).
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F ig .(3.3) Effect of substrate concentration on percentage recovery 
of live r microsomal cytochrome P-450 after 30 min at 46 C 
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F ig .(3.2) Thermal loss of live r microsomal cytochrome P-450 at 46°C
(fiX Oxidised cytochrome P-450 + Tween 80:<§>, reduced 
cytochrome P-450 + Tween 80; /^reduced cytochrome P-450.
Thermal protection by substrate binding in the presence of Tween 80 is 
therefore not due to enhanced or different substrate binding to a solubilized 
form of this enzyme..
For liver microsomal cytochrome P-450, N-ethylmorphine (type 1 
binding substrate) and aniline (type 2 binding substrate) in water (or a 
mixture of these) had no effect on the already good recovery of the 
oxidised form after heating alone which v/as about 90% in 30 min. The 
recovery after heating for 30 min, also in the presence of the Tween 80,f
was greatly enhanced, from 38 to 78% (an iline), 97% (N-ethylmorphine) and 
82% (aniline + N-ethylmorphine). There were no effects on the recovery 
of the reduced form, confirming that these substrates bind only to the 
oxidised form. For yeast microsomal cytochrome P-450, the recovery after 
heating for 30 min also in the presence of the Tween 80 was greatly enhanced 
from zero to 32% (aniline) and 50% (aniline + N-ethylmorphine). Fig. (3.3) 
shows the conceritration-dependence of thermal protection of liv e r microsomal 
cytochrome P-450 against Tween 80 by N-ethylmorphine and aniline. The 
49% (93 to 44%) fa ll in percentage recovery in 30 min with Tween 80 alone 
compared with the control (heated alone) was half restored by about 4.0 mM- 
N-ethylmorphine in 4 mM Tween 80, showing the similar a b ility  of these 
two ligands to bind to the type 1 s ite . The result with aniline shows 
clearly its  a b ility  to compete with the type 1 binding detergent Tv/een 80.
The enzyme activ ity  was half restored by about 1.5 mM aniline in 4 mM- 
Tween 80, demonstrating a strong type 1 binding a b ility  (preventing Tween 80 
binding) for a type 2 binding substrate. This conclusion may be suggested 
also by kinetic and spectral observations based on competition of binding 
(Gunsalus et al_, 1973).
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CHAPTER V
SOLUBILIZATION AND PURIFICATION
INTRODUCTION
Soluble cytochrome P-450 (abbreviation used; P-450) has been isolated 
and purified from bacterial sources and extensively studied using magnetic
and spectroscopic techniques (Yu et a/U 1970; Yu et aj[ 9 1974). Despite
extensive efforts in several laboratories, hepatic microsomal P-450 has not 
yet been purified to homogeneity (Imai et al_, 1974). Partial purification
has been achieved by Lu et al_ (1970). ,
Omura and Sato (1964) found that the bound hepatic P-450 which shows 
anomalous spectra was converted to a spectrally typical, but functionally 
inactive, haemoprotein, P-420, when solubilised with snake venom or deoxycholate 
Mason et al_ (1968) demonstrated that the structure of rabbit microsomal P-450 
is functionally altered by ionic detergents, mercurial-SH reagents, protein 
denaturants and reagents which chelate copper and iron. Imai and Sato (1967) 
showed that the conversion of P-450 to P-420 on exposure of live r microsomes 
to high concentrations of neutral salts proceeds more rapidly in the reduced 
form than in the oxidised. They concluded that th is was due to the 
conversion of the hydrophobic environment around the haem or by profound 
changes in the conformation of the haemoprotein.
The importance of hydrophobic interactions to P-450 s ta b ility  and the 
conversion of P-450 to P-420 in disruption of hydrophobic or sulphydrl bonds 
has been noted by several other workers - Ichikawa et  al_, 1967; Ichikawa et 
a l , 1969; Bjorkheim et aj_ 1974. P-420 can be converted back to P-450 by
addition of polyols and glutathione (GSH). This may be because polyols and 
GSH uncouple the detergents and sulphydryl reagents from P-420 so that its  
conversion to P-450 again becomes possible, or because some linkages in 
P-450 which are attacked on treatment with detergents and sulphydryl reagents
can again be formed on treatment with polyols and GSH under appropriate 
conditions.
The reversal with glyols of denaturation by non-ionic detergents may 
also include re-arrangements of a weakly hydrophobic environment (Herskowitz 
et a]_, 1970). Yu and Gunsalus (1970) found that the sulphydryl compounds 
cysteine, thioglycolate and 2-mercaptoethanol may be used to reconvert P-420 
to P-450,
Mitani and Horie (1969) noted that mammalian microsomal P-450 is not 
always unstable to detergents and that Lubrol W c la rified  a microsomal P-450
A
preparation without any appreciable conversion to P-420. Compared to microsomal 
P-450, mitochondrial P-450 was re lative ly  more stable to cholate and could 
be extracted in a state practically free from P-420 provided that the sodium 
cholate to protein ratio was maintained at 0.5 mg/mg or less. Kinoshita 
(1967) showed that extraction by cholate in low ionic strength medium 
resulted in liberation of only P-450 whereas cytochrome a, b and c remained 
in the undissolved residue. Nakamura et a^ (1968) obtained a preparation 
of P-450 from adrenal mitochondria by fractionation in the-presence of Tween 
and glycerol followed by treatment with a triethylamino-ethyl-cellulose 
column and a hydroxylapatite column.
Sodium cholate (Alvares et £]_, 1973), as well as treatment with protease 
V III  and Lubrol W (Yoshida et a l , 1971), produce extensive conversion of
A  1 '
P-450 to P-420. Later workers (Capdevila et al_, 1975) found that the 
denaturation could be partia lly  avoided by the use of the non-ionic detergent 
Triton X-jqq in concentrations ranging from 01 - 1.5%. The P-450 - P-420 
ratio during solubilization was dependent on the pH of the medium and the 
highest ratio wss obtained at pH 7,0. Imai and Sato (1967) found that a 
decline in P-450 at a lower pH was due to the lab iliza tio n  of the ligand its e lf .
(.100)
while ins tab ility  of P-450 at a higher pH is related to the structural 
integrity of the microsomal membrane.
Additional protection of P-450 (Capdevila et al^ 1973) was obtained 
by addition of EDTA and dithiothreitol to the medium. Dithiothreitol 
did not seem to affect the P-450 to P-420 ratio but some degree of protection 
of P-450 was observed. Addition of EDTA alone substantially increased the 
P-450 to P-420 ra tio , and this ratio was increased further by addition of 
both stabilisers. The results may be interpreted as being due to an increased 
aggregation of P-420 induced by EDTA in addition to the protection afforded 
by dith iothreito l (Auter et al^ , 1973). As a result P-420 could be removed 
easily by centrifugation.
Imai and Sato (1974) have developed a method permitting reproducible 
purification of P-450 from liver microsomes by using w-amino-n-actyl sepharose 
4B as an a ffin ity  or hydrophobic absorbent. The method yielded P-450 
preparations having specific contents of 16-17 nmoles/mg protein, with 
overall yield of 10%. The purified preparation of P-450 (oxidised form) 
was very stable in the presence of 20% glycerol and could be stored at 
least one month at -70°C without any spectral changes.
The object of the present experimentation was to solubilise P-450 
from ^accharomyces cerevisiae using, and possibly improving upon, methods 
successfully employed in extraction of P-450 from other sources. A 
combination of detergent, stabilisers and, possibly, solid supports giving 
a consistently good yield of solubilised microsomal P-450 was desired, and 
was obtained in these studies by using sodium cholate with various stabilisers. 
An attempt was made also to partia lly  purify the solubilised cytochrome P-450 
from S.cerevesiae
MATERIALS AND METHODS
Solubilization Studies:
These were performed on the microsomal fraction both from yeast and 
live r. The solubilizations were carried out using Tergitol NPX, Tween 80 
and Sodium Cholate with various concentrations of the stabilisers: cysteine, 
dith io th re ito l, mercaptoethanol, EDTA. Details of the concentrations used 
are given in the results section as these were different in most experiments. 
Controls in each case consisted of microsomal suspension with no additions.
f
The incubation media were magnetically stirred at 4°C for \  hr in the case
of live r microsomes and 1| hrs for yeast microsomes. This was then centrifuged
at 40,000 rpm for one hour. The supernatant was collected and the recovered
microsomal pellet resuspended in a known volume of 0.1  M-phosphate buffer.
Spectrophotometrie studies were done on different fractions thus obtained.
Purification of P-450:
The purification procedure was basically part of that used by Yoshida 
and Kumaoka (1975). The sample of solubilised P-450 was loaded onto a 
column (1.6 x 40 cm) of Sephadex G-25 equilibrated with 10 mM-potassium 
phosphate buffer (pH 7.6) containing 0.1 mM-EDTA. On the second attempt at 
purification the solubilised sample was freeze-dried in order to concentrate 
i t  before loading. Since the column was connected to a Unicord u ltrav io le t 
spectrophotometer and recorder, the protein being eluted from the column was 
easily detected and was collected as a single fraction. This was then 
appl ied to a column (1.6 x 20 cm) of DEAE-Sephadex equilibrated with the 
same buffer as the 1st column. The ion exchange column was eluted successively 
with 80 ml of the equilibrating buffer containing 0.1% Triton X-100 and 100 ml 
of 50 mM-potassium phosphate buffer (pH 7.5) containing 0.1 mM EDTA and 0.1% 
Triton X-100. The second eluting buffer was to spread the adsorbed cytochrome
(.101)01
over the column, and the third elutant was to elute i t  from the column.
This was a ll carried out in the cold room (4°C).
The finally-eluted protein was collected as a series of single fractions, 
which were pooled. The pooled sample was assayed for cytochrome and 
NADPH c^ytochrome c reductase content, and for P-450 content. Aliquots of 
this purified sample and non-purified sample were also run on polyacrylamide 
gel electrophoresis in order to determine the number of protein bands 
present, and to gain some idea of the effect of the purification procedure.
i
Polyacrylamide gel electrophoresis:
This was done to separate any different proteins present in the 
solubilised sample of yeast cytochrome P-450 purified by the column chromato­
graphy. The use of this technique was solely as a qualitative analysis of 
the preparation.
Since the molecular weight of cytochrome P-450 is usually around 
45,000 a 10% gel was necessary for electrophoresis (Gabriel 0 .,  Methods in 
Enzymology, Vol. XXII, p. 565). This gave the proper percentage of cross- 
linkage to provide a three dimensional network optimal for effective molecular 
sieving of the sample components. This gel was poured, while in its  liquid 
form, into small, plugged, glass tubes (5 mm i.d . x 60 mm) where i t  set.
(All solutions necessary for polymerisation were degassed with a vacuum 
pump before use, since oxygen acts as a chain terminater in the polymerisation 
process.) The plugs were then removed and the tubes were inserted into the 
electrophoretic chamber, both parts of which were f il le d  with buffer, ensuring 
that no a ir was trapped above or below the gels. Samples (50 yl of p a rtia lly  
purified or non purified P-450, in duplicate) were then layered onto the 
tops of the gel columns. Sucrose (10%) was added to the sample to fa c ilita te  
layering, and bromophenol blue was added as tracking dye.
The electrophoretic run was then carried out at about 3 mi Hiamps 
(constant current) per tube until the tracking dye approached the lower 
end of the separating gel. Each sample v/as run in duplicate.
The staining method of choice was that using Coomassie Blue (chrambach, 
et al_, 1967). This is less time-consuming with respect to destaining, than 
the use of Amido Black. Protein bands in the gel are shown up by this 
staining. The stain used was made up of 0.5 g Coomassie B rillia n t Blue,
91 ml water, 91 ml methanol, and 18.2 ml glacial acetic acid. This solution
t
v/as poured into separate tubes with the gels, which had been removed from 
the electrophoresis tubes, and staining was allowed to occur for 2 hrs. 
Restaining was then carried out in a solution of 10% glacial acetic acid 
and 2.5% ethanol, in water.
RESULTS
Solubilisation:
Cytochrome P-450 was solubilized from hepatic microsomes prepared from 
male rats and yeast microsomes prepared from S;accharomyces cerevisiae. 
Solubilization both from yeast and liver microsomes was always carried out 
as described in the Methods section, even though the soluble fraction was 
very unstable. The actual s tab ility  of the soluble preparations seemed to 
be variable, even though the conditions used were the same each time. Clearly 
a good solubilised preparation was necessary before purification could be 
carried out. A combination of detergents, stabilisers and a solid support 
gave a fa ir ly  good yield of solubilised microsomal P-450, suggesting that 
P-450 in S. cerevisiae is closely involved with the microsomal membranes.
The following results were obtained with various concentrations of detergents 
and stabilisers used:
003)
Method I
A) Sample 1 Tergitol 0.5%
Sample 2 Tergitol 0.5%
EDTA 0.04 M 
Dithiothreitol
B) Sample 1 Tergitol 1.0%
2 Tergitol 1.0%
i
EDTA 0.04 M 
Dithiothreitol 0.1 M
The stabilisers used here were found to be useful by other workers 
(Capdevila et aU 1973; Autor et al_, 1973), The samples were not centrifuged 
after incubation so the results in the following table do not show the 
amount of solubilisation but may be used to compare the effect of detergent 
and stabiliser on P-450 recovery, after the treatment.
Table V II
Sample: P-420 P-450 (nmol/g) P-420 + P-450
Control 0.79 0.7 1.49
A1 1.01 0.14 1.15
A2 0.25 0.77 1 .02
Bl 1.19 0.05 1.24
B2 0,56 0.44 1.00
The results do indicate that the stabilisers prevent a fa ir ly  large breakdown 
of P-450 to P-420 as seen in samples A! and Bl. Although 1% terg ito l allows 
a re lative ly  good release of P-420 + P-450, greater breakdown to P-420 is 
observed than with 0.5%, and the stabilisers give a better yield of P-450 in 
the 0.5% than in 1% preparation.
Method I I
A) Tergitol 0.5%
EDTA 0.04 M 
Mercaptoethanol 0.2 M
B) Tergitol 0.5%
EDTA 0.04 M
Cysteine 0,25 g/10 ml microsomal suspension
The samples were incubated overnight and centrifuged as described in the 
methods section. Samples of the group 'B1 showed an average 0.07 nmol/g P-420 
and 0,55 nmol P-450 in the supernatant and 0.05 nmol/g P-420 and 0.08 nmol 
P-450 in the pellet. The samples of the group 'A' did not give significant 
peak heights, probably due to the high dilution or the length of incubation. 
(The same problem was encountered in a similar experiment to compare the 
effect of Tergitol NPX with Tween 80.) However, the results of the group 
’ B’ samples do show that cysteine could be a useful stabiliser and possibly
more effective than mercaptoethanol. The cysteine concentration is that used
by Yu and Gunsalus (1974).
Method I I I
A) Sodium cholate 0.6% w/ v
EDTA 1.0 mM
Dithiothreitol 1.0 mM
B) Tergitol 0.5%
EDTA 0.04 M
Dithiotreitol 0,05 M
C) Tween 80 0.5%
EDTA 0.04 M
Dithiothreitol 0.05 M
The concentration used in group ’A' samples were:
* B1 Tergitol 0.5%
EDTA 0.4 mM 
Dithiothreitol 0.05 M 
Cysteine 0,25 g/10 ml cysteine
Each group samples were prepared in tr ip lic a te . The results are given in the 
following table:
Table V II I
Sample: P-420: P-450 (nmol/g) P-420 + P-450 % Recovery P-450
'A’ ( I )  0.10: 0.16 0.26 29
( I I )  0,10: 0.16 0.26 29
( I I I )  0,23: 0 .20  0.43 36
1B» ( I )  - 0.09 0,09 22
(TI) - 0.15 0.15 33
( I I I )  - 0.09 0.09 22
The agreement between trip lic a te  results of group ’B* samples is poor though 
this (Tergitol) and the cholate method gave some useful solubilisation. The 
cholate method is possibly more useful because of the greater consistency in 
the results and the smaller overall loss of P-450 between supernatant and 
pellet. Ihe following overall results were obtained using the cholate method 
with the stabilisers (V). Clearly a good solubilised preparation was 
necessary before purification could be carried out, so brief study was 
carried out on storage s tab ility  of yeast cytochrome P-450. A microsomal 
preparation was made from yeast, a few mis were retained for assay, and 
solubilisation of P-450 was carried out on the remainder.
The P-450 levels were measured in both cases. Both preparations were then 
stored overnight at 4°C, and the P-450 levels were measured again. I t  was, 
thus found that recovery of P-450 after solubilisation from microsomes was
Table IX RECOVERY OF CYTOCHROME P-450
Yeast
Sample: P-450 levels
Yeast cells . 5.2 nmol/g wet weight
Yeast microsomes 40% recovery
Yeast solubilized 50% recovery from microsomal fraction
Liver
Sample: P-450 levels
Liver 30 nm/g wet weight ,
Liver microsomes 32% recovery
Liver soluble 43% recovery from hepatic microsomal fraction
around 39,5% and the overnight recovery of microsomal P-450 was 73.5%. 
However, P-450 in the solubilised fraction was completely Tost after 
overnight storage.
The following results were obtained. The figures for P-450 refer to 
the amounts in the total volumes of the fractions in question rather than 
per gram of yeast:
Total P-450 % recovery after % recovery
(nmol) solubilisation a fter storage
a. Microsomes 102.3 - -
40.5 39,5b. Solubilized preparation
c. Microsomes 
(after storage)
d. Solubilised 
(after storage)
75.6 - 73.5
0 -  0
From these figures the instab ility  of solubilised cytochrome P-450 can 
be seen, as compared with the relative s tab ility  in microsomes. The yield  
of solubilised P-450, obtained from the microsomes, was good considering that
several earlier attempts at solubilisation had failed due to various factors.
The next step in this section involves the solubilisation of P-450 
from microsomes which had been stored overnight. The solubilisation 
procedure was carried out exactly as before, but the microsomes used had 
been stored overnight at 4°C. Cytochrome P-450 levels were measured in 
the whole yeast and microsomal preparation before and a fte r storage, and 
also in the solubilised sample obtained from the stored microsomes.
In order to do th is , 2 g of yeast were retained for assay on fresh 
and stored yeast,(1 g for each assay). The remaining yeast (36 g) was then 
homogenised and fractionated to microsomes which were suspended in 120 ml 
of 0.1 M-phosphate buffer, 10 ml of which were reserved for assay on fresh 
and stored microsomes. The remaining 110 ml of microsomal preparation was 
then subjected to the solubilisation procedure after storage. The to ta l 
P-450 in the solubilised sample was then compared with that in 110 ml of 
stored microsomal preparation. The following results were obtained:
Table X Sample Total P-450 (nmol)
Yeast (fresh cells) 115.5
Yeast after storage 103.0
Microsomes, fresh 84.3
Microsomes after storage (120 ml) 60.7
Microsomes before solubilisation (110 ml) 55.6
Solubilised preparation 8.5
(from stored microsomes)
% RECOVERY OF CYTOCHROME P-450 
in stored yeast 89.0%
in stored microsomes 72.0%
in solubilised preparation 15.0%
I t  can be seen that although the yield of P-450 in the microsomal fraction  
from whole yeast, and the recovery in stored microsomes, was nearly 75%, 
the solubilisation from these stored microsomes gave a very low recovery 
(15%), Such a low yield was not good enough for subsequent purification  
processes, so any purification which was later carried out was done on 
solubilised material from fresh microsomes.
Purification
The method used was part of the method of Yoshida et al_ (1975). Thus 
the solubilised material applied to the column was in a chude state. 
Consequently, any purification was only minimal. Since this experiment was 
only in a preliminary form, the idea was to see the effect of gel f ilt ra t io n  
and ion exchange on the s tab ility  of this partia lly  purified P-450.
Solubilisation of P-450 was carried out as before. The yield of P-450 
in the solubilised fraction was 40.4%. A few mis v/ere retained at 4°C for 
la ter assay in order to study the s tab ility  of P-450 in this solubilised form.
The remaining solubilised fraction was applied to the column of Sephadex G-25
(at 4°C) and eluted with the equilibration buffer described in the ’Methods' 
section. The eluted protein was collected as a single fraction, as shown by 
continual monitoring with an LKB Unicord, and was applied to the DEAE Sephadex 
column.
Although some bound to the DEAE Sephadex column, most of i t  passed 
straight through. This was collected and assayed for P-450. Soon after the
application of the f ir s t  (equibrations) buffer in the elution sequence,
the column became blocked, and a ll attempts to unblock i t  were unsuccessful. 
Thus, there was no further elution.
The column was then unpacked and a batch elution was attempted, on the 
material, with the strongest elution buffer (50 mM phosphate, pH 7.5 , containing
0,1% Triton X-100 and 0.1 mM EDTA) at 4°C. This medium was then centrifuged 
and the supernatant was decanted and assayed for P-450.
The following results were obtained (soluble fraction stored at 4°C
and assayed at 0, 18, and 23| hours).
Table X-I
Time of storage (hrs) P-450 Content (nmol) % Survival of P-450 
0 27.7 100
18 27.7 98
24 25.4 ,91.5
Thus, this shows a greater s tab ility  of solubilised P-450 as compared with 
that from the unfractionated material. Over a period of a day at 4°C there 
was l i t t l e  loss in P-450. While P-450 stayed fa ir ly  constant there was a 
negligible amount of P-420, and this amount seemed to decrease with time 
so that after a few hours the peak had changed into a small shoulder.
On assaying the sample obtained from batch elution of the column 
material, removed from the column, no P-450 v/as detected. The liquid  
which passed straight through the DEAE on loading did show a small sign of 
P-450 but not enough to account for the amount of P-450 loaded, giving a 
total of 16.7% recovery.
In a different attempt for the purification, two batches of solubilised 
P-450 were prepared in order to increase the loading concentration. The 
pooled fractions were then freeze-dried and redissolved in a known volume of 
buffer. A part of this freeze-dried sample of P-450 was saved for measurement 
of P-450, bg, and cytochrome c reductase and the other fraction was applied 
to the column for purification. Comparison of the levels of P-450 in each 
fraction was then made. See table of results following.
Table XII 
Samp!e
Volume
(ml)
P-450 Contents 
(nmol)
% yield of P-450
Microsomal fraction 120 71.0 -
Soluble fraction n o 24.0 34.0
Microsomal fraction ' n o 58.0 r*
Soluble fraction n o 27.0 46.0
Total soluble fraction 220 51.0 40.0
(overall)
Freeze-dried soluble fraction 64 24.0
r
20
(from microsomes)
The values for % yield of P-450 refer to the amount of each fraction
relative to total P-450 in an equivalent volume of original microsomal fraction. 
Thus, the total amount of P-450 freeze-dried from 206 ml of the pooled 
soluble fractions was 47.5 nmoles, but only 50% of this survived the process 
leaving 24 nmoles. During column chromatography the same thing happened as 
in the previous and subsequent experiments. Elution through Sephadex G-25 
proceeded satisfactorily and the eluate was applied to the DEAE Sephadex 
column. This ran straight through this column and was collected as a 'purified ' 
sample. The column then became blocked, with no further flov  at a l l ,  soon 
after the equilibrating buffer was applied to i t .  The small amount of elute 
from the brief elution with the la tte r buffer was assayed for P-450, although 
none was detected. Batch elution was then attempted on the DEAE Sephadex 
column and material was removed from the column with the strongest buffer.
The resulting eluate again showed no P-450. So a ll through these purification  
attempts the only fraction seen to contain P-450 was that eluted through 
the ion-exchange column (the 'purified' sample). The purified sample gave a 
recovery of 89.5% of the amount loaded onto the f ir s t  column.
The purified and non-purified samples were then assayed for cytochrome 
bfj and NADPH-cytochrome c reductase, in addition to the P-450. There appeared
to be none of the reductase in either sample. The purified and non­
purified samples were both stored overnight at 4°C and assayed for P-450 
once again. Percentage recovery of P-450 after storage was found, as
indicated below.
Table X III
Sample Total P-450 (nmol) Total P-450 (nmol) % Recovery
 (Fresh) (Stored) P-450
Purified 6.87 6.87 100
Non-purified 7.65 6.39 83.0
t
Stab ility  is shown to be greater in the partia lly  purified sample than in the 
solubilised, non-purified one. I t  seemed that the conversion of P-450 to 
P-420 did not occur to any great extent, and P-420 remained very low, even 
after storage. In fact, not only was the P-420 largely removed by the 
purification step, the P-420 levels actually decreased relative to the P-450.
Gel Electrophoresis
The electrophoresis of purified and non-purified preparations produced 
gels in which many protein bands were produced despite the very small amount 
of sample added. Although this process was far from quantitative i t  
gave some indication of the effect of the purification procedure. The bands 
in most cases were very fa in t. Inspection indicated that at least some 
purification was achieved by the columns, since the absence of some bands 
and the faintness of others in the purified sample shows that some of the 
material must have been removed.
Discussion
The results show that P-450 in Saccharomyces cerevisiae is a 
microsomal rather than a mitochondrial cytochrome. P-450 was also detected 
in the nuclear fraction due to insufficient disruption. Up to 70% was 
lost during disruption and preparation of the microsomal fraction. This 
low level of microsomal P-450 caused d ifficu lties  in some of the solubilisation
studies due to the sensitivity of lim itation of the methods. Addition of 
stabilisers during disruption and centrifugation could have been used to 
improve the y ie ld , but this might have interfered with the study of stabilisers 
added later during solubilisation studies. Loss of microsomal P-450 on storage 
was also noted, which suggested that the glycerol protection of P-450 in 
hepatic systems seen by other v/orkers (Imai et al_, 1974; Ichikawa et a l ,
1967) was not effective in S. cerevisiae.
Solubilisation of P-450 however, was eventually achieved with a final 
recovery of 40% in the case of yeast and about 50% in the*case of liv e r, 
from microsomal fraction with sodium cholate along with various stabilisers. 
Sodium cholate gave the most useful and consistent results though Tergitol 
and Tween 80 in other concentrations and/or with different stabilisers 
to those attempted could be useful. 0.5% Tergitol gave a better yield  
than 1.0%, Tween was the least useful detergent and this and Tergitol caused 
a more complete loss of P-450 than that observed with cholate, where P-450 
was converted to P-420 rather than lost altogether.
EDTA and dithiothreitol gave good protection of P-450 as seen by 
Autor et cH (1973). Cysteine was also found to be a valuable contributor 
to s tab ility , in agreement with the finding of Yu and Gunsalus (1970). 
Stabilisation by mercaptoethanol was only attempted in very few unsuccessful 
experiments. Levin et aj_ (1974) have found i t  to be useful, although they 
also observed that mercaptoethanol and dithiothreitol are not suitable 
for protecting purified P-450 cam because they react with i t  to a limited 
extent.
The importance of hydrophobic interactions in P-450 s tab ility  and the 
conversion of P-420 to P-450 by sulphydryl compound has already been discussed 
(Ichikawa et aj_, 1969; Herskowitz et al_, 1970). This conversion has been 
found to be highly dependent on temperature, pH, concentration and incubation
time (Imai et a l, 1967). Variation in cellular content of P-450 due to 
changes in environmental conditions has also been observed (Lshidate. et a l , 
1969; Wade et al_, 1972). The effect of these many variables may account 
for the d iffic u lties  encountered in the preparation of soluble cytochrome 
P-450 from yeast.
In very few cases addition of P-420 and P-450 from the supernatant and 
pellet fractions gave the 100% assumed for the control p e lle t. Therefore 
these methods are only useful where an emphasis is placed on obtaining
t
P-450 in solubilised form rather than P-450 in high y ie ld . The numerical 
results obtained for P-450 are more important than those obtained for 
P-420 and P-450. These are included because they could indicate preferred 
choice of different methods, in addition more stabiliser could give higher 
yield of P-450 from reconverted P-420. However, care must be taken not to 
give too great a significance to the P-420 results because of the various 
methods of calculation, and the fact that the exact extinction coefficients 
used for hepatic microsomal system may not apply. I t  should also be noted 
that solubilised samples, stored overnight at 4°C tend to lose much of 
their P-450 content, unless the preparation is very carefully made and 
kept cold constantly.
During the f ir s t  purification procedure the columns were overloaded 
with solubilised fraction. This probably explains why the second column 
blocked, plus the fact that the loaded samples were very crude. The very 
low recovery of P-450 from the f ir s t  purification may suggest that P-450 
had degraded while on the column. Alternatively, i t  may have remained 
adsorbed on the column material, but this is unlikely since the batch elution 
with the strongest buffer should have brought i t  o ff. Since the immediate 
eluate from the DEAE Sephadex after loading, contained a small amount of 
P-450, i t  is possible that the P-450 in the sample passed straight through
the column, leaving other materials adsorbed, and then degraded in the 
collected solution. I f  such degradation was occurring, i t  could not have 
produced P-420, since the P-420 peak was absent from the collected fraction.
I t  is also interesting that the soluble fraction loaded onto the column 
was very stable at lb°C, Even after overnight storage and 24 hours after 
solubilisation only 8% of the P-450 had been lost.
In other attempts to purify cytochrome P-450, although the same 
problem arose, nearly 90% of the loaded P-450 was recovered. This suggested
r
the complete removal of P-450 from the columns on in it ia l loading, and 
explains why no P-450 was found in the batch eluate. Assay showed that 
P-420 originally present in the sample, seemed to have been removed from 
the solubilised P-450 preparation by the purification procedure.
Again the solubilised P-450 showed fa ir ly  good s tab ility  on overnight 
storage at 4°C; while the purified material was very stable, maintaining 
fu ll activ ity  overnight. Clearly the purification step had induced greater 
stab ility  in the sample, probably by removing salts and detergents. The 
lack of P-420 and its  decreasing levels must again suggestr,the possibility  
of interconversion (Yu et al_, 1970), while P-450 remained fa ir ly  constant 
in the purified sample.
Further development is needed for the purification procedure, and already 
this has been radically modified here, from that used by Yoshida and 
Kumaoka (1975). Comparison of the electrophoretic gels from the purified 
and non-purified samples showed that purification occurred to a small degree, 
because the number and intensity of the bands in the non-purified sample 
was greater than in the purified one. Since yeast P-450 is lik e ly  to have 
a molecular weight of about 50,000, a standard protein of this size should 
have been run on a gel in parallel to the sample gel so that identification
of the P-450 band could have been made. A similar arrangement should also 
have been set up for P-420. A qualitative assessment of the relative  
amounts of the two cytochromes could have been possible in these preparations 
on the gels.
CHAPTER VI
IMMOBILISATION AND STABILIZATION
Immobilisation and Stabilization of Cytochrome P-450
Introduction
Wingard (1972) has. written "Immobilization refers to the modification 
of an enzyme so as to restric t the gross movement and keep i t  in a re la tive ly  
defined region of space". There are good reasons for considering that soluble 
enzymes may be replaced by immobilized enzymes for many of their present 
applications (Baker and Kay, 1975). Nearly a ll of these processes use 
extracellular hydrolases, but recently more consideration ha$ been given to 
the possibility of using the more expensive intracellu lar enzymes, which 
frequently require organic cofactors (Mispach and Mattiason, 1970; Marshall, 
1973; Hornby e ta lv  1974).
Since the development of immobilization techniques, there have appeared 
in the literature several reviews on immobilization of enzymes. The four 
main methods and various reviews have been mentioned in the general introduction 
chapter. Baker and Kay (1975) have written a comprehensive review on these 
methods and therefore they have not been fu lly  described in this thesis.
This chapter describes the immobilization of cytochrome P-450 from 
S. cerevftcae and rat liver by a variety of techniques, followed by stab ilization  
of the enzyme with glutaraldehyde. The aim of this study was to obtain an 
immobilized cytochrome P-450 preparation with high retention of specific 
enzyme activ ity , with enhanced conformational and thermal s ta b ility . Such 
a preparation may have potential industrial and therapeutic usage.
Immobilization by ionic adsorption on to DEAE-Sephadex and CM-Sephadex
The adsorption of enzymes on to an insoluble matrix such as DEAE-Sephadex, 
DEAE-Cellulose and CM-Cellulose is mainly due to multiple salt linkages.
The enzyme a-chymotripsin has been covalently bound on to CM-Sephadex (in  
Zaborsky, 1973). Numerous examples of enzymes adsorbed on to these inert
carriers appear in the literatu re .
Immobilization to microcrystalline cellulose and porous glass beads by the 
metal-link methods
The immobilization of enzymes on to cellulose, nylon or glass surfaces 
activated with the salts of titanium and other transition metals was developed 
by Noufs'; (1971). The enzymes amyloglucosidase, a amylase, trypsin, glucose 
oxidase and invertase have been coupled on to microcrystalline cellulose 
activated by titanium (Baker et al_, 1971). The particular interest to this 
thesis was the very low retention followed by destabilization when yeast 
and liver P-450 were immobilized by these methods. Thorton et al^  (1974) 
successfully immobilized lactoperoxidase and invertase on to glass beads, 
porous glass beads and sand by the metal link method (activated by titanium).
They found that for these tv/o enzymes, immobilization was pH-dependent, 
occurring most e ffic ien tly  at pH 4.5. I t  was inferred from this that the 
metal link method for the immobilization of enzymes is restricted to 
enzyme stable at pH 4.5. Indeed attempts to immobilize xanthine oxidase, 
lactase dehydrogenase and alcohol dehydrogenase by this method using alkaline  
pH values were unsuccessful (Conghdanr and Johnson, 1973; Thornton et a^, 1974a). 
By using the metal link method, enzymes have been coupled to numerous supports. 
Amyloglucosidase has been immobilized on to various forms of cellulose 
(microcrystalline), wood flour and sawdust, f i l t e r  paper, glass, terylene 
and nylon f ilte rs  (Emery et aj_, 1972). The specific ac tiv ity  of an enzyme 
immobilized by adsorption is usually lowered. For example Suzuki et al_ (1966, 
1967) found only 33% retention of the specific ac tiv ity  of the native enzyme 
when invertase was bound on to DEAE-Cellulose. Similar results were
demonstrated by Usmani et aj_ (1971). Maeda et al_ (1973) found that approximately 
55-70% of invertase activ ity  was lost on binding to DEAE-Cellulose. Interest­
ingly, no loss in the original enzyme activ ity  was found when tomato invertase
was adsorbed on to CM-Cellulos'e (Nakagawa et <al_, 1975). Tosa et al_ (1969) 
immobilised ami noacylase upon DEAE-Sephadex and reported an approximately 
50% loss in specific enzyme activ ity .
Immobilization of enzymes by adsorption can result in decreased thermal 
s tab ility  relative to the native enzyme. Enhanced thermal s tab ility  was 
found for ami noacylase On DEAE-Sephadex and DEAE-Cellulose (Tosa et a l , 1969) 
for lactate dehydrogenase attached to DEAE-Cellulose (Wilson et'al_, 1963) and 
for phosphomonoesterase adsorbed on to CM-Cellulose (in Zaborsky, 1973). On
t
the contrary decreased thermal s tab ility  was observed for ATP deaminase and 
invertase adsorbed on to DEAE-Cellulose (Chung et al_, 1968; Suzuki et a l ,
1966, 1967). Interestingly, purified tomato invertase that had been adsorbed 
on to CM-Cellulose was made heat stable than the soluble form (Nakagawa et 
jrt, 1975).
When an enzyme is immobilised on a charged carrier, changes can occur in 
its  pH optimum (Barker and Kay, 1975). The pH optimum v/as decreased for 
glucoamylase on DEAE-Sephadex (in Zaborsky, 1973) and for ATP deaminase, 
aminoacylase and invertase on DEAE. Cellulose (Chung et al_, 1968; Tosa et a l , 
1967; Suzuki et al_, 1966, 1967). Conversely, the pH optimum can be increased 
(shifted towards more alkaline pHs) for enzymes bound on to a negatively 
charged support such as CM-Cellulose or CM-Sephadex.
The reason for the displacement of the pH in either direction is attributed 
to the creation of a microenvironment around the water-insoluble adsorbed 
enzyme. Goldstein et al_ (1964) have made a detailed explanation of this 
behaviour which is summarized by Weetall (1975) and Zaborsky (1973). I t  is 
based upon a qualitative and quantitative treatment of the local hydrogen ion 
concentration in the domain of the charged enzyme support, compared with the pH 
of the external solution.
Changes in the value of the apparent Michael is constant (Km) can also occur
upon immobilization. The apparent Km for aminoacylase adsorbed on the DEAE- 
Sephadex or DEAE-cellulose was either increased or decreased relative to the 
Km of the native enzyme depending upon the substrate used (Tosa et a_l_, 1967, 
1969). Nakagawa et aj_ (1975) found that the Km of tomato invertase, adsorbed 
on to cm-cellulose has increased two fold relative to that of the native 
enzyme.
The apparent Km of an adsorbed enzyme is increased relative to the Km 
of the soluble enzyme, being due to the creation of a microenvironment around
r
the water soluble adsorbed enzyme. L illy 'e t'a l_  (1968) have explained that a 
diffusion barrier surrounding the insoluble particle w ill be the lim iting  
factor in the rate of reaction because the substrate concentration within 
this barrier w ill be lower than in the external solution. These diffusional 
restrictions of substrate into, and products out of the adsorbed enzyme can 
be overcome by reducing the physical size of the inert particle (Kay and 
L illy , 1970)> rapid stirring of the immobilised enzyme suspension (Hornby et 
a l , 1966) and by increasing the flow rate through a fixed bed reactor column 
containing the immobilised enzyme (Weetall, 1975). These techniques return 
the apparent Km of an immobilised enzyme to that of soluble enzyme (Barker 
and Kay, 1975). The difference between the apparent Km of an ionically adsorbed 
enzyme and the Km of the soluble enzyme can also be explained in terms of the 
effect of the electrostatic molecules in the microenvironment (Goldstein et a l ,
1964). Hornby jst al_ (1968) derived an equation which satisfactorily explains 
the effects of diffusion and electrostatic interaction on the apparent Km of 
an enzyme immobilised on a charged support. Generally, like  charges on substrate 
and support increases the apparent Km, and unlike charges decreases the 
apparent Km, compared to the Km of the soluble enzyme. The effect of diffusion 
always increases the apparent Km. The thermostability of amyloglucosidase 
coupled to microcrystalline cellulose and lactoperoxidase coupled to sand by
the metal link method, has been improved relative to the soluble enzymes 
(Emery et al_, 1972; Thornton e t ’al_, 1974a). There seems to be l i t t l e  effect 
on the pH optimum curves of these enzymes, except that slight spreading of the 
curve for amyloglucosidase was observed (Emery et aj_, 1972). For invertase, 
however, i t  v/as reported that the pH optimum of the enzyme bound to sand was 
4.6 compared to 4.4 for the soluble enzyme (Thornton _et^  1974a). These 
investigators also reported that the apparent Km of lactoperoxidase bound 
to sand was slightly increased.
i .
Stability  of enzymes by chemical modification including cross-linking reactions
The use of bifunctional reagents for the intermolecular cross-linking 
of crystalline enzymes has made possible physico-chemical studies and kinetic 
investigations on such crystals over an otherwise inaccessible range of 
conditions (Quiocho and Richards, 1964; Quiocho, Bishop and Richards, 1967).
The most commonly used reagents have been a-w-dialdehyde., especially 
glutaraldehyde. These reagents are finding increasing application in studies 
on the conformation and catalytic behaviour of enzymes in the crystalline state, 
and are also being increasingly used by protein crystallographers in structure 
determination (Reeke et al_, 1967). Bifunctional reagents have been shown 
to stabilize many enzymes including, lysozyme by phenol disulphonyl chlorides; 
glycogen phosphorylase by glutaraldehyde; and chymotrypsin by formaldehyde.
Some other enzymes were destabilised by bifunctional reagents (Zaborosky, 1972). 
This thesis reports the stabilization of immobilized yeast and rat liver cyto­
chrome P-450. Wiseman and Woodward (unpublished) have achieved the stabilization  
of yeast invertase by a variety of bifunctional reagents. The best thermal 
stabilization here was achieved with glutaraldehyde but with only 20% 
retention of enzyme activ ity . There was a 100% retention of enzyme activ ity  
using dimethylsuberimate, although the thermal stabilization with this reagent
was significantly less than that achieved by use of glutaraldehyde (Woodward
and Wiseman, 1977). Our work reports the preparation and properties of 
several immobilized forms of yeast and rat live r cytochrome P-450. As the 
main purpose of immobilized enzymes is to produce a more stable product we 
have studied the effect on the s tab ility  of the enzyme at various temperatures 
These studies have been performed in order to determine whether such 
derivatives have high retention of original specific ac tiv ity  and improved 
thermal s tab ility  compared to the native enzyme, and whether they would be 
stable in a suitable reactor system for the preparation of various drug 
metabolites otherwise very d iff ic u lt  and expensive to synthesise.
Material and Methods
Cm-cellulose and phosphocellulose were purchased from Pharmacia. 
Microcrystalline cellulose (Sigma cell type 20) were purchased from Sigma. 
Porous glass beads (pore diameter 1350 A0 particle diameter 177-850 microns) 
were a g if t  from Corning Biological Products Dept., Medfield, Mass. 02052, U.S 
Titanium trichloride and glutaraldehyde were purchased from Sigma.
Immobilisation studies on activated microcrystalline cellulose.
Remove fines from Sigma Cell
5 Gms microcrystalline cellulose (Sigma Cell type 20) was suspended and 
well shaken in 100 ml d is tilled  water and allowed to stand for 1 hr. The 
resulting fine particles in the suspension were removed by suction. The 
above process was repeated several times (8 to 10) -  until the v/ater layer 
stood clear after standing for 1 hr.
The resulting cellulose uniform in particle size was dried on a Buchner 
funnel in successive washes with 100 ml volumes of acetone/water, gradually 
increasing acetone proportion (25% to 100%). I t  was then le f t  to a ir  dry 
for 1 hr. The dried cellulose was stored for later use to activate.
Activation of Cellulose
The activation of microcrystalline cellulose was done by adding 5 mis 
of 15% Titanium trichloride to a tube containing 1 gm of microcrystal line  
cellulose. The suspension was mixed for 20 min by a ro lle r mixer at 4°C.
The activated microcrystalline cellulose was collected by centrifugation. I t
was then washed repeatedly (4 times) in 2M acetate buffer pH 5.8. The
suspension was shaken and buffer removed by suction.
Coupling '
Soluble cytochrome P-450, 1 ml was put onto 500 mg activated microcrystalline 
cellulose and mixed on a ro lle r mixer for 1 hr at 4°C. The cellulose was 
collected by bench centrifugation and washed 4 times in phosphate buffer pH 7.4 
and fin a lly  resuspended V-jq w/v in same buffer.
Immobilization of cytochrome P-450 on to glass beads
The method of Emery e t (1972) was mainly followed for this procedure.
0.5 gm of glass beads were shaken (end to end rotation) with 10 ml of 
titanous chloride solution (15% w/ v) for 3 hrs at room temperature. The 
activated beads were then washed several times in 10 mM sodium acetate buffer 
pH 4.7. They were then suspended in phosphate buffer and 5 ml of solubilised 
cytochrome P-450 was added. The enzyme and support were mixed overnight at 
4°C using rotation on ro llers . The enzyme support complex was then centrifuged 
using a bench centrifuge and the supernatant removed and assayed for cytochrome 
P-450 activ ity . The immobilised complex (on glass beads) was washed and re­
suspended in phosphate buffer pH 7.4.
Immobilization of cytochrome P-450 on to washed microcrystalline cellulose 
(unactivated)
Microcrystalline cellulose (Sigma 20) was used. The fines were removed
as described before and the cellulose dried using acetone. The solubilised 
cytochrome P-450 from yeast and rat liver microsomes was used. 10 ml samples 
of the solubilised cytochrome P-450 to 1 gm of cellulose were incubated at 4°C 
for varying intervals, 3 hrs to overnight. The shaking was done on a ro lle r  
mixer. The suspension was centrifuged at the end of the incubation and the 
cellulose was twice v/ashed with cold phosphate buffer (pH 7 .4 ). The immobilised 
enzyme (abbreviation: IME) was resuspended in phosphate buffer (V io  w/v  7 .4 ).
The above procedure was also used for the immobilization of cytochrome P-450
f
both on CM-cellulose and phosphocellulose.
Stabilising the immobilised fraction using glutaraldehyde
The immobilised fractions were treated with glutaraldehyde, 3 mM final 
concentration, using the fume cupboard. The suspension was le f t  for 2 hrs 
to overnight depending on the time available at 4°C, while shaking on the ro lle r  
mixer. The above method was later modified to get a better yield by adding 
glutaraldehyde to a final concentration of 3 mM to the resuspending buffer in 
which the immobilised preparation was fin a lly  resuspended.
The immobilised and stabilized fractions were used to determine the yield  
of cytochrome P-450, their storage and heat s tab ility  and fin a lly  their drug- 
metabolising a b ility  v/as compared with microsomal and soluble fraction, using 
biphenyl as the substrate.
Assay of cytochrome P-450
The immobilised fractions were diluted v-jq w/ v anc* the yield of cytochrome 
P-450 was recorded by difference spectrum as described in methods section.
Storage s tab ility  of immobilised cytochrome P-450
Samples of immobilised enzyme were stored in 10 ml conical flasks in 
phosphate buffer pH 7.4 in a cold room at 4°C. The enzymatic activ ity  of each
preparation was determined by the standard procedure (difference spectrum).
Thermal s tab ility  of immobilised cytochrome P-450
The immobilised fractions were resuspended in P-buffer pH 7.4 (Vio W/v ^ il)  
and 6 mis samples were taken ana incubated in a water bath as for microsomal 
and soluble fractions (range 30 to 50°C; 5 min to 30 min time intervals). The 
results were compared with immobilised and stabilised fractions.
Drug metabolising activ ity
f
The drug metabolising activ ity  of various immobilised and solubilised 
fractions were investigated using biphenyl as the substrate, and compared with 
normal microsomal and soluble fractions.
Results and Discussions
Immobilisation of yeast and rat liver cytochrome P-450 on cellulose supports
CM-cellulose and microcrystalline cellulose, v/ashed and dried with acetone, 
readily bound yeast and rat liver cytochrome P-450. Not a ll the soluble 
cytochrome P-450 added to the cellulose was adsorbed, but only 50 to 60% in 
different experiments. 20 to 30% of the enzyme activ ity  remained therefore 
in the soluble fraction of the supernatants that came off the cellulose 
suspension. I t  was found that 45 to 50% of the enzyme activ ity  was retained 
after allowing for the loss of enzyme in the washing of the immobilised enzyme 
preparation. Very l i t t l e  loss was observed due to in s tab ility  of the enzyme 
during the immobilisation.
With phospho-cellulose adsorption i t  v/as found that only 10% of the enzyme 
activ ity  was retained on to the solid support, the rest of the enzyme activ ity  
being either lost or remained in the soluble fraction. The partial adsorption
of cytochrome P-450 on to microcrystalline cellulose and CM-cellulose may be 
either due to the saturation of the cellulose particles (supernatant did not 
lose much of the remaining activ ity) or due to the presence of two different 
forms of the enzyme, i .e .  +ve charged in case of CM-cellulose and neutral in 
case of microcrystalline cellulose. Whether the microcrystalline cellulose 
takes up a negative charge after drying with acetone is not clear. Phospho- 
cellulose on the other hand adsorbs only a small fraction which may be due to 
the different charge or porosity of the particles, while most of the remaining 
enzyme activ ity  is lost after immobilisation which may indicate the presence 
of a negatively charged fraction.
I t  was also found that the titanium activated microcrystalline cellulose 
and glass beads do not adsorb any of the enzyme activ ity  and most of the enzyme 
activ ity  is lost during the immobilisation. The activation of both cellulose 
and glass beads was done at pH 5.8 while the s tab ility  of the soluble cytochrome 
Pv450 is maintained only from pH 7 to 7.8. The acid pH necessary for the 
activation of the solid supports may be the reason for the loss of most of the 
enzyme activ ity  with these methods, while the microcrystalline cellulose 
(washed) and CM-ceT’ulose bound enzyme complexes exhibited 90% of the activ ity  
at pH 7 to 7.8. Table (Iq.) shows the various concentrations of immobilised 
preparations on to various supports.
The storage s tab ility  of yeast and live r cytochrome P-450 immobilised on 
celluloses was determined. Supernatants from immobilised samples centrifuged and 
incubated at 4°C for 46 hrs lost 40% of their enzymatic ac tiv ity  (difference 
spectrometry). Immobilised washed samples on the other hand lost 90% of their 
activ ity  stored at room temperature for 10 hrs. The immobilised and washed 
samples (CM and microcrystalline cellulose) retained fu ll ac tiv ity  over a period 
of 46 hrs stored at 4°C. The immobilised preparation with phospho-cellulose
lost 50% activ ity  after storage of 46 hrs at 4°C and both the above preparation
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had lost most of their activ ity  at room temperature after 24 hrs.
The crosslinking reagent, glutaraldehyde, was added to the cellulose 
preparations which increased the storage stab ility  of both yeast and live r cyto­
chrome P-450 from 46 hrs to 1 month at 4°C.
The thermal s tab ility  of the uncharged preparation (microcrystalline 
cellulose bound) and positively charged (CM-cellulose bound) preparations of 
immobilised cytochrome P-450 which are stable on storage were compared with 
soluble preparations. Comparison was also made between the jmmobilised and 
cross-linked preparations. Table (15 ). The results show that immobilisation 
considerably enhanced the s tab ility  of the cytochrome P-450 especially in the 
oxidised state of the enzyme, at enhanced temperatures. The immobilised 
enzyme preparations retained ac tiv ities , whereas the soluble enzyme preparations 
lost most of their activities under these conditions. After 30 min preincubation 
at 37°C the soluble enzymes were completely inactivated, whereas the uncharged, 
positively charged and the "3rd fraction" immobilised enzyme preparations 
retained 77, 51 and 33% of their original activ ity  respectively. Similar results 
were also found with heat and radiation s tab ility  studies, where the decay 
curve shows the presence of at least two fractions (stable and unstable at 
37°C). The immobilised enzyme preparations (yeast and liv e r) in a reduced state 
(achieved with sodium dithionite) retained much less, i .e .  22, 26 and 0% of 
activ ity  after incubation at 37°C.
Heat s tab ility  of immobilised compared to soluble enzyme
Most reports deal with the thermal s tab ility  of immobilised enzymes rather 
than the pH solvent, salt or proteolysis s tab ility . Some of these have been 
compared with the corresponding free enzymes at the pH optimum of the free 
enzymes. Apparent shifts in pH optimum of one or two units are common in enzymes 
immobilised to highly charged supports. The small changes in optimum pH are 
readily accounted for i f  the immobilised enzyme, is functioning at a pH d ifferent
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from that of the surrounding medium. This difference in pH can be caused by 
the negatively charged carrier attracting protons into the support and so 
lowering the effective pH at which the enzyme is acting. This should increase 
the apparent optimum pH-. Similarly the positively charged carrier should 
increase the effective pH of the immobilised enzyme and so lower the apparent 
optimum pH (Goldstein, 1972).
Melrose (1971) has listed 50 immobilised enzymes, and their s tab ility .
About 60% were more stable than the free enzyme; 16% were less stable. Wiseman
1
and Thacker (unpublished) noted the decreased thermal s tab ility  of yeast 
alcohol dehydrogenase when chemically immobilised to a wide range of supports. 
Many enzymes are stabilised by their substrates as was noted in our work.
Yeast and rat liver cytochrome P-450 is stabilised against thermal denaturation 
by biphenyl.
Increases in thermal s tab ility  following immobilisation are usually 
considered to be due to conformational constraints introduced by the presence 
of the support. Increased thermal s tab ility  is to be expected in a more rigid  
structure, v/hether held together by internal bonding or external constraints.
The microcrystalline-cellulose and CM-cellulose immobilised yeast and live r  
cytochrome P-450 complexes, exhibited enhanced s tab ility  to thermal inactivation 
at 37°C. This enhanced s tab ility  could be explained by diffusional limitations 
which would result in apparent decrease of the rate constant for inactivation (k 
O llis (1972) theoretically described the influence of diffusion on the apparent 
thermal s tab ility  immobilised in a porous solid and showed that the immobilised 
enzyme would be more thermally stable than the soluble enzyme, even though the 
kinetic constants Km and Vmax were similar for the soluble and immobilised 
enzymes. He showed that as diffusion lim its the reaction rate of an immobilised 
enzyme, there w ill be an enhanced difference in the temperature dependence 
between the rates of reaction of a soluble and immobilised enzyme. The rate
of diminition of activity at high temperatures would be less for the immobilised 
enzyme because the effectiveness factor (the ratio of actual rate of reaction 
in pore: maximum rate possible without diffusion influences) increases even 
though there is a decrease in the active enzyme concentration.
Korus and O’Driscoll (1975) have produced a numerical solution for the 
kinetics of enzymes immobilised by entrapment in spherical gel particles of 
radius to over a wide range of [S] and of Danskohler number p.
3 = Kcat Ei roz 
DK"1
where D is the substrate d iffu s iv ity , Ei is the concentration of immobilised 
enzyme in the gel, Kcat is the rate constant for the Immobilised enzyme. They 
were able to study the denaturation process for an immobilised enzyme under 
any condition of diffusion control and substrate concentration. Apparent 
enhanced s tab ility  for gel entrapped enzymes could be achieved by increasing 
the enzyme concentration, the particle size or membrane thickness or by 
decreasing the substrate d iffus iv ity  thereby increasing p.
I t  is not known whether diffusional control is responsible for the enhanced 
thermal s tab ility  of the microcrystalline cellulose, or CM-cellulose cytochrome 
P-450 complexes. The cross-linking between the support and enzyme may be 
responsible for the enhanced thermal s ta b ility , presumably by restricting  
unfavourable conformational changes.
The drug metabolising activ ity  of yeast and live r cytochrome P-450 showed 
a lower efficiency compared to the microsomal enzyme fractions. I t  has been 
established that the low efficiency of immobilised enzymes can be due to film  
diffusional resistances by increasing their apparent Km values relative to those 
of the soluble or native enzymes (L illey  et al_, 1968), and that such resistances 
may be significant in the use of immobilised preparation in any type of reactor
(Zaborsky, 1973). Microcrystalline cellulose, and CM-cellulose immobilised 
yeast and live r cytochrome P-450 preparations exhibited enhanced thermal 
stab ility  in oxidised states, and the above preparations (cross-linked with 
glutaraldehyde) showed enhanced thermal (oxidised and reduced states) storage 
stab ility  and were able to hydroxylate biphenyl.and benzo(a)pyrene.
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CHAPTER V II
DRUG METABOLISM
Pharmacological Importance of Drug Metabolism
Modern drug therapy relies greatly on the knowledge that a given drug at 
a particular dose, w ill evoke a known effect, for a characteristic and predict­
able period. The duration of a drug action is usually limited by the rate 
at which the body removes or inactivates the therapeutic agent, and is proportional 
to the drugs biological half l i fe  (Quinn et_ al_, 1958). The eventual fate of 
most drugs in man is excretion through the kidneys and elimination from the 
body in the urine; alternative rates of elimination include the b ile , faeces, 
sweat, and exhaled breath. Since the body almost to ta lly  conserves lip id
i
soluble compounds by reabsorption during their nephritic passage, were there 
no biochemical mechanisms for making drugs morewater soluble, then pharmacological 
activ ity  would be a most prolonged a ffa ir . Thiopental, less than 1% of which 
is urinary excreted in its  administered, high lipid-soluble form, and chlor- 
promazine would, i f  not metabolised, have tissue half l i fe  exceeding one hundred 
years (Brodie and Reid, 1967; G ille tte , 1962, 1963). The rate of elimination 
of compounds from the kidneys depends not only upon their lip id -s o lu b ilit ie s , 
but also on their ionisation constants; ionization at urinary pH conferring 
greater urine solubility . Thus soon after drug dosage, the plasma contains 
mainly protein-bond parent drug and lipid-soluble metabolites, whilst the more 
acidic water soluble metabolites predominate in the urine (Park and Williams,
1969).
During the past th irty  years i t  has become evident that the vast majority 
of drugs, and other toxic organic compounds are metabolised by surprisingly 
few enzymic reactions. These may be conveniently grouped in two phases (Williams, 
1967). Phase one (pre-conjugation) includes oxidative, asynthetic reactions, 
usually introducing a hydroxyl group into the drug, but occasionally forming
amines, oxides, sulphydryls and carboxylic acids. Other reactions include a ry l, 
alkyl, and N-hydroxylation, 0 -, N- and S-dealkylation, deamination, ring cleavage 
and cyclization. Reduction and hydrolysis are also possible. Phase one
products may be equally, less or more pharmacologically active than the parent 
drug, but are usually more amenable to excretion. Detoxication predominates, 
as for barbiturates (Parke and Williams, 1969); imipramine is hydroxylated to 
equally effective agents (Uehleke, 1971); whilst phenacetin produces its  
major effects through its  metabolite, paracetamol (Williams, 1967). In phase 
two (synthetic reactions) parent drug or, more usually, its  phase one metabolites, 
are conjugated with very polar groups, including glucuronic acid and sulphate, 
or a variety of amino acids of which glycine predominates in man. Phase two 
conjugates are the most readily nephritically excretable drug metabolites. 
Metabolism thus rapidly detoxifies drugs in dual fashion: metabolites are, 
generally? less toxic and more readily eliminated from the body.
Metabolic loci
Tissue experiments have revealed that most of the enzymic systems active 
in drug metabolisnrare located in the liver endoplasmic reticulum (ER)(Cooper 
et a^, 1954; Smith, 1950; Sung and Way, 1950; Smith 1950; Sung and Way, 1950). 
Similar systems operate, nevertheless, in very many body tissues, including 
gastric mucosa (Wattenberg et al_, 1962); kidney (Uehleke and Greim, 1968); 
lung (Nebert and Gelboin, 1969); placenta (Welch et aTU 1969) and skin 
(Wiebel et aj_, 1971). Recent acknowledgement has been accorded to the important 
role in drug metabolism of intestinal bacteria whose actions include activation 
of neoprontosil and maintenance of an enterohepatic circulation for steroid 
hormones (Clark et al_, 1969; Gingell et al_, 1969; Williams, 1971). The present 
work reports the presence of drug metabolising enzymes in the microsomal fraction 
from a yeast (Saccharomyces cerevisae) .
Metabolic Influences
Many factors affect drug metabolism. Intrinsic animal variations arose 
due to species (Bond and Howe, 1967; Creaven et al_, 1965b; Gram et a l , 1968b;
Kato et al_, 1971; Parke, 1960; Williams, 1964); age (Basu et al^ 1971, Das and
Holtzman and G ille tte , 1969; Kato and Takahasen, 1968; Noordhoek and Rumke,
1969; Schenkman et al ,^ 1967b; S trip pet al_, 1971); strain (Gram et al_, 1965;
Page and Vesell, 1969; Quinn et al_, 1968); and steroid hormone leve l, which 
includes pregnancy influences, (Castro et cH_, 1970; Kato and Takahashi, 1968;
Neale and Parke, 1969).
Extrinsic influences include dietary composition (Becking, 1972; Dickerson 
et^  al_, 1971; Holtzman and G ille tte , 1969; Prang et^  aT_, 1966; Zannoni et a l , 1972); 
malnutrition (Basu et^  a^, 1971b; Gigon and Bickel, 1971; Gram et a l , 1970;
Kato, 1967); low temperature and stress (Dewhurst, 1963; Stitzel and Furner, 1967) 
disease (G ille tte , 1963; Mflting, 1963) and environmental chemicals, including 
drugs themselves, pesticides, food additives and preservatives, and pollutants 
(Conney, 1967; Creaven and Parke, 1966; Fouti, 1970; Kuntzman, 1969; Parke and 
Rahman, 1970; Shep, 1971).
For obvious practical, ethical and legal reasons, contemporary drug 
metabolism theory is based on animal experiments supplemented by some cell 
culture work, and plant, fish and insect investigations (Adamson, 1967; Cassida, 
1969; Gielen and Nebert, 1971; Henderson and DeWaide, 1969; Holtzman et a l ,
1972; Markham al_, 1972; Poland and Kappas, 1971). Some human hepatic drug 
metabolism has been studied, in biopsy and post-mortem samples (Coccin and 
Westerfeld, 1967; Darbyebal, 1970; Kuntzman et al_, 1966; Vessel, 1971). The 
present work successfully supplements the drug metabolism v/ork using yeast 
(S. cerevisae) and draws a comparison with the much studied liver enzyme system. 
Biphenyl:
Biphenyl is a widely used agricultural fungicide, and as such enters the 
human d iet. In recent years, a growing interest in the metabolism of biphenyl 
and its  chlorinated derivatives has been apparent. Much attention has centred 
upon polychlorinated biphenyls (PCBs), industrial chemicals with a variety of
applications in the manufacture of insulations and plastics. The toxicity of 
these compounds for industrial workers has been known for years, such as the 
occupational disease known as chloacne (Jones and Alden, 1936; Schwartz, 1936;
Meigs et aj_, 1954). More recently the consumption of rice bran oil accidently 
contaminated by PCB resulted in many cases of chloracne in Japanese consumers 
(Crow, 1970). The widespread distribution of PCBs throughout the ecosystem 
has been demonstrated (Hammon ert al_9 1970; Greichus et al_, 1973) with accumulation 
occurring in the food chain, and i t  has been suggested that declining population 
of several species of raptorial and fish eating birds can be'attributed to PCBs 
(Carlson and Ruby, 1973), while in rats, mice and dogs PCBs have been reported 
as toxic, and hepatic carcinogenic in mice (Nagasaki et a l,  1972).
The hepatic microsomal enzyme inducing capacity of PCBs is well-documented. 
These compounds have been shown to induce hepatic microsomal enzymes in the 
pigeon (Pisebrough et al_, 1968), rat (Street e1tal_, 1969; L itte rs t et a l , 1972;
Chen and Rubois, 1973) and American Kestrict (Lincer and Peakall, 1970).
In mammalian species biphenyl urinary metabolites include the 2-hydroxy, 
4-hydroxy,.4-4, dihydroxy, 2 ,2-dihydroxy, 3-4-dihydroxy and conjugated derivatives. 
The major in v itro  hepatic microsomal metabolite is 4-hydroxybiphenyl, but
2-hydroxylation also occurs in ra t, rabbit and hamster (Creaven et al_, 1965b;
Raig and Ammon, 1970; Burke et aJ_, 1972) whilst in rat cell culture the metabolites 
are almost to ta lly  conjugates (Wiebkin, P ., Personal Communication).
Gram negative bacteria form 2 ,3-dihydroxybiphenyls ( Lunt and Evans, 1970). 
Mammalian 4-hydroxylation of biphenyl involves an NIH sh ift with 64% 2H retention 
to 4-hydroxybiphenyl-3-2H; a4-fluorine blocks hydroxylation, resulting in 
formation of 4-fluor-4-hydroxy-biphenyl-3-2H (Daly ert al_, 1968). 4-Fluoro- or 
4-chloro^biphenyls do not undergo the phenobarbitone and carcinogen d iffe re n tia lly  
induced alterations in the degree of deuterium retention and migration character­
is tic  of other aryl hydroxylation (Daly et al_, 1969).
A variety of natural compounds and SKF 525A inhib it biphenyl-4- but not
2-hydroxylation, although i t  is doubtful whether the low rates of 2-hydroxylation 
are accurately measured (Graham et_ al_, 1969).
Species and sex differences are apparent in the NADPH dependence of liver
10,000 g supernatant, but there is never any difference between 2- and 4 -hydroxy- 
lation. A different pattern of species and sex variations arise i f  NADPH is 
replaced by NADPH, which is reduced by the 10,000 g supernatant. Damaged
mitochondria from female but not male liver inhibit both 2- and 4 -hydroxylations,
1
possibly by u tilis ing  NADPH (Bachmann and Golberg, 1970).
Piperonyl butoxide and analogues, including safrol and isosafrol activate 
biphenyl 2-hydroxylation whilst inhibit 4-hydroxylation, both directly in vitro  
and after injection (Epstein et al_, 1970; Jaffe et al_, 1969; Parke and Rahman,
1970). The degree of carcinogenic polycyclic hydrocarbon induction of alkoxy- 
biphenyl 0 -dealkylation is related to the alkyl side chain length, but no 
such pattern is discernable for phenobarbitone induction of the same ac tiv ity . 
Concordant with its  selective induction of biphenyl 4-hydroxylation, pheno­
barbitone selectively induces 4- rather than 2-0-dealkylation, but whereas 
carcinogens selectively induce the 2-hydroxylation, they preferentially inducer- 
the 4-dealkylation (Davies and Creavens, 1967).
In developing rats both biphenyl 2- and 4-hydroxylation reach maximum 
activ ity  between 21 and 24 days after b irth , thereafter the 2-hydroxylation decays 
to zero activ ity  by the 70th day whereas 4-hydroxylation fa lls  to a constant 
40% of maximum activ ity  (Basu et al_, 1971).
Materials and Methods
Male adult rats (^/^) were chosen as the species for our study because 
measurable 2 and 4 hydroxylation occurs in the adults. Use of adults obviates 
the need for s tric t age control, which must be applied in studies of immature
animals drug metabolism, due to their activ ity  increases up to puberty.
Similarly brewer's yeast Saccharomyces cerevisiae (NCYC No. 240) was used 
for the drug assay study. The yeast was harvested in the logarithmic phase 
of growth. The microsomal fraction was derived both from live r and yeast as 
described in the material and methods chapter. The solubilised and immobilised 
fractions of liver and yeast cytochrome P-450 were also used to study the drug 
metabolising a b ility  of the preparations.
Biphenyl 2- and 4-hydroxylations were assayed by the fl,uorometric method 
of Creaven et al_ (1965) described in material and methods chapter. Biphenyl 
4^hydroxylation in yeast microsomal fraction was also checked using the thin 
layer chromatography. Using both the methods we could not detect any 2-OH 
activ ity  using yeast microsomal fractions.
Results and Discussion
The following table shows the results of 4-OH activ ity  obtained both in 
live r and yeast microsomal, soluble and immobilised fractions.
The Measurement of Biphenyl Hydroxylatien
Biphenyl 4-OH activ ity  
(nmol/min/nmol P-450)
YEAST LIVER
Microsomal 3.7 ± 0.25 4.4 ± 0.31
Soluble 1.6 ± 0.3 3.8 ± 0.8
Immobilised 1,1 ± 0.2 5.4 ±1. 1
The metabolism of biphenyl has been extensively studied in animal species. 
The major metabolite being 4-hydroxybiphenyl while minor products include 2- 
hydroxybiphenyl, 3-hydroxybiphenyl, dihydroxy-, trihydroxy-, hydroxymethoxy- and 
dihydroxymethoxybiphenyls (Raig and Ammon, 1970 and 1972; Raig et a l , 1976;
Meyer and Scheline, 1976; Meyer et a iy  1976a and b and Meyer, 1977). In
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S. cerevisiae only 4-OH was detected. We find the efficiency of the yeast and 
liver enzymes are remarkably similar. Thus liver has ^28 nmoles of enzyme/g 
and yeast contains ^5 nmoles of enzyme/g wet weight.
The selective enhancement of biphenyl 2-hydroxylase activ ity  by carcinogens 
both in vivo and in vitro has been described and i t  has been suggested that this 
enhancement could provide a basis for a preliminary in vitro  screening system 
for testing potential chemical carcinogens (McPherson et al_, 1974 and 1976).
Using yeast disruptase, slightly higher values of biphenyl hydroxylations 
were obtained from the snail gut enzyme disrupted yeast. Undisrupted yeast 
appeared to carry out biphenyl hydroxylation as effectively as disrupted yeast -  
possibly i t  is the disruption procedure that may be destroying some of the P-450, 
or possibly releasing inhibitors. Alternatively biphenyl is able to penetrate 
the yeast cell wall - which is confirmed by our work on the growth of yeast in 
the presence of fungi-state, although no metabolites could be extracted.
Determination of Aniline Hydroxylation
The hepatic cytochrome P-450 catalyses the enzymatic hydroxylation of 
aniline; the predominant metabolite is the 4-hydroxy derivative P-aminophenol 
(PAP), the commonly used method for PAP estimation is that of Kato and G ille tte  
(1965) which is a modified method of Brodie and Axelrod (1948). In this procedure, 
PAP is separated from incubation mixtures by extraction with ether containing
1.5% isoamyl alcohol. The PAP is then coupled with phenol in alkaline solution 
to form an indophenol dye, which is measured spectrophotometrically. In the other 
extensively used method (Imai et al_, 1966), the proteins of the incubation mixture 
are precipitated with trichloroacetic acid (TCA), and the p-aminophenol, in the 
supernatant is measured directly by the phenol-indophenol reaction. For the liv e r  
and yeast microsomal, soluble and immobilised fractions, we have used the choloro- 
metrtc method, Guarino et al (1969) similar to the f ir s t  method, described above 
(ether extraction method).
Materials and Methods
All the materials were selected as before, i .e .  male rats and Brewer's 
yeast. The methods have been described in material and methods chapter.
Results and Discussion
The following table shows the recovery of p-aminophenol (PAP) formed with 
various fractions of both liver and yeast.
Recovery of p-aminophenol (nmol/hr/g wet weight)
LIVER YEAST
Microsomal Fraction 721 ± 29 Nil
Soluble Fraction Nil Nil
Immobilised Fraction Nil Nil
Yeast microsmmal aniline hydroxylase activ ity  was studied with 3 different 
NADPH-generating systems, and the PAP formed was estimated after ether extraction.
Composition of NADPH-generating System
0.5 mL 
25 ymoles 
25 ymoles 
5 ymoles
I I .  Glucose 6-phosphate dehydrogenase 10 units
Glucose 6-phosphate and MgCl2 25 ymoles each
and NADP 5 ymoles
I I I .  NADPH 15 ymoles
For the above assay pH ranges from 6.5 to 8 were tried but no activ ity  was 
observed for p-aminophenol formation. Only liver microsomal fraction gave the 
positive results.
Among type I I  substrates for the hepatic microsomal mixed function oxidase 
system aniline is used most frequently (Schenkman et al_, 1967). The major
I .  Soluble fraction 
Glucose 6-phosphate 
MgCl2 
and NADP
product of aniline hydroxylation in most species, p-aminophenol, is isolated 
for analysis either by extraction (Kato and G ille tte , 1965) or by precipitation 
of protein with TCA (Imai et a l , 1966). The PAP is then coupled with phenol in 
an alkaline solution to form an indophenol dye which is quantitatively determined 
spectrophotometrically. The ether extraction method is time consuming and 
inconvenient when large numbers of samples are involved. The TCA-precipitation 
method is simple and can be used for large numbers of determinations. This 
has led some workers to adopt the TCA precipitation method while using live r  
homogenates or 9,000 g supernatant fractions in studies of apiline hydroxylase 
activity'(Rubin and Lieber, 1968; Williams and Casterline, 1970). Chbabra et al 
(1972) found that ether-extraction method was superior to TCA-precipitation for 
PAP assay when hepatic soluble fraction was used as the NADPH-generating system, 
but that the procedure gave comparable results when either chemically reduced 
NADPH or a generating system u tiliz ing  yeast glucose-6-phosphate dehydrogenase 
was used. I t  has been reported that rat live r contains higher concentrations 
of TCA-soluble-SH groups than other rat tissues (Calcutt and Doxy, 1962).
The high reactivity of -SH groups with the reagents used for determination of 
amino groups, aliphatic and aromatic hydroxyl groups, imidazole and guanidine 
residues is well-known (Chinard and Hellerman, 1967) Chhabra et al_ (1972) have 
suggested that presence of chelating agents in incubation mixtures may interfere 
with aniline hydroxylase assays performed by the TCA-precipitation method. I t  
would certainly be interesting to re-investigate the aniline hydroxylase activ ity  
in yeast using the TCA method. Metal ion effects on hepatic and yeast microsomal 
aniline hydroxylase activ ity  should also be re-investigated i f  the PAP is estimated 
with the TCA-precipitation method. This is especially true i f  the metal ions 
can react with -SH groups.
The O^Dealkylation of 7-Ethoxycoumarin by liver and yeast microsomes
The hepatic monooxygenase system present in microsomal fraction requires 
sensitive and reproducible tests for the determination of enzyme ac tiv ity . Most
of the tests described are based on the extraction and separation of the 
products with subsequent quantification. The microsomal preparation being 
variable from preparation to preparation especially yeast requires several assays 
to be done to obtain a s ta tis tica lly  significant reproducibility of the assays. 
Some of the direct fluorimetric assays described meet, the requirement. U llrich  
et al_ (1972) have described a direct fluorimetric method for the O-De-ethylation 
of ethoxycoumarin to 7-hydroxycoumarin. We have used the assay to test the 
comparative a b ility  of yeast microsomal a b ility  of yeast and liver microsomal 
fractions to carry out the reaction. f
C20
NADPH+0
(Ullrich et a l, 1972)
Materials and Methods
These are described in the materials and methods chapter.
Results and Discussion
An increasing blue-green fluorescent light was observed under the UV lamp 
after starting the incubation by addition of NADPH. U llrich et al_ (1972) found 
that the fluorescent compound formed had Rp values on thin layer chromatograms 
identical to umbel1 iferon (7-hydroxycoumarin) and showed the same absorption, 
emission and infra-red spectra. The ethyl group v/as also detected as acetaldehyde 
in the incubation mixture.
The O-De-ethylation of 7-Ethoxycoumarin 
Formation of 7-hydroxycoumarin: nmol/hr/g wet weight
LIVER YEAST
Microsomal Fraction 34.13 + 3.15 25 ± 2.5
Soluble Fraction Nil Nil
Immobilised Fraction 55.83 + 5.5 25.3 ± 1 . 5
The assay is based on the 0-dealkylation of 7-ethoxycoumarin to the highly 
fluorescent umbel 1 iferon. Rat liver microsomes exhibit a very high a ffin ity  
for this substrate. Yeast microsomal fraction does carry the reaction but at 
a lower rate which may be due to higher turbidity and self-absorption of the 
fluorescence in the cuvette. No reaction was observed with the soluble fractions 
both in liver and yeast samples. There again as the soluble samples are not 
fu lly  separated from detergents these may inhibit the reaction. The immobilised 
samples on the other hand do carry out the reaction with immobilised hepatic 
microsomes the rate is surprisingly higher compared to the microsomal fraction  
i ts e lf .  This could be due to the greater reflection by the white cellulose 
particles in the cuvette however. The yeast immobilised samples give much the 
same results as the microsomal fraction. U llrich etal_ (1972) found that 
pretreatment of mice with phenobarbital increases the specific dealkylation 
activ ity  of microsomes but decreases the a ffin ity  for the substrate. Their 
inhibition experiments indicate that two cytochromes P-450 containing mono- 
oxygenases are involved in the 0-dealkylation of 7-ethoxycoumarin. I t  would be 
interesting to carry out the assay using the 3-MC treated yeast microsomal 
fraction to investigate whether that enhances the specific dealkylation ac tiv itv  
of yeast microsomal fraction.
The O-De-ethylation of Ethoxyresorufin
The mono-oxygenase enzyme system functional in hepatic microsomes and other 
animal tissues is very substrate non-specific. The choice of its  substrate 
is often decided purely by convenience of assay. The original interest in 
this enzyme complex as a detoxifying and drug metabolizing system, is because 
most commonly used substrates are drugs or environmentally encountered chemicals. 
The simplest assays for metabolism of most of these substrates involve solvent 
extraction of the metabolic products. Frequently, subsequent chemical reaction
i
is required to develop a measurable, coloured derivative of the metabolite, as 
in the assay for ethylmorphine demethylation (Cochin et al_, 1959). More sensitive 
assays measure the extracted metabolite's fluorescence. A very few direct 
assays of mono-oxygenase activ ity  have been developed. Netter et al_ (1964) 
have reported a direct spectrophotometric assay conducted in a reaction cuvette, 
for the O-demethylation of p-nitroanisole and Netter, K.J. (1966) has published 
a similar assay for N-monomethyl-p-nitro-aniline N-demethylation. U llrich and 
Weber (1972) have detailed a direct fluorimetric assay for 7-ethoxycoumarin 0- 
de-ethylation. Burke et al_ (1974) have described a direct fluorim etric assay 
for 0-de-ethylation of ethoxyresorufin. The present work was done to test the 
yeast microsomal fraction in comparison with the 3-MC induced rat liv e r microsomes.
OCoH0
NADPH
Materials and Methods
Materials and methods of the assay are described in the chapter of materials 
and methods.
Animals, Yeast and Pretreatment Techniques
Male albino (^/^) ra ts were used and allowed food and water ad libitum .
3-MC in corn oil (20 mg/kg body weight) was administered i.p . once daily for 
3 days; control animals received 0.2 ml of corn o il i .p . once daily for 3 
days. Animals received their last injection 24 hrs before death; they were 
not starved before death.
Yeast was grown in 20% glucose medium supplemented with 0.1 mM 3-MC in 
corn o i l ,  and was harvested after 72 hrs; the control yeast was grown in 20% 
glucose medium supplemented with corn oil only. The microsomal fractions were 
derived as described previously.
Results and Discussion
Fluorescence changes directly measured during the incubation of yeast 
and live r microsomes with ethoxyresorufin and NADPH in a fluorimeter cuvette 
at 30°, suggested that the 0-de-ethylation of ethoxyresorufin to resorufin 
was being observed. By adjusting the fluorimeter ligh t path the turbidity  
effect due to thicker suspensions of yeast microsomes, was conveniently 
removed. The following table shows the results obtained in this assay.
Formation of Resorufin (nmol/g/hr)
“  OVER YEAST
Control microsomal fraction 91.8 ± 7.8 6.5 ± 0.3
3-MC treated microsomal fraction 1284.6 ± 129.3 32.5 ± 1 . 3
Burke and Mayer (1974) reported that the reaction exhibited a re la tive ly  
low apparent Km which was different in the control and induced rat (150-259 nM). 
Phenobarbital, but not 3-methylcholanthrene pretreatment altered the apparent 
Km for ethoxyresorufin de-ethylation observed with rat live r microsomes. Both 
inducing agents increased the apparent Km for the reaction with hamster liv e r  
microsomes. 3-Methylcholanthrene pretreatment of the animals increased the
reactions apparent Vmax 70-fold in the rat and 8 -fold in the hamster, whereas 
phenobarbital pretreatment did not stimulate the reaction in either species.
Our work indicates enhanced activ ity  both in liver and yeast systems. Yeast 
shows slightly less activ ity  compared to liv e r , both from control and 3-MC 
treated rats, which again could be due to the thickness of the yeast microsomal 
membranes and the higher turbidity therefore of the samples in the fluorimetric  
cuvette. Alternatively, the yeast microsomal enzyme system has inherently 
low activ ity  compared to liv e r. Treatment of yeast with other inducing agents 
certainly would allow more useful comparison with liver microsomal activ ity  
for Ordeethylation of ethoxyresorufin.
The O-Demethylation of P-Nitroanisole
The direct spectrophotometric method for measuring the O-demethylation of 
P-nitroanisol to p-nitrophenol as described by Netter and Seidel (1964) was 
used to investigate this reaction.
Materials and Methods
These are as described in the chapter of Materials and Methods.
Results and Discussion
An increase in absorbance at 420 nm was observed, which indicated the 
formation of p-aminophenol both in yeast and liver microsomal fractions. The 
following table shows the comparative ac tiv ities .
Formation of p-aminophenol 
(nmol/g/hr)
LIVER YEAST
Microsomal fraction 950 ± 76 214 ± 10
Yeast microsomal fraction does catalyse the reaction for the formation 
of p-aminophenol. As this is a direct spectrophotometric assay done on a 
Perkin Elmer 353 Spectrophotometer the turbidity of the yeast samples was a 
great hindrance in the measurements. The yeast cytochrome P-450 catalyses 
the 0 -de-ethylation of ethoxyresorufin which is enhanced by treating the yeast 
with 3-MC. I t  would be interesting to investigate the effect of 3-MC treated 
microsomal fraction on the O-demethylation of p-nitroanisole ac tiv ity .
The N-Demethylation of Ethyl morphine and Aminopyrene
Determination of aminopyrene dernethylase:
The measurement of'the metabolic conversion of aminopyrene is based on the 
formation of formaldehyde or 4-arninoantipyrene. Thus the dealkylating activ ity  
may be determined by measuring the formation of either of the two. Aminopyrene 
is used as i t  is a model substrate to study N-dealkylation of drugs and the 
method described can be applied to a number of substrates which are demethylated 
by hepatic microsomal enzymes.
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The formation of formaldehyde was measured by the use of the Nash reaction 
(Nash, 1953). This is widely used, and is simple, fast and accurate. The 
formaldehyde formed is trapped as the Semicarbazone (vja the incorporation of 
Semicarbazide in the incubation mixture) and measured by the colourimetric 
method of Nash. The above method was used to measure the dernethylase activ ity  
of yeast cytochrome P-450 in comparison with liver cytochrome P-450.
Material and Methods
Liver and yeast microsomal fractions were prepared as described previously.
Incubation mixture:
Aminopyrene 5 ymoles 1.0 mL
Magnesium chloride 25 ymoles 0.5 mL
Yeast or liver  
microsomal fraction 1.5 mL
Phosphate buffer 0.4M 
pH 7.4 containing NADP 0.55 ymol
G-6-P 10 ymol
Nicotinamide 50 ymol
Semicarbazide 45 ymol
3.0 mL
The total volume of 6 mis was then incubated with shaking for 30 mins at 37°C. 
The reaction was terminated and formaldehyde measured as described in the 
materials and methods chapter.
Standard formaldehyde curve:
A 40% solution of formaldehyde was diluted to concentrations of 4, 2, 1 
and 0.5 g/rnL (in trip lic a te ) and 5 mLs of this mixed with 2 mL of Nash reagent 
and le ft  at 60°C for 30 min. When the optical density was measured at 415 nm 
with tissue blanks (Schenkman et, aj_, 1967}.'
Determination of Ethylmorphine N-demethylase
Two common preconjugation reactions are demethylation and nitroreduction.
The N-demethylation is measured by the formation of formaldehyde during 
metabolism. Ethylmorphine is an ideal substrate for kinetic studies of drug 
metabolism as i t  is metabolised only by dealkylation in v itro . The small amount 
of acetaldehyde formed by O-demethylation does not interfere with the formalde­
hyde determination by the Nash reaction, and the enzyme system responsible for 
Ordemethylation does not appear to be the same as that which catalyses N-demethyl- 
ation (Axelrod, J ., 1956; Elison, C. et £]_, 1964). Ethylmorphine is preferred 
to morphine because i t  is demethylated much more rapidly (Takemore, A.E. and 
Mannering, G.J., 1958).
The estimation of formaldehyde is carried out by heating the deproteinised 
supernatant with Nash reagent, and the resulting colour due to 3, 4, diacetyl- 
1, 4, dihydrolutidine (DDL) is measured at 412 my.
Incubation medium is as described in the materials and methods chapter. The 
reaction was carried out and stopped (as in aminopyrene dernethylase). The 
absorbance was read at 415 my, and the formaldehyde was determined from the 
standard curve (Gigon et al_, 1968; Thorgeinson and Davies, 1971; Andus and 
Mannering, 1966).
Results and Discussion
N-demethylation of Aminopyrene and Ethylmorphine
ymol/g/hr
LIVER YEAST
Aminopyrene 9.45 ± 1.3 6.14 ± 0.37
Ethylmorphine 11.74 ± 2.4 8.06 ± 0.38
Similar results of N-demethylation of aminopyrene and ethylmorphine may 
show the sim ilarities between the two enzyme systems. The somewhat lower rate 
of N-demethylation in the case of yeast microsomes may be due to the presence 
of different membrane environments and not necessarily the presence of two 
different enzyme species. Holtzman et al_ (1968) noted that mixed function 
oxidase ac tiv ity , when measured by the N-demethylation of ethylmorphine is 
significantly higher in the smooth hepatic endoplasmic reticulum than in the 
rough. In the rabbit the smooth membrane/rough membrane ac tiv ity  ratios are 
significantly greater than 1 .0  whether the activ ities  are expressed per g of 
liv e r (ratio 5 ), per mg of protein (ratio 3 -5 ), per g of phospholipid 
phosphorus (ratio  2 ), per unit of cytochrome P-450 (ratio  1.7) or per unit of 
NADPH-cytochrome c reductase activ ity  (ratio 2 ). On the other hand, i f  the 
activ ities  are normalised to the NADPH-cytochrome P-450 reductase leve l, there 
is no significant difference between the rough and smooth membranes. These 
results suggest that in the rabbit the rate lim iting step is  the reduction of 
cytochrome P-450. In contrast, in the rat the differences in activ ities  can be 
explained by differences in the concentration of cytochrome P-450.
Imipramine demethylations
This reaction was carried out as described in the materials and methods 
sections. No formaldehyde was detected either in liver or yeast microsomal 
fraction incubates. Therefore, the reaction needs to be re-investigated further 
using methods other than formaldehyde formation. '
P-Nitrobenzoate Reductase
Hepatic microsomes are knov/n to reduce p-nitrobenzoic acid to p-aminobenzoic 
acid probably through the formation of nitroso and hydroxyl amine intermediates. 
The method is essentially that of Fouts and Brodie (1957) and is described in 
the materials and methods sectionl
The above method was tried both with liver and yeast microsomal fractions, 
for the reductase activ ities . The mauve colour did not develop more than the 
background samples. Most of the drug assays needed large numbers of experiments 
to get reproducible results. More experiments on yeast microsomes in comparison 
wTth liver need to be done to re-investigate the drug assay.
The Metabolism of Benzo(a)pyrene by Saccharomyces cerevisiae
The role of hepatic enzymes in the metabolism of numerous drugs and 
carcinogens has been amply documented in experimental animals. Polycyclic 
aromatic hydrocarbons are in it ia l ly  metabolised by the microsomal mixed function 
oxidase system to epoxides, which can then either be converted ( i)  enzymatically 
by the microsomal epoxide hydrase system to the corresponding dihydrodiols or 
( i i )  to glutathione conjugates by the soluble enzyme glutathione S-epoxide 
transferase or ( i i i )  by spontaneous re-arrangement to the corresponding phenols
J
(Sims, P. and Grover, P.L., 1974). Whilst the above reactions are thought to 
be detoxication reactions the epoxides, in what is believed to be their toxic 
reactions, can also react with nucleic acids and proteins. Sims and co-workers 
have also shown that dihydrodiols may be further metabolised by the microsomal 
mixed function oxidase system to diol-epoxides which can then bind to DNA.
For example, the conversion of 7,8-dihydro-7,8-dihydroxy-benzo(a)pyrene to 
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide is possibly followed by its  
reaction with DNA (Sims, P. and Grover, P .L., 1974).
Whilst the liver is the major organ for the metabolism of anutrients, 
benzo(a)pyrene metabolism has been shown to occur in a wide number of extra- 
hepatic tissues, including kidney, skin, intestine, placenta and lung (Wattenberg, 
L.W. and Leong, J .L ., 1971). Cohen and More have shown that benzo(a)pyrene is 
metabolised by isolated perfused lungs and tracheal, bronchial and lung cultures, 
both in rat and hamster. The ethyl acetate-soluble metabolites from the medium 
are qualitatively similar in the tracheal and bronchial cultures. In the lung 
cultures large amounts of a new metabolite derived from 3-hydroxybenzo(a)pyrene 
and 3-hydroxybenzo(a)pyrene was observed in rat and hamster lung cultures (and 
isolated rat lung perfusions). Benz(a)pyrene, 7-methylbenz(aJanthracene,and 
benzo(a)pyrene are metabolised by both rat lung homogenate and microsomal 
preparations (Grover et al_, 1974) and by cultures of human bronchi and trachea
of rat and hamster (Pal, K. et al_, 1975). In both of these studies benzo(a)- 
pyrene was converted to a number of ethyl acetate-extractable metabolites 
including 3-hydroxybenzo(a)pyrene, 4,5-dihydro-4,5-dihydrobenzo(a)pyrene, 7,8- 
dihydro-7,8 -dihydroxybenzo(a)pyrene and 9 ,10-dihydro-9,10-dihydroxybenzo(a)-  
pyrene. The present work reports the metabolism of benzo(a)pyrene by Brewer’s 
yeast, S. cerevisiae, and the rat liver microsomal fractions.
Materials and Methods
These are described in the materials and methods chapter. The metabolism 
of benzo(a)pyrene by the ary hydrocarbon hydroxylase from Saccharomyces cerevisiae 
and rat liver microsomal fraction was investigated using the fluorometric assay 
for the formation of the highly fluorescent metabolite, 3-hydroxybenzo(a)pyrene 
(Kuntzman et al_, 1966).
Results and Discussion
The following table shows the values of the 3-OH benzo(a)pyrene metabolite 
formed.
Formati on of 3-hydroxybenzo(a)pyrene 
ymol/hr/g wet weight
LIVER YEAST
Microsomal fraction 21.3 ± 4.7 39.0 ± 1 . 6
The yeast microsomal cytochrome P-450 does therefore carry out the above reaction. 
The figures given in the above table indicate a better yield of 3-hydroxybenz- 
pyrene using yeast microsomes.
Wiseman and Woods (1979) found that yeast enzyme has a pH lower than that 
of the liver enzyme, these being 7.0 and 7.4 respectively, for the benzo(a)- 
pyrene hydroxylation assay. They showed that the Michael is constant (Km) for 
benzo(a)pyrene, as determined by the method of least squares, for untreated yeast 
is larger than that for the liver enzyme, being 0.52 mM as compared with various ~
estimates of 0.6 yM (Nebert and Gelboin, 1968), 23 yM (Rickert and Fouts, 1970) 
and 1 yM (Robie et al_, 1976). Grov/th of yeast in the presence of benzo(a)pyrene 
(5 yg/mL of medium) induces a form of the enzyme having a higher a ffin ity  for 
benzo(a)pyrene and the Km is decreased to 0.16 mM. Pretreatment of yeast with 
phenobarbital has no effect on the Km for benzo(a)pyrene (0.50 mM). Pretreat­
ment of yeast with 3-methylcholanthrene in this work did show the enhancement 
of de-ethylation activ ity  of 7-ethoxyresorufin. I t  would be interesting to 
investigate the effect of other carcinogens and inducers on yeast growth along 
with the identification of and effect on the production of various metabolites. 
That should make a better comparison with the liver microsomal system.
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DISCUSSION
Extracts of yeast Candida tropical is grown on tetradecane contain a 
cytochrome P-450 that can hydroxylate fa tty  acids and demethylate drugs 
(Lebeaul t  et aj_, 1971; Duppel et al_, 1973). A similar enzyme in this yeast 
was shown to be located exclusively in the microsomal fraction (Gallo et a l ,
1971). We have described conditions for cytochrome P-450 biosynthesis in 
brewer's yeast; its  hydroxylation and demethylation reactions of the whole
yeast c e ll, and derived microsomal fraction, both from yeast and liv e r. The
!
solub ility , s tab ility  and immobilization studies indicate a s im ilarity  with 
the much studied drug metabolizing cytochrome P-450 of ra t liv e r microsomal 
fraction.
Arjjkerobically grown yeast shows a good yield of cytochrome P-450 per gram 
of yeast. Arjaerobically grown S. cerevisae contains typical mitochondria with 
classical enzyme properties (E. V ito ls e ta l_ , 1961), specifically the 
capacity for electron transport, oxidative phosphorylation and the complete 
oxidation of pyruvate via the c itr ic  acid cycle. The terminal electron 
transoort cytochromes of yeast are inducible enzymes under the control of 
oxygen (Lindenmayer et a l , 1958). The anaerobically grown cells do not contain 
the a + a3 and b cytochromes but s t i l l  synthesise small amounts of cytochrome 
c and other haematin components. The number and nature of these components 
vary with the physiological age of the c e ll. Three components characterised 
by a absorption bands at 552, 558 and 57.5 my have been described by Chaix et al 
(1961). While in the stationary phase three additional bands appear at 540,
585 and 630 my. The nature and function of these haematin components are not 
known and on aeration of the cells they are replaced by the normal cytochromes 
of the aerobic c e ll, a - a3,b.and c. In agreement with a mitochondrial repression 
requirement for cytochrome P-450 appearance, we can f i r s t  detect cytochrome 
a + a3 only at 70 h in 20% glucose, at 30 h in 1% glucose; and at 17 h in 0.1%
glucose, where no cytochrome P-450 is seen. Nevertheless, we express caution 
on the simple hypothesis of conversion of cytochrome P-450 into cytochrome 
a + a3 or of role in synthesis of other components of the mitochondrial 
membrane. We consider that the low amount of intracellu lar cyclic AMP associated 
with the condition of glucose repression of yeast enzymes, including cytochrome 
a + a3 (Wiseman ed: a^, 1974a,b) is the determining factor in the appearance of 
cytochrome P-450 under these conditions.
Formation of mitochondria is induced on aeration of the anaerobically
i
grown cells, with the induction being accompanied by the synthesis of the 
cytochromes characteristic of the aerobic cell (Wallace et _al_, 1964). Many 
inducible enzyme systems are repressed by glucose and its  metabolic products.
In addition to oxygen, another parameter which exerts a controlling influence 
on the development of the respiratory activ ity  of yeast is the glucose concen­
tration available to the ce ll. Anaerobically grown yeast cells aerated in the 
presence of low concentrations of glucose rapidly develop the a b ility  to respire, 
whereas high concentrations of glucose restric t this development (Slonimake 
et aj_, 1955). Cells cultured aerobically also develop limited respiratory 
activity in the presence of high concentrations of glucose but pursue essentially 
aerobic metabolic pathways when grown on low concentrations of glucose or on 
galactose, independently of the galactose concentrations (Strttmatter et a]_, 1957) 
Linhane (1962) reported that the number and the manner of formation of the mito­
chondria from the oxygen-induced vesicles of S. cerevisae are controlled by the 
concentrations of glucose available to the c e ll. Glucose maintained at 
concentrations in excess of 5% repress the oxygen induced formation of mitochondri 
and the synthesis is partia lly  repressed in a medium of 2% glucose, and is 
virtua lly  unrepressed in a medium of 0.66% glucose. The glucose repression 
appears to function separately at different levels; on the development of the 
electron transport vesicles to dense granules, and on the stage of vesicle
development which gives rise to mitochondria. High glucose concentrations 
(59%) arrest both the synthesis of mitochondria and the development of 
the vesicles. The cytochromes of yeast aerobically grown are well characterised 
and are identical to those of animal cells. The position with regard to the 
haematin component of the anaerobic cells is much more complex, the nature 
of the haematin components being influenced by such factors as the age of the 
cells and whether glucose or galactose serves as the energy source for 
anaerobic growth (Linnane et aj_, 1962). The mitochondrial cytochrome is 
more susceptible to repression by glucose, which acts as a catabolite repressori
of the oxygen induced mitochondrial synthesis, and may be used to control the 
synthesis.
Cysteine, in high concentrations, seems to exhibit some stabilising  
effect on P-450, reduces the P-420 peak and removes the mitochondrial 
cytochromes. The P-420 peak has been postulated to arise by several mechanisms.
I t  could be a degradation product of P-450, or represent the absorption due 
to cytochrome c peroxidase or cytochrome oxidase, or due to cytochrome 
precursors such as proto-haem or the product of cytochrome b degradation.
Imai & Sato (1967) assummed a reversible conversion of a conformational form 
of P-450 in which two haem groups were able to interact with one another to 
make another conformational form, in which each haem could interact with the 
ligand separately. This form was assumed to be similar to , but d ifferent 
from P-420. I t  is however unlikely that cytochrome P-450 contains two haems 
in one molecule. Ichikawa (1969) drew similar conclusions from the conversion 
of P-450 to P-420. The P-450 to P-420 conversion has been explained (Lean et a l , 
1964) as due to a loss of protein linkages, possibly RSH groups from the *B1 
positions of a pyrrole ring, but the explanation seems unlikely. Jefcoate 
and Gay!or (1969) postulated a linkage of the proto-haem between a histidine  
imidazole and an -SH compound. This assumed that a Fe-S linkage was s p lit  on
reduction and provided an open c le ft for haem-haem interactions to occur
and for oxygen to enter. The conversion of yeast P-450 to P-420 in our heat-loss
and radiation-loss experiments would explain the la tte r cause.
The magnitude of the P-450 pigment varies depending on the order of 
addition of carbon monoxide and reducing agent. Using beef adrenal cortex 
microsomes in phosphate buffer, with CO (gassing for ten min) then adding 
the reducing agent, NADPH, Imai and Sato showed that a smaller P-420 and a 
larger P-450 peak was obtained than when the reverse order was used. They 
also recorded a spectral change at 420 nm in the CO difference spectrum which 
varied between preparations that was shown to be enhanced when sodium dithionite  
was used as reducing agent instead of NADPH. Similar results were obtained in 
our yeast preparations. Yeast microsomal fraction, reduced with sodium dithionite, 
gave 20% more 450 nm . absorptions, than when reduced with NADPH, which may be 
due to the enhanced effect of sodium dithionite, on the microsomal membranes 
of yeast. The dithionite, however, had no effect when cytochrome P-450 was 
measured in whole yeast cells , because P-450 was in a reduced state in whole 
cells. Our result with yeast also showed a larger P-450 peak by adding the 
CO f ir s t .  This effect, however, v,as less than that recorded by Imai and Sato(1967) 
possibly due to the fact that CO was always bubbled through for a shorter 
(30 sec) time.
Cytochrome P-450 is considered to exist in more than one form. These are 
the high and low-spin states. The low-spin state having a soret peak in the 
oxidised form at 416 nm. The same spectral characteristic is observed in buffers 
of low ionic strength and in the presence of detergent. When the ionic strength 
is increased and the detergent is omitted the spectrum is partia lly  converted 
to the high spin form, as shown by the appearance of a 395 nm peak in the soret 
region. This conversion was found to be reversible. Thus, the addition of 
Triton 100 to the high spin form of cytochrome P-450 leads to its  reversion to
the spectrally low spin form, i .e .  the oxidised, form of yeast cytochrome P-450 
can exist in both high and low spin states and the equilibrium between the 
two states depends on the environmental conditions. Thus, Triton X100 causes 
the transition of the high to low spin states whereas increasing the ionic 
strength shows the reverse effect. Addition of alcohols to the high spin 
state of cytochrome P-450 cause: the conversion to the low spin state. This 
may account for the binding spectra which were obtained (type I)  on addition
of biphenyl in 1.15% KC1 and 4% Tween 80, and type I I  spectra on addition of
biphenyl in alcohol to undisrupted yeast samples. f
Aniline causes a spectral change in the oxidised form of mammalian 
cytochrome P-450 (Mannering et al_, 1966) and in yeast, the aniline induced 
spectrum is different depending on the spin state of the cytochrome employed.
In agreement with the multiple form nature of the enzyme we noted the 
biphasic nature of the loss of cytochromes P-450 on thermal or radiation s tab ility  
study using' preparations made by snail gut enzyme disruption of the yeast. 
About 40% of the total is more labile  to radiation (37% survival, i .e . D37 
is 195 KR) the rest having a of 2.4 MR. Biphasic inactivation is  seen 
too in heat s tab ility  studies. We noted also the presence in microsomal 
fraction of a thermolabile (at 46°C) component in the dithionite-reduced liv e r  
cytochrome P-450 and in the oxidised form of yeast cytochrome P-450. The
oxidised form of the liver enzyme is almost completely stable at 46°C for
20 min, the reduced form of the yeast enzyme is rapidly destroyed by heating 
at 46°C. Studies at 37°C agree with these conclusions. This raises the 
suggestion that oxidised-reduced form conformational changes occur, perhaps 
controlled by substrate or oxygen binding which may be important for the noted 
rate lim iting step, in the mechanism for oxidation of substrates, in conversion 
of oxidised into reduced form (Gunsalus et cil_, 1973). I t  seems lik e ly  that 
yeast cytochrome P-450 exists in several spectrally distinguishable states, 
like those reported for hepatic cytochrome P-450 (Jefcoate et al_, 1969)
The conformation states exist in equilibrium mixtures and the formation and 
destruction of intramolecular hydrophobic interactions controls this 
equilibrium.
Yeast and live r cytochrome P-450 were solubilised from microsomal fraction  
in low yield with sodium cholate in the presence of various stabilisers. The 
solubilised form, however, is thermally unstable at 30°C. The in s ta b ility  
of the soluble forms defeated attempts to establish biphenyl hydroxylation 
activ ity  but i t  was found that a normal type 2 binding spectrum was obtained
t
with aniline although slightly displaced from normal wavelengths.
The d ifficu lty  encountered in attempts to solubilise yeast cytochrome P-450 
in addition to the instab ility  of the solubilised forms are in agreement with 
the extreme importance of membrane environment to the structure and function 
of the cytochrome. The general level of recovery of P-450 from microsomes 
into a solubilised form was around 40%. However, this solubilisation had 
to be carried out on fresh microsomal fraction. Obviously besides the loss 
of P-450 from microsomes on storage, as seen in our work about 25%, the 
solubilisation its e lf  was reduced, for some reason in the case of stored 
microsomes. I t  was also observed that solubilised samples, stored overnight 
at 4°C tend to lose much of the P-450 content, unless the preparation is  
very carefully made and kept cold constantly.
Protection of P-450 by glycerol v/as observed with microsomal fraction in 
agreement with previous stabilization studies (Burke et _al_, T972 ) and use of 
mercaptoethanol also stabilised the P-450 to detergent treatment giving higher 
total yield of the cytochrome after the tergitol treatment, as well as increased 
levels in the soluble fraction. Yu & Gunsalus (1974) have observed that mercapto 
ethanol and dithiothreitol are not suitable for protecting purified P-450 cam, 
however, as they react with i t  to a limited extent. In the
solubilization treatment in the presence of EDTA and mercaptoethanol the EDTA
causes a sh ift in the absorbance peak from 450 to 445 nm, but the appearance 
of a similar spectrum in the supernatant fraction indicates either solubilization  
of the P-450 in this form or solubilization and subsequent reaction with EDTA.
The yields of P-450 and P-420 when solubilised in the presence of the 
stabilising agents dithiothrectol or mercaptoethanol, were increased. 
Mercaptoethanol appears to give less improvement in yield and a slight 
shift in the spectrum, possibly due to interaction with the solubilised 
P-450 as in P-450cam (Yu et aj[, 1970). The fact that concentrations of 
0.2% and above of Tergitol caused destruction of the cytochrome whereas lower 
concentrations fa c ilita te  solubilization, suggest that at the higher concen­
trations the P-450 was in fact being solubilised then rapidly destroyed, the 
soluble form apparently being very unstable and declining below measurable 
levels within 1 hr of solubilization. Stabilisers prevent the rapid disappearance 
to only a small extent, appearing to stabilise the cytochrome to the in it ia l  
detergent treatment but not to subsequent existence in soluble form. The 
binding spectrum of solubilised cytochrome P-450 with aniline gives a typical 
type 2 trace but this binding spectrum is displaced by about 5 nm from the 
values quoted for liver cytochrome P-450, having a minimum a t '385 nm and a max­
imum at 425 nm. This is interesting in relation to the type of binding 
spectrum obtained with the nuclear containing membrane bound P-450 where the 
minimum occurs at 370 nm and the maximum at 424 nm. This may suggest that i t  
is the hydrophobic environment of P-450 which is important in the type of 
binding observed spectrally, and that the solubilised P-450 from yeast 
corresponds more closely in its  binding pattern to liver microsomal P-450.
The purification procedure used was in part that described by Yoshida and 
Kumkae (1975). Thus the solubilised material applied to the column was in a 
crude state. Consequently any purification was only minimal. Since this  
investigation was only in a preliminary form, the idea was to see the effect
of gel f iltra t io n  and ion exchange on the stabilization of P-450. The 
solibilised P-450 fraction was applied to the column of Sephadex G-25 and 
eluted with the equilibration buffer described in the "Methods" section. The 
eluted protein was then applied to the DEAE Sephadex column. The very low 
recovery of P-450 from the f ir s t  purification may suggest that the P-450 
had been degraded while on the column. Since the immediate eluate from the 
DEAE Sephadex after loading contained a small amount of P-450 i t  is possible 
that the P-450 in the sample passed straight through the column leaving other 
materials adsorbed, and then was degraded in the collected solution.
On the second attempt at purification of P-450 nearly 90% of the P-450 
loaded onto the column was recovered. Assay showed that P-420 originally  
present in the sample seemed to have been removed from the solubilised 
P-450 preparation by the purification procedure. However, cytochrome b,- was 
present in just the same amount in the purified sample. The solubilised 
preparation after both steps of purification showed fa ir ly  good s tab ility  
on overnight storage at 4°C. while the purified material was very stable, 
maintaining fu ll activ ity  overnight. The purification step had clearly  
induced greater s tab ility  in this sample probably by removing salts and 
detergents. The lack of P-420 and its  decreasing levels may suggest the 
possibility of reconversion to P-450 so that P-450 remained fa ir ly  constant in 
the purified sample.
Stabi1isation and Immobilisation of Enzymes
For practical purposes the concept of s tab ility  of an enzyme refers to the 
endurance of catalytic activ ity  despite storage, use (Wiseman, 1975) and the 
presence of a variety of possible destructive agents including solvents and 
heat. In recent years highly sophisticated studies of enzyme conformational 
changes, by a variety of physical techniques, have revealed the great complexity 
of response of enzymes to small molecules. These include the so-called a llosteric  
changes in enzyme conformation, including dissociation of sub-units, caused
t
by binding of ligands (the effectors, activators or inhibitors) that act at 
sites distinct from the active site of the enzyme.
I t  is often overlooked that enzymes in solution, and no doubt even in 
membrane bound form in suspension, are in a state of conformational flux due 
to the effect of temperature. All enzymes display a time-dependent fluxation  
in catalytic site conformation where a few molecules reach high energy states 
and lose the correct conformation by crossing the activation energy barrier to 
denaturation especially at higher temperature or above a particular te perature 
(Silverstein, Crisolia, 1972). Increases in thermal s tab ility  by cross-linking 
apart from that associated with immobilisation may be due to increased r ig id ity  
of conformational features of the enzyme or in some cases the prevention of 
sub-unit dissociation. Increases in thermal s tab ility  without cross-linking is 
more d iff ic u lt  to explain, and must be viewed in relation to the functional 
groups attached.
Other reports of stabilization, often thermal, include very many studies 
on the use of glutaraldehyde, usually in the presence of a solid support 
(Zaborsky, 1973). One particular case of interest here is the preparation of 
water soluble papain derivatives which had been extensively modified with 
glutaraldehyde at pH 6.0 by reaction of 80% of its  available amino groups. We 
have successfully achieved the stabilization of yeast and rat live r cytochrome
P-450 using glutaraldehyde. Wiseman and Woodwards, 1977, have reported the 
stabilisation of yeast invertase by a variety of bifunctional reagents. These 
attempts at stabilisation remain largely empirical however.
Drug metabolism
Cytochrome P-450 is thought to exist in more than one form (G ille tte , 
1969), these being the high and low-spin states. The low spin state having 
a Soret peak in the oxidised form at 4.6 nm. The same spectral characteristic 
is observed in buffers of low ionic strength and in the presence of detergent. 
When the ionic strength is increased and the detergent omitted the spectrum 
was partia lly  converted to the high-spin state, as evidenced by the appearance 
of a 395 nm peak in the Soret region. This conversion was found to be 
reversible, the addition of 0.4% Triton X-100 to the high spin form of 
cytochrome P-450 leading to its conversion to the spectrally low spin form.
The oxidised form of yeast cytochrome P-450 can exist therefore in both high 
and low spin states and the equilibrium between the two states depends on the 
environmental conditions. Thus Triton X-100 causes the transition o f the high 
to low spin states whereas increasing the ionic strength (e .g . adding KC1) 
shows the reverse effect. Addition of alcohols to the high spin state of 
cytochrome P-450 causes its  conversion into the low spin state . This probably 
accounts for the binding spectra which were obtained on addition of biphenyl 
in 1.5% KC1 (containing 4% Tween), and by adding biphenyl in alcohol to 
undisrupted yeast samples. Aniline causes a spectral change in the oxidised 
form of mammalian cytochrome P-450 (Schenkman, J.B., 1967) and in yeast the 
aniline induced spectrum changes with the spin state of the cytochrome.
Like liv e r , yeast (S. cerevisiae) appears to carry out biphenyl 
4-hydroxylation- ethylmorphine and aminopyrene N-demethylation; p-nitroanisol 
0-demethylation; 0-deethylation of coumarin; 0 -deethylation of ethoxyresorufi 
and 3-hydroxylation of benzo(a)pyrene. In the liv e r system there is a 
distribution of components of the mixed function oxidase between rough and
and smooth endoplasmic reticulum (Holtzman et a l, 1968), with more activity  
in the smooth than rough. For example, smooth endoplasmic reticulum shows 
an aniline hydroxylase activity of 72.8 + 7.2 nmol of p-aminophenol formed/
20 min/gram liv e r , whereas rough endoplasmic reticulum shows an activity of 
15.1 + 0.8. Similarly for ethylmorphine demethylase, 244.7 + 27.8 nmOl of 
formaldehyde are formed/2 0  min/gram of liv e r for smooth endoplasmic reticulum 
compared to 17.1 _+ 0.9 for the rough. Per gram of liv e r the smooth endoplasmic 
reticulum also contains greater amounts of protein, cytochrome P-450 phospholipi 
(Holtzman, et  al_, 1968). ,
Davies et al_ (1969) found that species variation in ethylmorphine 
demethylase was closely paralleled by differences in the cytochrome P-450 
content and NADPH cytochrome c reductase ac tiv ity , or the magnitude of the 
type I spectral change. These findings suggest that the rate lim iting step 
of ethylmorphine demethylase might be the rate of reduction o f cytochrome P-450. 
Remmer et al (1966) also found a relationship between P-450 content and 
metabolic activ ity  with aniline hydroxylase. Comparison, however, of the rate 
of hvdroxylation with the content of P-450 present in the liv e r  microsomes 
indicated a lack of correlation between the two c rite ria , when hexobarbitaT 
and other type 1 substrates were examined. These authors also showed that 
increasing the concentration of aniline decreased the rate of cytochrome P-450 
reduction, for example 0.3 mM aniline gave 8.74 nmol of P-450 reduced per min 
per mg of protein compared to 3.99 nmol/min/mg protein when 2.0 mM aniline was 
used. Possibly too high a concentration of aniline in the incubate was a 
possible explanation for the absence of aniline hydroxylase activity detectable 
in yeast.
In liv e r, the relative rates of metabolism of various drugs, as shown 
by Lu ^ t £l_ (1970 )are as follows (taking benzphetamine as 100%) -
Benzphetamine 100%
Ethylmorphine 72%
Hexobarbital 42%
‘ Aminopyrene 32%
Anili ne 0%
whereas for yeast (Candida tropical is grown on tetradecane) Lebeault et al
(1971) obtained the following specific activ ities for demethylation determined 
by formaldehyde formation.
Aminopyrene 0.9 nmol/min/mg'protein 
Benzphetamine 0.5 " " "
Hexobarbital 0.5 " " "
Ethylmorphine 0.2 " " "
The results for S^ . cerevisiae appear to correlate better with rat liv e r than 
the £ . tropical is or enzymes isolated from other bacteria. Our yeast 
(S. cerevisiae No. 240 ncyc) grown in 20% glucose medium often has an equal 
ab ility  to ra t live r to metabolise these drugs, on a gram wet weight basis. The 
efficiency (specific activity expressed per nmol/cytochrome P-450) of the yeast 
enzyme may be higher than the liv e r enzyme in some cases. The la tte r  is a 
complex mixture of many isoenzymes, including cytochrome P-448 induced by 
carcinogens. Our yeast system is active on /-ethoxyresorufin (0 -deethylation) 
especially i f  grown on 3-methylcholanthrene-containing medium. Action on this 
substrate indicates the presence of the cytochrome P-448 form of the enzyme.
I t  seems like ly  that yeast cytochrome P-450 exists in two spectrally distinguished 
states like those repprted for mammalian cytochrome P-450. The two states 
being in equilibrium, and the formation and destruction of intramolecular 
hydrophobic interactions seem to affect the equilibrium.
Woods and Wiseman (1979) have reported that the incubation of the yeast
3
(S .cerevisae) enzyme with (G . H) benzo(a)pyrene and separation of the 
metabolites by high-pressure liquid chromatography has shown that besides
3-hydroxybenxo(a)pyrene, 9-hydroxy- and especially the 7,8-dihydrodiol 
benzo (a) pyrene are formed. Schenkman et^  a]_ (1969) and Powis et al 
(1976 have shown that the cytochrome P-450 induced by benzo(a)pyrene 
or 3-methylcholanthrene (usually called P-448) is able to form a type I 
spectral complex with benzo(a)pyrene. The yeast enzyme is able to produce 
type I spectral changes with benzo(a)pyrene without any pretreatment 
although the spectrum produced varies somewhat from the normal type I 
spectrum in having an additional peak at 360 nm. Experiments with 
untreated rat liv e r microsomal fraction (cytochrome P-45p/P-448) produced 
the same spectrum, including the extra peak at 360 nm.
Ethoxyresorufin has been synthesized (Burke et a l , 1974) to serve as 
a model substrate for the direct fluorimetric assay of the hepatic microsomal 
0-dealkylation reaction. Liver microsomes from rat and hamster, O-deethylate 
ethoxyresorufin to resorufin, in an NADPH and oxygen dependent reaction 
involving the flavoportein, NADPH-cytochrome c reductase and cytochrome 
P-450, The reaction exhibited a relative low apparent Km which was 
different in the control and induced rat (150-259 nm), and hamster (40-163 nm) 
phencbarbital, but not 3-MC, pretreatmert altered the apparent Km for 
ethoxyresorufin deethylation observed with rat live r microsomes, whereas 
both inducing agents increased the apparent Km for the reaction with 
hamster liv e r microsomes. 3-MC pretreatment of the animals increased the 
reaction apparent Vmax 70-fold in the rat and 8 -fold in the hamster, whereas 
phenobarbital pretreatment did not stimulate the reaction in either species.
The formation of benzo(a)pyrene metabolites by microsomal enzymes 
from yeast or live r is dependent on the presence of NADPH and molecular 
oxygen (Conney et al_, 1957; Nebert and Gelboin, 1968). We have been able 
to make the process more amenable to large scale application by replacing 
the expensive NADPH-regenerating systems normally used in the assay by
cumene hydroperoxide, an organic hydroperoxide which has been previously 
used in steroid hydroxylation (Hoycay et al_, 1975) and drug metabolism 
studies in mammalian systems.
Solubilization of the cytochrome P-450/P-448 with sodium cholate 
resulted in a preparation that could metabolise biphenyl to 4 -hydroxy- 
biphenyl and could hydroxylate benzo(a)pyrene. The immobilised preparation 
could also metabolise the two substrates. I t  is concluded that the patterns 
of biphenyl hydroxylation and ethoxyresorufin deethylation, observed with 
both yeast and live r microsomal fraction from untreated o'r treated (3MC) 
yeast or ra t, are due largely to the inherent enzymic specificities of 
their cytochromes P-450 and P-448.
Continuation of the work: some suggestions
Extraction of yeast cytochrome P-450 at various levels of yeast 
growth (specially at the start of the log phase) and testing its  drug 
metabolism activ ities may give a better insight into the cytochrome 
specificities and a better comparison with hepatic microsomal function.
The isolation of the monooxygenase system from yeast solubilization  
of the various components (cytochrome P-450, cytochrome and c-reductase) 
followed by immobilization and stabilization by the methods described in 
this thesis may make a more effic ient enzyme system to make a P-450 reactor 
for the production of various drug metabolites especially carcinogens. The 
above method could also be applied to hepatic systems and a better 
comparison could be made.
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